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Summary. 
The lipid fraction of human semen has been separated by 
LH 20 Sephadex chromatography and TLC and the resulting 
fractions analysed by GCMS. Evidence is presented for the 
existence in semen of several prostaglandins, including 
19 -0H PG F1x, 19 -0H PG F200 8 -iso 19 -0H PG El, 8 -iso 19 -0H 
PG E2, 8 -iso PG F10, 8 -iso PG F20 , 8 -iso PG E1 and 8 -iso 
PG E2. None of these compounds have previously been described 
in semen, and the first five have not been described from 
any source. Evidence is also presented for the existence 
of a group of prostaglandins isomeric with the dinor prosta- 
glandins El, E2, F1oCand F2a. 
A method for the preparation of crystalline 19-0H PG 
E1 from macaque semen is described. Evidence is presented 
for the existence of a pair of dihydroxy E prostaglandins, 
tentatively identified as 18,19 dihydroxy PG E1 and an iso- 
meric compound in the semen of the stump- tailed macaque. 
The effects of 19 -0H PG E1 on non -pregnant and pregnant 
human isolated myometrial strips have been studied. 19 -0H 
PG E1, like PG E1, was found to relax nbn- pregnant strips, 
the equipotent molar ratio being E1:19 -0H E1 = 1:4. 
19 -0H PG E1 was also found to relax pregnant strips, unlike 
PG E1, and a significant effect was demonstrated at 50 ng /ml. 
Examination of homogenates of the seminal vesicle of 
the stump tailed macaque by GCMS showed them to contain 
large amounts of 19-0H E prostaglandins, and these levels 
increased on incubation, an effect which was inhibited by 
(1) 
indomethacin. Incubation of homogenates with radioactively- 
labelled eicosa -8,11,14 -trienoic acid, arachidonic acid, 
PG E1, PG E2, PG 
F20Cor 
PG F3 produced no significant 
incorporation of radioactivity into the 19- hydroxy prosta- 
glandin fractions. It is concluded that the biosynthesis 
of 19 -0H PGs takes place via a separate pathway from that 
leading to the classical prostaglandins. 
Some observations on dynamic aspects of seminal prosta- 
glandin production in man are presented, along with the 
results of a study on the species distribution of the 19- 
hydroxy E prostaglandins. 
(2) 
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Introduction. 
The prostaglandine are a group of biologically active, 
hydroxylated fatty acids, originally detected in human semen 
and subsequently shown to be functionally involved in the 
operation of most mammalian organs. It is now nearly fifty 
years since the first observations of the spasmogenic effects 
of human semen were made, and twenty years since the first 
prostaglandins extracted from biological sources were crystal- 
lised, and in that time the ubiquitous occurrence and wide 
ranging biological activity of the compounds have led to 
an exponential growth of publications by workers in the 
field. Despite this, the role of the seminal prostaglandins 
in reproduction remains speculative, and this thesis describes 
a series of studies designed to contribute to an understanding 
of their function. 
Throughout this thesis the individual prostaglandine 
are referred to by their trivial names, using the semi - 
systematic nomenclature which has evolved among workers in 
the field and which was described and codified by Nelson 
(1974). The systematic names and structural formulae of 
all the prostaglandins discussed are listed in table 1.1 




In the early years of this century, several workers 
demonstrated autopharmacological effects using extracts of 
the male reproductive tract. Japelli and Scafa (1906) found 
that saline extracts of dog prostate, when injected into 
rabbits produced a depression of the blood pressure and 
retarded clotting of blood samples taken shortly thereafter. 
When administered to dogs the same extracts produced a 
rise in blood pressure, dyspnoea, cardiac arhythmia and 
arrest. Similar work by Legeu and Gaillardat (1912) using 
extracts of dog, horse and hypertrophied human prostate 
showed that the human prostate yielded a much more active 
and toxic extract than those of the other animals. That 
this effect was not due to the pathological state of the 
glands was shown by Battez and Boulet (1913) who made an 
extract from the prostate of an executed criminal immediately 
after death, and showed that it produced depression of the 
blood pressure and contraction of the bladder when injected 
into decerebrate or curarised dogs. Von Euler (1937) later 
ascribed some of these effects to adrenaline, which he had 
demonstrated to be present in the prostate (Von Euler, 
1934a), but some may well be due to prostaglandins. 
The first observation of an effect which may definitely 
be attributed to prostaglandins was made by Kurzrok and 
Lieb (1930), who noted that semen placed in the lumen of 
(8) 
the uterus during artificial insemination could sometimes 
produce strong uterine contractions. Later, Cockrill et al 
(1935)demonstrated effects of human semen on isolated human 
myometrial strips. The majority of semen samples were shown 
to produce relaxation of the strips, but in some cases 
contraction resulted. 
Meanwhile, Goldblatt (1933, 1935) and Von Euler (1934b) 
had independantly demonstrated that semen and extracts 
of male accessory sex glands contained a substance which 
reduced blood pressure and stimulated contraction of smooth 
muscles. Von Euler initially suggested that the active 
principle was basic, but by the following year (Von Euler, 
1935a) had identified the substance as a lipid soluble acid 
and named it 'prostaglandin'. At the same time he demonstrated 
the presence of a similar substance which he named ' vesiglandin' 
in the vesicular gland of the rhesus monkey (Von Euler, 
1935b). Vesiglandin was shown, like prostaglandin, to 
have a powerful depressor action but to have little or no 
effect on isolated smooth muscle preparations, and was also 
shown to be inactivated more rapidly by extremes of pH 
(Von Euler, 1937). 
In the sheep, the seminal vesicle was the only source 
from which prostaglandin could be demonstrated when extracts 
of a number of different organs were assayed for their 
effect on blood pressure in rabbits and on the isolated 
rabbit jejunum. It was concluded therefore that prostaglandin 
must be specifically involved in reproduction since it was 
(9) 
not found other than in the male reproductive tract (Von 
Euler and Hammarström 1937). Von Euler (1938) and later 
Bergström (1949) concluded that prostaglandin was a hydroxy- 
lated, unsaturated fatty acid on the basis of the chemical 
and physical properties of preparations purified by pre- 
cipitation of the barium salt. 
Structure identification. 
In the late 1950s Bergstrom separated prostaglandin 
into two fractions on the basis of their polarity, and named 
these PG E and PG F, since one could be extracted into ether 
while the other remained behind in the phosphate buffer (fösfat 
in Swedish) (Hamberg, 1973). Prostaglandins E and F were obtained 
in crystalline form by purification of extracts of sheep prostate 
(Bergström and Sjövall, 1960a, b), and were also shown to be 
present in ram semen (Bergström et al, 1960), and later in human 
semen (Bergström and Samuelsson, 1962; Samuelsson, 1963b, o). 
Two further prostaglandine were then isolated from 
the sheep prostate, differing from PG E only in degree of 
unsaturation. These compounds were named PG E2 and PG E3, 
and the former PG E was renamed PG E1, the subscript numerals 
referring to the number of unsaturated groups which the 
compounds possessed (Bergström et al, 1962a). 
The empirical formulae for PG El and PG F1, C20H3405 
and C20H360 respectively were obtained, and it was demontrated 
that the former could be converted to the latter by boro- 
hydride reduction, yielding a pair of compounds now known 
as PG F1 and PG F (Bergström et al, 1962b, c). The 
naturally occurring PG F compounds belong to the Fa series. 
The structures of the natural prostaglandine were further 
elucidated by chemical degradation (Bergström et al, 1963a, b; 
Samuelsson 1963a). The absolute configuration of the C11 hydroxyl 
was not correctly established until 1966 when Nugteren et al 
(1966a) demonstrated that prostaglandin synthetase enzymes 
will also convert eicosa -11,14 -dienoic acid to 11S- hydroxy 
12 -trans 14 -cis eicosadienoic acid, and determined the 
configuration of the 11 hydroxyl of this compound by comparison 
of its optical rotation with that of similar monohydroxylated 
fatty acids of known configuration. These authors proposed 
the (now conventional) representation of the prostaglandin 
molecule with the ring to the left and the use of the Cahn - 
Ingold -Prelog convention for the notation of the asymmetrical 
centres in the side chains. 
In 1962 the first prostaglandin was identified from a 
source other than the reproductive system when Bergström 
et al (1962d) purified and crystallised PG E2 from 880 lb 
of swine lung, and two years later PG F3 , a prostaglandin 
which has not been detected in semen, was identified in 
bovine lung (Samuelsson, 1964). The prostaglandins have 
since been shown to be almost ubiquitous in mammalian tissues 
(Karim et al, 1967, 1968a), although levels are generally 
two to three orders of magnitude lower than in human or 
sheep semen, and sophisticated techniques are required for 
their detection and measurement. 
The E prostaglandine may be readily dehydrated by exposure 
to extremes of pH, yielding under acid conditions a compound 
originally known as PG E217 and now called PG A, and under 
basic conditions PG E278 (modern name PG B). The subscripts 
217 and 278 refer to the ultraviolet absorption maxima 
shown by these compounds. A systematic search for compounds 
having an absorption maximum at 278 nm before or after 
base treatment produced evidence for eight further prosta- 
glandins in human semen (Ramberg and Samueleson, 1965, 
1966a,b). Extracts of human semen were chromatographed 
on silicic acid columns along with tritiated PG F3 and 
aliquots of the fractions obtained were treated with base 
and their absorption at 278 nm measured. The resulting 
chromatogram ( Hamberg and Samuelsson, 1966a,b) shows four 
peaks, and further analysis by mass spectrometry, NAM, IR 
and chemical degradation showed that these contained in 
order of increasing polarity : I - PGs A1, A2, B1 and B2; 
II - PGs E1, E2 and E3; III - PGs 19- hydroxy Al, 19- hydroxy 
A2, 19- hydroxy B1 and 19- hydroxy B2. The fourth peak, 
containing compounds more polar than the 19- hydroxy PGs 
A and B was not identified. 
In order to guard against the possibility that the 
dehydrated prostaglandins had been formed during storage 
or extraction the experiment was repeated using semen to 
which tritiated PG E1 had been added. It was shown that 
only 14% of the radioactivity was incorporated into the 
dehydrated prostaglandine while the unlabelled material 
in peak I amounted to 90 of that in peak II. The authors 
concluded that the dehydrated prostaglandine were of biological 
origin, and asserted that the 19- hydroxy compounds could 
not have arisen by dehydration of 19- hydroxy PG Es since 
these were absent from semen, although they presented no 
evidence to support this. Initially, the level of the 
19- hydroxy compounds was given as about four times that 
of the E prostaglandine, but later work did not support 
this, and Bygdeman et al (1970) give a figure roughly equal 
to that of the E prostaglandine. 
The steric configuration of the 19- hydroxyl group 
was later established by Ramberg (1968) who acetylated 
19- hydroxy PG B1 with tritiated acetic anhydride and degraded 
the product oxidatively to yield 3- acetoxy butanoic acid. 
This was then mixed with unlabelled dl 3- acetoxy butanoic 
acid and the morphine salt of the mixture resolved. The 
tritium label was found to be incorporated into the D en- 
antiomer, indicating that the original compound had the 
19R configuration. 
Further indirect support for the conclusion that 19- 
hydroxy A and B prostaglandine did not arise by dehydration 
of the analagous 19- hydroxy E compounds was provided by 
Israelsson et al (1969) who reported that guineapig liver 
microsomes could hydroxylate PG Al at the 19 and 20 positions 
but not PG El or 13,14 dihydro 15 -keto PG El. A very recent 
paper by Kupfer et al (1978) has reported that under slightly 
different conditions the guineapig liver microsome preparation 
(13) 
can hydroxylate the E prostaglandins, yielding mainly the 
19- hydroxy isomer. These authors analysed the products 
of the reaction by base treatment followed by high pressure 
liquid chromatography of the resulting 19- hydroxy PG B 
compounds and therefore did not establish whether the added 
PG E had dehydrated prior to hydroxylation. It is doubtful 
whether this work has much relevance to the biochemistry 
of semen, since liver microsomes can hydroxylate a wide 
range of compounds in connection with the process of de- 
toxification. Guinea pig semen has not been shown to contain 
19- hydroxy prostaglandins and there is no evidence to suggest 
that 19- hydroxy prostaglandins synthesised in the liver 
are transported to the seminal vesicles. 
Two new prostaglandins were identified in 1968 as a 
result of work with the prostaglandin synthetase of seminal 
vesicles. Incubation of seminal vesicle preparations with 
eicosa -8,11,14 -trienoic acid gave rise, in addition to 
PG E1 and PG F1cc , to 8 -iso PG E1 (Daniels et al, 1968) 
and PG D1 (Granstrom et al, 1968). During the course of 
the work described in this thesis semen was investigated 
for these and similar compounds and the results are described 
in chapter 1. 
In 1974 we reported the presence of high levels of 
19- hydroxy E prostaglandins in human semen (Taylor and 
Kelly, 1974). The compounds were detected and tentatively 
identified by GCMS, using an aqueous oximation technique for 
the first stage of derivatisation which stabilises the 
(14) 
/e-ketol system in the ring of the E prostaglandins and 
eliminates the possibility of subsequent dehydration. 
The structure of the compounds was confirmed by chemical 
degradation and identification of the products by comparison 
of their chromatographic and mass spectral properties with 
those of authentic compounds. These results were independantly 
confirmed by Jonsson et al (1975, 1976) who also demonstrated 
that levels of 19- hydroxy A and A prostaglandins increase 
in semen samples during incubation, approximately two thirds 
of the 19- hydroxy PG Es and half of the PG Es being dehydrated 
after three hours at 37oC. 
It would seem probable therefore, that despite the 
precautions taken by Hamberg and Samuelsson, the high levels 
of 19- hydroxy A and 19- hydroxy B compounds which they reported 
were the result of dehydration of 19- hydroxy E prostaglandins. 
The levels of the 19- hydroxy E prostaglandins which have 
been reported both in the three papers cited above and in 
more recent work (Templeton et al, 1978) compare well with 
levels of 19- hydroxy A and B prostaglandins originally reported 
by Hamberg and Samuelsson. The Swedish workers used ether 
extraction at an early stage of their preparation, and the 
very polar 19- hydroxy E prostaglandins extract only poorly 
into this solvent. Any dehydrated 19- hydroxy prostaglandins 
present at this stage would therefore have been concentrated 
relative to their parent compounds. The subsequent use 
of silicic acid chromatography introduces an additional 
risk, as Jouvenaz et al (1970) have pointed out that prolonged 
(15) 
exposure to silicic acid can dehydrate E prostaglandins, 
and the 19- hydroxy E prostaglandins appear to be rather 
less stable than the PG Es. 
In 1975 we demonstrated the presence of four new compounds 
in human semen, two of which were identified as 19- hydroxy 
prostaglandin F1lend 19- 
hydroxy prostaglandin F2ot(Taylor 
and Kelly, 1975). The remaining compounds were tentatively 
identified as the 8- epimers of the 19- hydroxy PG Fs. (Evidence 
for the structure of these compounds forms part of this 
submission and is described in chapter 1.) 
Several other prostaglandins and related compounds 
have been identified in sources other than semen, and the 
relevance of these compounds to the problems of semen bio- 
chemistry is not known at present; they will be described 
briefly for the sake of completeness. 
Prostaglandin C1 has been demonstrated as a product of the 
action of the prostaglandin isomerase enzyme of cat plasma on 
PG Al (Jones, 1972). PG C1 is unstable in even slightly 
alkaline conditions, isomerising to PG B1. Since fresh 
human semen contains little if any PG A or PG B the presence 
of C prostaglandins seems unlikely. 
Prostaglandins G and H are intermediates in the bio- 
synthesis of the classical prostaglandins, and are also 
themselves highly active in biological systems. They were 
first isolated by Ramberg and Samueleson (1973) and Ramberg 
et al (1974) as a product of the incubation of sheep seminal 
vesicle microsomes with arachidonic acid. They will be 
(16) 
discussed in more detail later, as intermediates in the 
biosynthesis of the seminal prostaglandins. It seems im- 
probable that PG G and PG H occur in semen, since addition 
of stannous chloride (which converts PG G or PG H to PG F) 
to fresh semen immediately after ejaculation produced no 
significant change in the ratio of PG E to PG F (R.W. Kelly, 
personal communication). 
Hamberg et al (1975) have shown that PG G and PG H 
can be converted by exposure to human platelets into a new 
group of compounds containing a six- membered octane ring. 
The authors named these compounds thromboxanes, and showed 
that they were extremely active in the aggregation of platelets. 
The primary product, thromboxane A is extremely unstable, 
with a half life of about thirty seconds in aqueous solution 
and decays to thromboxane B which is stable but biologically 
inactive. Thromboxanes have not been shown to exist in 
seminal plasma, nor to be produced by the seminal vesicle. 
Prostaglandin I2 (PG X or prostacyclin) has been shown 
to be produced from PG G2 or PG H2 by artery wall microsomes 
(Gryglewski et al, 1976; Moncada et al, 1976). PG I2 is 
a potent inhibitor of platelet aggregation, and is again 
unstable in aqueous solution, decaying to 6 -keto PG Fla 
(Johnson et al, 1976). The latter compound could not be 
detected in semen (R.W. Kelly, personal communication) 
but two groups have reported its detection as a product 
of the incubation of arachidonic acid with sheep (Cottee 
et al, 1977) or bull (Chang and Murota, 1977) seminal vesicle 
(17) 
microsomes. Homogenates of seminal vesicle must inevitably 
include some arterial microsomes since the seminal vesicle 
is a vascular organ, and these last results may well be due 
to this. 
Origin and biosynthesis. 
The origin of the seminal prostaglandins in man was 
located by Eliasson (1959) using a split ejaculate technique. 
The various accessory sex glands which contribute to an 
ejaculate do not discharge their contents simultaneously, 
and it may be shown that an ejaculate consists of three 
main fractions. The first fraction consists mainly of 
prostatic secretion, as evidenced by its high level of 
acid phosphatase which is secreted solely by the prostate. 
The second fraction contains the secretions of the epididymes 
and ampullae and therefore carries the bulk of the spermato- 
zoa. The final fraction consists largely of the secretion 
of the seminal vesicles, and contains most of the fructose, 
which is secreted only by the seminal vesicles. The content 
of prostaglandin in the various fractions of split ejaculates 
was measured, along with acid phosphatase, sperm count and 
fructose, and it was shown that prostaglandin activity 
was positively correlated with fructose concentration, but 
not with the other markers, indicating that the seminal 
vesicles were the source of prostaglandin. 
Eliasson also examined sheep seminal vesicles, and 
showed that the amount of prostaglandin which could be 
(18) 
extracted from their homogenates was increased if the homo- 
genate was incubated at 37 °C before extraction, and that 
this process was speeded up if phospholipase A was added 
to the medium. He concluded that the prostaglandin was 
stored in an esterified form and that the increase in levels 
on incubation represented release of prostaglandin from 
this inactive phospholipid (Eliasson, 1959). More recent 
work has shown that in other tissues prostaglandins are 
not stored, but synthesised rapidly in response to demand 
(Davies et al, 1968; Piper and Vane, 1971).and that the 
increase in prostaglandin levels observed by Eliasson was 
probably due to a release of precursor fatty acids which 
are themselves stored as phospholipid (Kunze and Vogt, 1971). 
The first clear demonstration of in vitro biosynthesis 
of prostaglandins came in 1964 when two groups simultaneously 
announced their demonstration of synthesis of PG E2 from 
arachidonic acid using homogenates of sheep seminal vesicle 
(van Dorp et al, 1964a; BergstrBm et al, 1964a). Shortly 
thereafter the syntheses of PG El from all cis eicosa -8,11, 
14- trienoic acid (van Dorp et al, 1964b) and of PG E3 from 
all cis eicosa -5,8,11,14,17 -pentaenoic acid (Bergstrßm 
et al, 1964b) were announced. Van Dorp et al (1964b) also 
showed that the prostaglandin synthetase activity of the 
ram seminal vesicle was located in the microsomal fraction 
after cell fractionation. Wallach (1965) showed that the 
prostaglandin synthetase enzymes could be preserved for 
(19) 
storage as an acetone powder, and much of the work on prosta- 
glandin synthesis has since been carried out using acetone 
powders of seminal vesicle microsomes. The method of pre- 
paration is convenient and ensures that endogenous prosta- 
glandins, precursors and cofactors are removed from the 
enzyme preparation. 
That the prostaglandin synthetase was not confined 
to the seminal vesicles was first demonstrated by Anggard 
and Samuelsson (1965) who showed that homogenates of guinea 
pig lung could synthesise PG E2 and PG F2OC, from arachidonic 
acid. 
Owing to the difficulty of obtaining fresh human seminal 
vesicles for experimental purposes, the direct demonstration 
of prostaglandin synthetase activity in this organ was 
not made until 1976 when it was shown that incubation of 
human seminal vesicle homogenate with eicosa- 8,11,14 -trienoic 
acid yielded PG El (Bamberg, 1976). 
The mechanism of prostaglandin biosynthesis has been 
the subject of much attention, and has mainly been studied 
using preparations of sheep or bull seminal vesicle microsomes. 
Nugteren and van Dorp (1965) and Ryhage and Samuelsson (1965) 
showed that both the hydroxyl groups of the E prostaglandins 
were derived from molecular oxygen by performing incubations 
in the presence of 1802, isolating the products and recording 
their mass spectra. These experiments gave no information 
concerning the origin of the 9 carbonyl oxygen since this 
readily exchanges with water. In the same year Samuelsson, 
(20) 
in a most elegant experiment, showed that not only was the 
oxygen at C9 derived from molecular oxygen, but that both 
the oxygen atoms of the prostaglandin ring were derived 
from the same oxygen molecule (Samuelsson, 1965). Eicosa- 
-8,11,14 -trienoic acid was incubated with the prostaglandin 
synthetase enzyme in an atmosphere consisting of a mixture 
of 1802 and 1602. The resulting PG El was reduced to PG F1 
with sodium borohydride to prevent exchange of the 9 oxygen. 
PG F11 was isolated and oxidised to give a C13 dicarboxylic 
acid containing the two oxygens of the ring and the diethyl 
ester of this compound was subjected to mass spectrometry. 
The mass spectrum showed that the derivative contained either 
two 160 atoms or two 180 atoms but not one of each isotope. 
The experiment was later applied by Foss et al (1971) to PG Flct 
who showed that the oxygen atoms of the ring of this compound 
were likewise derived from the same molecule of oxygen. 
Synthesis of PG El from eicosa- 8,11,14 -trienoic acid 
labelled with 4C at C3 and 3H at C8, C11 or C12 gave a 
product with unchanged 3H/ 14C ratio, indicating that the 
reaction did not involve exchange of the hydrogens at C8, 
C11 
or C14 (Samuelsson, 1967). Incubation of (13D -3H, 
3 -14C) and (13L -3H, 3 -14C) eicosa -8,11,14 -trienoic acid 
followed by isolation of the resulting PG El and PG Flu 
showed that the hydrogen removed from C13 has the L con- 
figuration. 15- hydroperoxy eicosatrienoic acid and 15- 
hydroxy eicosatrienoic acid were shown not to be substrates 
for prostaglandin biosynthesis (Hamberg and Samuelsson, 
1967a). These observations led the authors to propose a 
mechanism involving the initial formation of 11- peroxy 
eicosatrienoic acid which would then cyclise to the 9,11 
endoperoxide. As additional evidence Samuelsson stated 
that eicosa -11,14 -dienoic acid could be converted by the 
prostaglandin synthetase enzyme into 11- hydroxy -12,14- 
eicosadienoic acid in high yield (Samuelsson, 1967). 
Hamberg and Samuelsson (1967b) showed that incubation 
of eicosa -8,11,14 -trienoic acid with sheep seminal vesicle 
prostaglandin synthetase preparations produced in addition 
to the prostaglandine: 11- hydroxy eicosa- 8,12,14 -trienoic 
acid, 15- hydroxy eicosa- 8,11,13 -trienoic acid, 12- hydroxy 
heptadeca -8,10 -dienoic acid and malondialdehyde. It was 
shown that the last named compound was derived from C9_11 
and it was suggested that it arose by cleavage of the endo- 
peroxide intermediate at C8/9 and 
C11 /12, giving 
rise also 
to the C hydroxy acid. 
Wiodawer and Samuelsson (1973) used a novel technique 
to demonstrate that PG F2 PG E2, PG D2 and 12- hydroxy 
heptadecatrienoic acid (HHT) are all formed from the same 
pool of endoperoxide precursor in the prostaglandin synthetase 
reaction. They incubated a mixture of unlabelled and 5,6, 
8,9,11,12,14,15 octadeutero arachidonic acid with PG synthetase 
in the presence of glutathione and hydroquinone and showed 
that the D / H ratio for the products PG F2°Land HHT increased 
(22) 
with time, whereas that for PG E2 and PG D2 did not. Owing 
to an isotope effect, the formation of PG E2 and PG D2 
takes place preferentially from the unlabelled endoperoxide, 
leaving the remaining pool of endoperoxide progressively 
enriched with deuterium. Since formation of PG F2 
«,and 
HHT does not involve D -C bond cleavage, the D / H ratio 
of these compounds reflects that of the pool of endoperoxide 
precursor at the time of synthesis. Curiously enough, 
this effect was abolished when adrenaline was used as cofactor 
in place of glutathione and hydroquinone. 
The existence of the postulated endoperoxide precursor 
was finally proved when two such compounds were isolated 
from incubations of sheep seminal vesicle microsomes with 
arachidonic acid (Harnberg and Samuelsson, 1973; Hamberg 
et al, 1974). The compounds were synthesised during a 
short incubation in the presence of p- mercuribenzoate (which 
inhibits the PG E isomerase enzyme which converts the endo- 
peroxide compounds to PG E). The products were separated 
by silicic acid chromatography, and were shown to act as 
precursors for the prostaglandins. The two compounds were 
shown to have the postulated 9,11 endoperoxy structure but 
to differ in the substituent at C one having a 15- hydro- 
peroxy group was named PG G2, and the other with a 15- hydroxy 
structure PG H2. The two compounds were shown to be bio- 
logically active, PG G2 being 50 -200 times as active as 
PG E2, and PG H2 100 -400 times as active on the superfused 
(23) 
aorta strip. The compounds were unstable in aqueous solution 
with a half life of about five minutes. 
The cofactor requirements of the prostaglandin synthetase 
system have been extensively studied since Nugteren et al 
(1966b,c) showed that the biosynthesis of PG E required 
reduced glutathione, and that antioxidants such as hydro - 
quinone or propylgallate also stimulated the reaction. 
The quantity of glutathione oxidised was calculated as 
2.4 moles per mole of PG E synthesised. Samuelsson (1967) 
showed that boiled supernatant, boiled rat liver supernatant, 
reduced glutathione, tetrahydrofolic acid and 6,7 dimethyl- 
tetrahydropteridine all stimulated the biosynthesis of 
PG E by microsomal preparations. NADH, NADPH and ascorbic 
acid (all at 0.1 mM) were ineffective. 
Yoshimoto et al (1970) showed that ascorbate at 10 mM 
stimulated the reaction and that the microsomes could be 
rendered inactive by freezing and thawing. Preparations 
inactivated in this way could be restored to full activity 
by the addition of haemoglobin, myoglobin, haemin or super- 
natant. Reduced glutathione was shown to stimulate only 
if present at the beginning of the reaction and was ineffective 
if added after four minutes of an eight minute incubation. 
Omission of reduced glutathione from the reaction mixture 
drastically reduced the yield of PG E but did not affect 
the consumption of oxygen, from which it was concluded that 
the initial oxidation of fatty acid did not require glutathione 
while the transformation of the endoperoxide intermediate 
(24) 
into PG E did, and that if the glutathione was absent at 
the beginning of the reaction the endoperoxide was irreversibly 
transformed into other products and was not subsequently 
available for the production of PG E. Omission of haem 
or hydroquinone from the reaction mixture reduced both 
oxygen consumption and PG E synthesis, showing that these 
cofactors were involved in the initial, oxidative steps of 
the reaction. 
A wide range of aromatic compounds have been shown 
to be effective in place of hydroquinone in stimulating 
the oxidative phase of the prostaglandin synthetase reaction. 
Sih et al (1970) demonstrated that catecholamines and sero- 
tonin were effective, and observed that seminal vesicle 
homogenates contain high levels of tryptophan, the compound 
which is now believed to be the natural cofactor for the 
reaction (Chan et al, 1975). 
A major advance came when Vane (1971) demonstrated 
that non -steroidal anti -inflammatory drugs such as aspirin 
and indomethacin are potent inhibitors of the prostaglandin 
synthetase reaction, providing both a physiological explanation 
for the well known anti -inflammatory, antipyretic and analgesic 
effects of aspirin and evidence for the involvement of 
prostaglandin synthesis in inflammation, fever and the 
perception of pain. These drugs have been shown to act on 
the oxidative phase of the reaction, and therefore inhibit 
the formation of the endoperoxides, together with all their 
(25) 
products (Miyamoto, 1976). 
Studies of the specificity of the prostaglandin synthetase 
system towards various polyunsaturated fatty acids have 
shown that although some acids of differing chain length 
can act as precursors for prostaglandin -like compounds 
(Struijk et al, 1966; Van Dorp, 1971), some naturally - 
occurring acids inhibit the reaction, and it has been pointed 
out that the rate of the reaction in vivo may depend on 
the mixture of acids available to the enzyme (Lands et al, 
1972). 
The production of PG F from the endoperoxide involves 
a reduction, unlike the production of PG E, and has been 
shown to be stimulated by Cu ++ and dithiols such as dithio- 
threitol and dihydrolipoamide (Lands et al, 1971; Lee 
et al, 1971). The presence of copper and dithiols stimulates 
PG F production more than it inhibits PG E production, showing 
that the effect is due to an increase in the rate of formation 
of PG F rather than an inhibition of the PG E isomerase 
system. Chan et al (1975), using a partially purified 
enzyme system which contained no PG E isomerase activity 
(as evidenced by the lack of action of reduced glutathione) 
showed that the pattern of products produced in the absence 
of the Cu + 
+/ 
dithiol complex was identical with that produced 
by the decay of PG H in buffer, and concluded that the 
production of of PG F was probably therefore non -enzymic. 
Wlodawer et al (1971) showed that a bicycloheptene analogue 
of PG H specifically inhibits the PG E isomerase enzyme, and 
(26) 
incubations in the presence of this compound produce low 
levels of PG E with slightly raised levels of PG F and 
hydroxy acids. 
Several groups have now succeeded in making the enzyme 
complex soluble, and studies have been published on the 
separated enzymes (Miyamoto et al, 1974; Chan et al, 1975; 
Rome and Lands, 1975; van der Ouderaa et al, 1977). Miyamoto 
(1976) separated the enzymes of bull seminal vesicle microsomes 
into two fractions and demonstrated that fraction I contained 
the cyclo -oxygenase activity, and although apparently homo- 
geneous by electrophoresis, catalysed two separate reactions. 
In the presence of haematin, eicosatrienoic acid was con- 
verted to PG G1, and in the presence of tryptophan and haem 
PG G1 was converted to PG H1. The products of incubations 
with fraction I were unaffected by the presence of reduced 
glutathione. Indomethacin and aspirin were shown to block 
the synthesis of PG G1, but to have no effect on the conversion 
of PG G1 to PG H1, or on the PG E isomerase which was present 
in fraction II. 
Hemler and Lands (1976) and Lands (1977) have purified 
the cyclo -oxygenase and shown that it has a molecular weight 
of 70,000 by SDS electrophoresis but 300,000 by direct 
measurement, indicating a tetrameric structure. The enzyme 
was shown to bind labelled aspirin, and in the active form 
to contain two haem groups and two atoms of non -haem iron 
per molecule. 
(27) 
The biosynthesis of the 19- hydroxy prostaglandins has 
so far received little attention. As mentioned previously, 
two groups have demonstrated 19- and 20- hydroxylation of 
prostaglandins by guinea pig liver microsomes (Israelsson 
et al, 1969; Kupfer et al, 1978) but the relevance of 
these observations to the 19- hydroxy prostaglandins of human 
semen remains to be established. 19- hydroxy E prostaglandins 
have been prepared using biosynthetic methods by Sih et al 
(1969) who demonstrated that the fungus Ophiobolus gramminis 
could hydroxylate arachidonic acid at the 18 or 19 positions, 
and incubation of these hydroxy acids with bovine seminal 
vesicle microsomes gave 18- hydroxy and 19- hydroxy PG E2, 
although in low yield. Oxidation of the hydroxyl to a 
ketone followed by incubation with the microsomal preparation 
gave 18 -oxo and 19 -oxo PG E2 in high yield. 
The biosynthesis of seminal prostaglandins in vivo 
has not yet been examined in detail. Eliasson (1959) measured 
levels of prostaglandin in ejaculates taken at 24 hour 
intervals, and showed that these did not differ significantly 
from those in ejaculates preceded by a longer period of 
abstinence, concluding that the prostaglandin produced in 
one ejaculate can be replaced within 24 hours. 
The administration of drugs can affect seminal prosta- 
glandin levels, and two groups (Collier and Flower, 1971; 
Horton et al, 1973) have shown that large doses of aspirin 
can depress seminal prostaglandin levels in men. Collier 
(28) 
and Flower measured E and F prostaglandins and showed that 
levels of both groups of compounds were significantly lowered 
in subjects taking 2.4 g aspirin per day. Levels of E 
prostaglandins tended to rise after an initial drop while 
those of the PG Fs remained low for the duration of the 
aspirin treatment. Horton et al measured 19- hydroxy A and 
19- hydroxy B prostaglandins in addition to PG E and PG F, 
and explored the effect of higher doses of aspirin (up to 
7.2 g /day). These authors found all the prostaglandin 
levels to be depressed by up to 80% at the highest dose 
rate. The lowering of prostaglandin levels was unaccompanied 
by changes in seminal volume or fructose levels, and the 
subjects experienced no difficulty in ejaculating even 
when receiving the maximum dose. The effect of anti - 
inflammatory drugs on male fertility has not yet been in- 
vestigated. 
The treatment of hypogonadal men with gonadotrophins 
(Sturde and Bohm, 1971) or with androgen (Sturde, 1971b; 
Skakkebaek et al, 1976) has been shown to raise seminal 
prostaglandin levels. In the case of the latter study 
the administration of testosterone produced a more pronounced 
rise in the levels of l9- hydroxy E prostaglandins than in 
those of the PG Es. The effect followed rapidly upon ad- 
ministration of the drug, and it was later suggested that 
testosterone may exert a direct effect on prostaglandin 
synthesis rather than by stimulating proliferation of the 
tissue responsible for the secretion (Kelly, 1978). Sturde 
(29) 
(1971a) has shown however, that the anti -androgen cyproterone 
stimulates a steep rise in seminal prostaglandin levels 
when administered at 200 - 400 mg daily. The effect occurred 
only after about six weeks of treatment, and the author 
attributed this result to an inhibition of the feedback 
effect of testosterone on pituitary gonadotrophin release, 
leading to increased testicular androgen production. 
Levels of prostaglandins in human semen. 
The measurement of levels of prostaglandins in human 
semen is a problem fraught with difficulty. The complex 
mixture of compounds poses problems of specificity if the 
levels of individual compounds are to be estimated, and 
the labile nature of the PG E and 19- hydroxy PG E compounds 
can lead to erroneous results, especially when measurements 
are made on frozen semen (Brummer and Gillespie, 1972; 
Clarke et al, 1974). Other techniques liable to introduce 
this type of artifact include the use of high temperatures 
in the extraction procedure (as in Eliasson, 1959) and 
the use of silicic acid chromatography (many workers, including 
most work published by Bygdeman et al between 1964 and 1970). 
The earliest workers in the field measured the effect 
of semen or crude extracts thereof on smooth muscle prepar- 
ations and expressed their results in terms of a standard 
preparation of 'prostaglandin' or as micrograms of PG El 
equivalent per millilitre of semen (Asplund, 1947a; Eliasson, 
(30) 
1959; Hawkins and Labrum, 1961; Bergstrom and Samuelsson, 
1962; Horton and Thompson, 1964). These studies indicated 
a figure of around 100)4g PG El equivalent / ml of semen. 
Later methods included thin layer chromatography, 
often preceded by group separation on silicic acid columns 
and followed by either bioassay, measurement of ultraviolet 
absorption after base treatment (PG E) or GLC (PG F) 
(Bygdeman and Samuelsson, 1964, 1966; Bygdeman et al, 
1969, 1970, 1973; Bygdeman, 1969; Srivastava and Clausen, 
1973; Brummer and Gillespie, 1972; Collier et al, 1975). 
One group (Clarke et al, 1974) used radioimmunoassay, using 
an antiserum which did not discriminate between the E and 
F prostaglandine. Measured levels during this period average 
about 50 jig / ml for the E prostaglandins and 7 jg / ml 
for the PG Fs. (For a detailed review of this work see 
Cenedella, 1975). 
Two modern papers give what are currently the most 
reliable estimates of the prostaglandin content of normal 
semen. Perry and Desiderio (1977) measured E and 19- hydrozy 
E prostaglandins in human semen by GCMS using deuterated 
PG E2 as an internal standard, and Templeton et al (1978) 
measured PG Es, PG Fs and their 19-hydroxylated equivalents 
in the semen of men whose wives had recently given birth, 
using GLC for the E and 19- hydrozy E prostaglandins and 
GCMS for the F and 19- hydrozy F prostaglandins. The results 
of these two studies are given in table 0.1. 
( 31 ) 
Table 0.1 
n. 
Seminal prostaglandin levels in fertile men. 
PG Es 19-0H Es PG Fs 19 -0H Fs 
10 142 ±102 527 ±375 (Perry and Desiderio, 
1977) 
22 73 ±72 267 ±240 (Templeton et al, 
1978) 
17 2.1 ±1.8 tl 
16 18 ±14 
(all figures are fg/m1 ±P-) 
The high levels of E prostaglandins reported in these 
two studies are not unexpected, since the instability of 
these compounds must have depressed most previous estimates. 
The wide range of levels encountered (Templeton et al quote 
2 - 272 )pg /ml for the PG Es for example) is surprising, 
since if the seminal prostaglandins have a biological function, 
the mechanisms involved must be extremely uncritical to 
operate over such a large dynamic range. 
Seminal prostaglandins and fertility. 
Several studies have compared the levels of prostaglandins 
in the semen of fertile and infertile men, and suggested 
that levels are lower in the infertile group (Hawkins and 
Labrum, 1961; Bygdeman and Samuelsson, 1966; Hawkins, 
1968; Bygdeman, 1969; Bygdeman et al, 1970, 1973; 
Collier et al, 1975; Perry and Desiderio, 1977). Brummer 
and Gillespie (1972) could show no significant difference 
(32) 
in levels between the normal and infertile groups, but 
claimed that the normal group showed a significantly wider 
scatter. Clarke et al (1974) compared their measured levels 
in semen from men with suspected infertility with 'normal' 
levels as defined by Bygdeman (1973) and showed that eleven 
out of thirty had lower levels. Sturde (1968), however 
showed that azoospermic men had significantly higher prosta- 
glandin levels as measured by bioassay. 
Much of this work is rather unsatisfactory, the statistical 
analyses used to demonstrate the significance of the observed 
differences being for the most part perfunctory, and generally 
based on Student's T test. As long ago as 1961 Hawkins and 
Labrum pointed out that the statistical distribution of 
measured seminal prostaglandin levels is extremely skewed, 
making the T test invalid. These authors corrected for 
this by taking logarithms of the measured levels and testing 
these transformed results for significance. The transformed 
results showed no significant difference between the 
fertile and infertile groups as originally defined. Much 
of the work cited above was performed on a number of samples 
too small to draw conclusions about the nature of the statistical 
distribution of the results. 
Early work on the levels of prostaglandins in human 
semen tends to show a much narrower spread of results than 
is revealed by modern methods. The most rigorous investigation 
of the relationship between seminal prostaglandin levels 
and fertility was that of Bygdeman et al (1970). These 
(33) 
workers measured levels of PG Es, PG A +Bs and 19- hydroxy 
PG A +Bs in semen samples from three groups. Group A included 
only men of recently proven fertility (n.29), group B men 
whose marriages were infertile for reasons which had not 
been investigated (n=100) and group C men whose marriage 
remained infertile for unknown reasons after thorough in- 
vestigation (n =17). The incidence of levels of PG Es below 
(two standard deviations below the mean for the 
fertile group) in the three groups was 0%, 17% and 41% 
respectively, a difference which was shown to be highly 
significant (P L 0.001) in the case of groups A and C, 
and significant (P L 0.01) in the case of groups A and B. 
There were no significant differences in the levels of A 
and B prostaglandins or 19- hydroxy A and B prostaglandins. 
Statistical significances were demonstrated by non -parametric 
tests since the frequency distribution observed in groups 
B and C appeared anormal. Templeton et al (1978) have 
suggested that these results may be explained by differing 
storage times or conditions for the three groups of samples, 
since it was not known in 1970 that PG E levels decline 
in frozen semen. However, there is no evidence of a con- 
comitant rise in the measured levels of dehydrated prosta- 
glandins as would be expected if this were the case. 
Fig. 0.1 shows the frequency distribution obtained 
in group A of this study (redrawn after Bygdeman et al, 
1970) together with a frequency distribution of levels 
(34) 
of PG Es in the semen of fertile men measured by modern 
methods (I. Cooper, R.W. Kelly und A. Templeton, unpublished). 
Fig. 0.1 
Frequency distribution of levels of E prostaglandine in 









A. Bygdeman et al (1970) 
fertile men, n - 29. 
lÓ lj 25 
class interval. 
B. Cooper, Kelly and Templeton 
(unpublished results) 
fertile men, n . 29 
15 20 25 
class interval. 
(Class intervals are multiples of 11 yg PG E / ml.) 
(35) 
Comparing the two sets of results in fig. 0.1, it is 
evident that the spread of measurements is much greater 
in the modern work. Although the number of measurements 
is the same in both cases, the modern work shows six cases 
of levels above 100 yg /ml and four below 11 jg /ml, while 
the early results all lie between these extremes. The 
explanation for this may lie in the methods used by the 
earlier workers. Semen contains approximately four times 
as much 19- hydroxy PG E as PG E (Perry and Desiderio, 1977; 
Templeton et al, 1978) and the 19- hydroxy E prostaglandins 
can be converted by base treatment to 19- hydroxy PG Be 
which absorb at 278 nm and would therefore be detected by 
Bygdeman et al's assay. The large amounts of 19- hydroxy 
E prostaglandins in semen can overload TLC plates, increasing 
the apparent Rf of the spot to an extent where it merges 
with the PG E spot. Bygdeman et al's results may therefore 
include a contribution from the 19- hydroxy E prostaglandins, 
accounting for the apparent lack of fertile individuals 
having low levels of E prostaglandins. The apparent lack 
of individuals with very high levels of E prostaglandins 
may be due to a similar effect, since overloading the plate 
with PG Es could lead to spreading of this spot, reducing 
the amount of prostaglandin to be found in the expected 
area of the plate. Errors of this type could therefore 
have led to gross underestimates of the standard deviation 
of measurements in the early work, and therefore to over- 
estimates of the significance of observed differences between 
(36) 
the fertile and infertile groups. 
Estimates of the significance of differences in seminal 
prostaglandin levels between fertile and infertile men 
using modern methods of assay would require very much larger 
numbers of measurements (Templeton et al, 1978) and until 
the results of such work become available the connection 
between seminal prostaglandin levels and fertility must 
be considered unproven. 
Species distribution. 
Von Euler (1934b, 1937 ) showed prostaglandin to be 
present in extracts of male accessory sex glands of man 
and sheep, but could not demonstrate activity in extracts of 
those of the rabbit, dog, horse, bull or pig. He also 
demonstrated the presence of vesiglandin, a related substance, 
in extracts of rhesus monkey seminal vesicles (Von Euler, 
1935b). Eliasson (1959) found prostaglandin activity in 
the semen of sheep and goats but not in horse, bull or 
pig semen. Extracts of male accessory sex glands showed 
activity when prepared from the seminal vesicles, ampullae 
and prostate of the sheep, but not from the organs of other 
animals, including bull, pig, dog, cat, rabbit and guinea 
pig. 
The distribution of prostaglandine outside the repro- 
ductive tract was studied by Karim et al (1967, 1968) who 
(37) 
were able to demonstrate the presence of (or at least the 
capacity to synthesise) prostaglandins in a wide range 
of mammalian organs. Prostaglandins have also been de- 
tected in non -mammals, perhaps the most striking case being 
that of the sea whip, Plexaura homomalla, in which Weinheimer 
and Spraggins (1969) demonstrated the presence of A prosta- 
glandins at a concentration of 1.5% dry weight. 
Eliasson (1959) and later Poyser (1974) both suggested 
that the presence of prostaglandins in the semen may be 
related to the type of insemination practised by that species; 
whether intravaginal (man, sheep, cow, rabbit) or intra- 
uterine (horse, pig, dog, rat). Measurements of the seminal 
prostaglandin levels in various species could not support 
this hypothesis. Poyser (1974) found that levels of E 
prostaglandins were less than 5 ng /ml in pig and dog semen, 
while horse semen contained 24 ng /ml and rabbit 71 ng /ml. 
Ventura and Freund (1973) found PG El at 1 ng /ml and PG 
F1 m at 0.5 ng /ml in rat semen, but found that rat semen 
also contains another uterine stimulant which was not extract- 
able into ethyl acetate and was non -dialysable. Voglmayr 
(1973) measured the level of PG F2 a in the semen of dairy 
bulls and found a level of 0.17 ng /ml, a quantity comparable 
to that found in venous blood. Estimation of prostaglandin 
levels in male accessory sex glands of the rat have led 
to contradictory results. Jouvenaz et al (1970) measured 
PG E2 in the prostate and seminal vesicles as 0.25 and 
(38) 
0.16 pg /g respectively. De Cuminsky and Mercuri (1971) 
measured PG El in the seminal vesicle as 0.5,pg /g. Tan 
and Privett (1972, 1973), however, claimed that the content 
of E prostaglandins in the seminal vesicle was as high as 
500 /g /g. Bartke and Koener (1974) showed that fluid from 
the vasa deferentia of rats and mice contained high levels 
of F prostaglandins. 
19- hydroxy prostaglandins were first detected in human 
semen by Harnberg and Samuelsson (1965, 1966a, b) as 19- 
hydroxy PG A and 19- hydroxy PG B, but the authors could 
not detect these compounds in ram semen. Taylor and Kelly 
(1974) demonstrated the presence of 19- hydroxy E prosta- 
glandins in human semen, and they were later shown to be 
present in the semen of other primates, including the 
chimpanzee, gorilla, orang -utan, rhesus monkey and stump - 
tailed macaque. 19- hydroxy E prostaglandine were not de- 
tected in the semen of the horse, bull, sheep, pig, rabbit 
or chicken (Kelly et al, 1976 and this thesis). In primate 
species other than man, levels of 19- hydroxy PG El far 
exceeded those of other prostaglandine detected, and it 
was suggested that this compound is identical with the 
vesiglandin extracted by Von Euler from rhesus monkey seminal 
vesicles. 19- hydroxy F prostaglandine have been demonstrated 
in the semen and in prostate gland extracts from the brush - 
tailed possum, Trichosurus vulpecula (Marley et al, 1977). 
In summary, high levels of seminal prostaglandins 
(39) 
have been demonstrated only in primates, sheep and goat. 
Levels of seminal prostaglandine in other species are typically 
one to ten thousand times lower, and as such may well result 
from the secretions of organs other than the seminal vesicle. 
19- hydrozy prostaglandins have so far been detected only in the 
semen of primates and one marsupial. 
The biological role of the seminal prostaglandine. 
The earliest hypothesis on the role of the seminal 
prostaglandine in vivo was that of Goldblatt (1935), who 
suggested that they might promote vasodilation in the male 
reproductive organs in the period immediately preceding 
ejaculation, a proposition which is difficult to test owing 
to the inaccessibility of most of the male reproductive 
system. 
Several workers have claimed that prostaglandins (Okazaki 
et al, 1978; Webb et al, 1974) and human seminal plasma 
(Stites and Erickson, 1975) possess immunosuppressive pro- 
perties on the basis of their ability to inhibit phytohaem- 
agglutinin- induced DNA synthesis in cultured lymphocytes. 
The intravaginal route is adequate for the production of 
immunity in vivo, and Stites and Erickson suggest that the 
function of the seminal prostaglandine may be to prevent 
the development of anti -sperm antibodies in the female. 
The same authors also suggest that the immunosuppressive 
ability of seminal plasma may be responsible for the poor 
(40) 
immunological response in the male to genital infection 
by cytomegalovirus or to first infection by Neisseria 
gonorrhea. A very wide spectrum of compounds has now been 
shown to inhibit phytohaemagglutinin stimulation of lymphocyte 
DNA replication, and it is doubtful whether in vitro tests 
of this type are a real guide to the immunosuppressive 
abilities of compounds in vivo. Further work is therefore 
required before the relevance of this interesting observation 
can be properly assessed. 
The three most probable explanations for the presence 
of the seminal prostaglandine, however, remain those dis- 
cussed by Eliasson (1959). 
"1. Prostaglandin may act as a chemical stimulator 
inducing the emptying of the accessory genital 
glands. 
2. Prostaglandin may be of importance for the motility 
(or other function) of the spermatozoa. 
3. Prostaglandin may facilitate the migration of the 
spermatozoa in the female genital tract: 
In order to assess the likelihood of these three explanations, 
the biological action of the seminal prostaglandins on the 
male tract, on spermatozoa and on the female tract will 
now be considered. 
(41) 
The action of the seminal prostaglandins on the male reproductive 
tract. 
Owing to the inaccessibility of the male reproductive 
tract, most information on the effects of prostaglandins 
has so far been obtained from experiments performed in vitro 
on isolated organs. In addition, most of this work has 
been performed on animals whose semen contains little or 
no prostaglandins, and its relevance to primate reproductive 
physiology is therefore subject to question. 
Holmes et al (1963) recorded the pressure in the lumen 
of the rabbit vas deferens in vivo, after cannulating 
one end of the vas and ligating the other, and showed that 
PG E1 inhibited contractions produced by adrenaline. The 
effect of PG E1 on the isolated guinea pig vas deferens, 
studied by Graham and A1- Khatib (1967) was to produce strong 
contraction (at 0.2 - 0.5 yg /ml). Furthermore, these authors 
found that after washing out the prostaglandin the action 
of subsequently- applied noradrenaline was potentiated by 
a factor of five. Von Euler and Hedqvist (1969) found 
PG E1 to be inhibitory on the electrically -stimulated guinea 
pig vas (at 0.01 - 0.025 jg /ml). PG E2 was found to be 
about half as active in this system. Using a similar pre- 
paration, Ambache and Zar (1970) found PG E2 to potentiate 
the effect of noradrenaline, but inhibit electrically - 
stimulated contractions. PG F2oiwas found to have no effect 
on this preparation. The effect of prostaglandins on isolated 
(42) 
vas deferens preparations from the guinea pig, rabbit, 
cat and rat were studied by Hedgvist and Von Euler (1972). 
In all four animals the response to E prostaglandine was 
found to be biphasic when the tissue was electrically 
stimulated, doses of PG El or PG E2 below 0.2 pg /ml inhibiting 
the contractions, while higher doses enhanced the response. 
The response of the organs to PG E in the presence of nor - 
adrenaline was, however, uniformly one of enhancement. 
F prostaglandine showed similar effects but were less potent 
than the PG Es. Bhagat et al (1972) found that PG E2 increased 
the response of the isolated guinea pig vas deferens to 
nerve stimulation or direct electrical stimulation at 10 -7M 
(0.035 )4g /ml) but that the effect on the tissue when stimulated 
simultaneously by nor adrenaline and electrically was once 
more biphasic. 
Similar effects of prostaglandins have been demonstrated 
on the seminal vesicle. Clegg (1966) showed that PG El, 
F2oLand F13 all potentiated the response of the isolated 
guinea pig seminal vesicle to adrenaline, and this effect 
was shown to last up to 30 minutes after a single dose 
of prostaglandin. Using a similar preparation, Eliasson 
and Risley (1966a, b) showed that PG El (0.012 - 0.5 )pg /ml) 
caused a marked potentiation of response to adrenaline, 
noradrenaline, acetyl choline or serotonin. PG F1o(.in 
the same range had no effect. PG E1 alone provoked con- 
traction at 0.3 ,pg /ml, while PG Fl 
DL 
had no effect at 1.2 ug /ml. 
(43) 
There was no apparent difference in response between pre- 
parations from normal and castrated animals. The effect 
of PG E1 on the isolated hamster seminal vesicle was studied 
by Risley and Hui (1968) who found that contraction of the 
tissue in response to catecholamines was enhanced at prosta- 
glandin concentrations of 0.01 - 0.1 jg /ml but that the 
response-to acetyl choline was unchanged. Naimzada (1969) 
found that PGs E1, E2, Al and F1m all potentiated the response 
of the isolated guinea pig seminal vesicle to electrical 
stimulation and sympathetic amines. PG E1 was effective 
at 0.111g /ml and the ratio of activity was 
E1 /E2 /A1 /F1 
100/10/2/1 . 
Biphasic response of the isolated guinea pig seminal 
vesicle to PG E1 in the presence of nerve stimulation were 
found by both Sjöstrand and Swedin (1970) and Hedqvist 
(1972). Both groups found PG E1 to be inhibitory at low 
doses (up to 0.06 yg /ml) and stimulatory at high doses 
(0.1 - 1.0 pg /ml). Hedqvist (1972) proposed that PG E1 
has a dual action, with low doses inhibiting the release 
of noradrenaline from nerve terminals while high doses 
potentiate the effect of the neurotransmitter on the receptor, 
suggesting the presence of an endogenous prostaglandin - 
mediated regulation of the smooth muscle response to nerve 
activity. 
In the only study to date of the effect of prostaglandins 
on human seminal vesicles Ito et al (1972) found that PG E1 
(44) 
at a concentration of 1.3 jg /ml inhibited adrenaline -stimulated 
contractions in vitro. Since human semen contains around 
70 jig /ml of PG E and the concentration at the point of 
secretion must be far higher than this, it would seem that 
the levels tested by Ito et al were far lower than physio- 
logical levels. 
Stahl (1972) tested the effect of E prostaglandins 
on the isolated hamster seminal vesicle and vas deferens, 
and found that PG E1 inhibited the response to adrenaline 
of the seminal vesicle at levels below 1 ng /ml and enhanced 
the response above 100 ng /ml. PG E2 had no effect at 10 - 
100 ng /ml but gave an enhanced response above and below 
these levels. In the case of the vas deferens, PG E1 en- 
hanced the response at levels above 100 ng /ml while PG E2 
showed enhancement at all levels from 1 pg /ml to 2 pg /ml. 
These observations led him to propose that prostaglandin 
levels control the timing of ejaculation as follows : 
Initially, low levels of PG E enhance the activity of 
the vas deferens to bring up spermatozoa while inhibiting 
the seminal vesicle. As the levels of PG E rise the seminal 
vesicle is stimulated to contract, expelling its contents 
behind the mass of spermatozoa. 
The low levels at which these effects were observed 
fits with the low levels of prostaglandins in rodent semen. 
Ito et al's observation that the human seminal vesicle 
is inhibited by levels of PG E1 which are low compared 
(45) 
with those in human semen leads one to speculate that these 
authors might once more have found a biphasic response had 
they investigated the effect of levels of the order of 
hundreds of micrograms per millilitre. Since the prostate 
gland is the first of the accessory sex glands to discharge 
in the process of ejaculation, Stahl's hypothesis would 
predict that sensitivity to stimulation by prostaglandins 
should be greatest in this organ; however, I can find 
no reference in the literature to any effect of prostaglandins 
on the prostate. 
Prostaglandins have been shown to have profound effects 
on the testis, inhibiting contraction of the testis capsule 
(Hargrove et al, 1971), reducing blood flow and increasing 
venous pressure at levels which had no effect on central 
blood pressure (Free and Jaffe, 1972a, b). Studies on the 
affects of prostaglandins on testosterone secretion have 
led to conflicting results. Saksena et al (1973) showed 
that rats injected with PG E2 (500 pg s /c, twice daily 
for three days) had lowered plasma testosterone levels 
and decreased testis weight while plasma LH levels remained 
unchanged. Similar results were reported by Bartke et al 
(1973) using mice, however, Eik -Nes (1971) found that levels 
of testosterone in the spermatic vein of dogs increased 
when PG E2 was infused via the spermatic artery at 11 jg /min. 
The remote position of the testis relative to the 
seminal vesicles implies that any physiological effects 
(46) 
of prostaglandins on this organ are probably due to synthesis 
occurring in the testis itself, and since the testis is a 
very rich source of prostaglandin 15- dehydrogenase (Nakano 
and Prancan, 1971) presumably testicular prostaglandins 
do not contribute to levels in semen. 
The epididymis is a contractile organ, and has been 
shown to respond by contraction to catechol amines and 
acetyl choline in vivo (Hib, 1976). There is, however, 
no information so far on the effect of prostaglandins on 
epididymal smooth muscle, although prostaglandins have 
been shown to affect sperm maturation (see following section). 
Prostaglandin El has been shown to relax the retractor 
penis muscle of the dog at very low concentration (Luduena 
and Grigas, 1972). Relaxation of this muscle precedes 
erection and is mediated via the parasympathetic nervous 
system, and the authors suggest that PG E1 is involved in 
parasympathetic neurotransmission in this muscle. 
In summary, prostaglandins may be shown to stimulate 
contraction of the seminal vesicle and vas deferens, and 
the biphasic response shown by these organs may indicate 
the existence of a trigger mechanism operating when a threshold 
level of prostaglandin is reached. The testes and epididymes 
are probably too remote from the seminal vesicle to be 
affected by prostaglandins synthesised there, but the 
possibility of endogenously synthesised prostaglandins 
contributing to their discharge cannot be ruled out. 
(47) 
The action of seminal prostaglandins on spermatozoa. 
Early work by Horton (1965) showed no effect of added 
PG El (100 ug /ml) on the motility of ejaculated human spermato- 
zoa, and later Eliasson et al (1968) could show no effect 
of PG E1 at physiological levels on the metabolism of washed, 
ejaculated human spermatozoa. Pento et al (1970) studied 
the effect of PG E1 and PG Fla on the carbohydrate metabolism 
of ejaculated and epididymal ram spermatozoa, and found 
both prostaglandins to stimulate glycolysis in epididymal 
spermatozoa but to have no significant effect on ejaculated 
spermatozoa. 
Spermatozoal glycolysis and motility have been shown 
to be under the control of intracellular cyclic AMP levels 
(Hoskins and Casillas, 1975), but the mechanisms controlling 
cyclic AMP levels in the sperm cell are at present unknown. 
In most tissues other than adipose tissue, E prostaglandins 
stimulate adenyl cyclase (Horton, 1972). If the seminal 
prostaglandins could be shown to raise intraspermatozoal 
cyclic AMP levels and therefore stimulate motility this 
would provide an explanation for the presence of the seminal 
prostaglandins. Unfortunately, the only published work 
to date on this topic showed E prostaglandins to depress 
intraspermatozoal cyclic AMP levels in washed, ejaculated rhesus 
monkey spermatozoa (Casillas and Hoskins, 1971). However, 
the major prostaglandin present in monkey semen is 19- hydroxy 
PG E1, the E prostaglandins being present at much lower 
(48) 
levels (Kelly et al, 1976) and prior exposure of ejaculated 
spermatozoa to prostaglandine may produce irreversible 
changes which render them insensitive to subsequent prosta- 
glandin treatment. 
19- hydroxy E prostaglandins have been shown to depress 
the respiration of washed, ejaculated human spermatozoa 
(Kelly, 1977), an effect not seen with E or F prostaglandins. 
Earlier work had already shown that washing spermatozoa 
stimulated oxygen uptake by a factor of three (Eliasson, 
1971), an effect which is presumably due to the removal 
of 19- hydroxy E prostaglandine. The aerobic pathway of 
metabolism is presumably of relatively little importance 
in ejaculated spermatozoa, since Peterson and Freund (1974) 
have shown that fructose consumption does not increase 
under anaerobic conditions (Pasteur effect). Addition of 
19- hydroxy E prostaglandins did not affect the anaerobic 
pathway of metabolism, as evidenced by the unchanged pro- 
duction of lactate, and did not affect the motility of the 
spermatozoa (Kelly, 1977). 
Spermatozoa may be shown to bind prostaglandins, and 
in the rabbit this binding takes place in the acrosomal 
region of the sperm plasma membrane (Bartoszewicz et al, 
1975). The human spermatozoon has been shown to bind PG E1 
and PG F2cc (Mercado et al, 1978) and on the basis of 
differing binding constants and fluorescence -quenching 
efficiencies the authors concluded that the two prostaglandins 
(49) 
bind to different receptors. 
Exogenous prostaglandins have been shown to affect 
spermatogenesis and sperm maturation, although the relevance 
of this information to the seminal prostaglandins is doubtful. 
Ericsson (1973) showed that twice -daily injection of E 
prostaglandins in male rats suppressed spermatogenesis 
as measured by the occurrence of immature germinal cells 
in the epididymis. This effect may have been due to suppression 
of testosterone production however, since decreased testicular, 
epididymal, seminal vesicle and ventral prostate weights 
were recorded, and other workers have shown that injection 
of prostaglandins depresses testosterone levels in rats 
(Bartke et al, 1973; Saksena et al, 1973). 
Sorgren and Glass (1972) attempted to demonstrate 
an effect of PG F2o(.on the maturation and fertility of 
rabbit spermatozoa by incubating spermatozoa from the caput 
and cauda of the epididymis and ejaculated spermatozoa 
with this compound before artificially inseminating does. 
They could show no effect on the fertility of ejaculated 
or caudal spermatozoa, and the caput spermatozoa remained 
infertile. Injection of male rabbits with PG El or PG 
F2oc 
was shown to accelerate sperm production in work by Hunt 
and Nicholson (1972). Rabbits were given a single injection 
of tritiated thymidine on day zero and were given prosta- 
glandins (1 mg s/c twice daily) thereafter. Radioactive 
spermatozoa were produced first on day 45 by control rabbits 
(50) 
and two days earlier by the prostaglandin treated animals. 
Setty and Kar (1972) were unable to show any effect of 
injected prostaglandins on the residual fertility of castrated 
male rats maintained on testosterone. 
In summary, a conclusive demonstration of the requirement 
of spermatozoa for seminal prostaglandins has yet to be 
achieved. Although the work of Kelly (1977) and Pento 
et al (1970) is especially interesting in this connection, 
more work with epididymal spermatozoa which have never 
experienced high levels of prostaglandins will be necessary 
before the importance of these compounds in relation to 
sperm motility and metabolism can be assessed. 
The effects of seminal prostaglandins on the female repro- 
ductive tract. 
An extensive literature exists on the effects of prosta- 
glandins on the female, and responses to physiological or 
pharmacological levels have been demonstrated in the vagina, 
cervix, uterus and fallopian tubes. The role of prostaglandins 
in luteolysis and menstruation will not be considered here, 
as they result from endogenous production in the female 
and are not relevant to the seminal prostaglandins. As 
is usual with any aspect of reproductive physiology, marked 
species differences are evident, and conclusions drawn 
(51) 
from experiments on non -human material must be treated with 
caution when applied to the human. 
Sperm transport in the female tract appears to be 
extraordinarily rapid, the rate at which spermatozoa are 
transferred from the vagina to the fallopian tubes far 
exceeding that which would be expected if the sole means 
of transport was the motility of the spermatozoa. Settlage 
et al (1975) showed by artificially inseminating women 
shortly before surgical removal of the fallopian tubes 
that sperm can be found in the tubes within five minutes 
of deposition in the vagina. Work by Bickers (1951) showed 
a reduced rate of sperm transport in 8/24 women with un- 
explained infertility. It would seem therefore that the 
active transport of sperm by the female tract is essential 
to fertility. 
The first barrier faced by the sperm in the female 
tract is the cervix, and it is not certain at present whether 
transport of sperm through the cervical canal is an active 
or a passive process on the part of the female. Bickers 
(1951) showed that during sexual stimulation uterine activity 
increases, followed by temporary inhibition after orgasm 
with a simultaneous increase in vaginal pressure. There 
exists therefore a pressure gradient between the vagina 
and the uterus which could facilitate sperm transport by 
sucking the vaginal contents through the cervical canal. 
The existence of this pressure gradient has been confirmed 
(52) 
by Fox et al (1970), using direct measurement of the pressures 
by radio -telemetry. 
Early reports by Amersbach (1930) and Trapl (1943) 
described instances of uptake of carbon particles and carmine 
dye through the cervix during intercourse. Egli and Newton 
(1961) placed a suspension of carbon particles in dextran 
gel in the vagina of anaesthetised women before surgery and 
simultaneously administered intravenous oxytocin. Carbon particles 
were found in the fallopian tubes in 2/3 cases 28 -34 minutes 
later. De Boer (1972), however, in a similar investigation 
studied the transport of carbon particles placed in the 
vagina, cervical canal or uterus before laparotomy, and 
later found carbon in the fallopian tubes in 50% (uterus) 
or 30% (cervical canal) of cases. When the material was 
placed in the vagina, transport to the fallopian tubes occurred 
in only one case out of thirty seven. No effect of oxy- 
tocin could be detected in this work, and the stage of the 
patient's menstrual cycle showed no influence on the results. 
Masters and Johnson (1966) and Sobrero (1967) both 
placed radio -opaque material in a cervical cap applied to 
a woman before masturbation or intercourse, and subsequent 
radiography showed no radio -opaque material to be drawn 
into the uterus in either case. Immediate examination of 
cervical mucus after normal intercourse has shown that 
spermatozoa reach the internal os of the cervix within 1.5 - 
3 minutes of ejaculation (Sobrero and Macleod, 1962). In 
(53) 
three cases where the semen was necrospermic no transport 
of the immotile sperm occurred, and no vaginal epithelial 
cells were found in the cervical mucus as might be expected 
if the semen were drawn in by sucking. 
Sperm cells observed in cervical mucus show a higher 
motility than in the original specimen (Sobrero and Macleod, 
1962; Moghissi, 1973) and it would appear that the barrier 
posed to spermatozoa by the cervical mucus is functional, 
in that it serves to weed out spermatozoa of reduced motility. 
In addition, the convoluted folds of the walls of the cervical 
canal provide a series of crypts which retain sperm and 
release them for a period of several hours after intercourse 
(Moghissi, 1973). These functions of the cervix would appear 
to be incompatible with a mechanism which involves the 
uterus rapidly sucking the semen through the cervical canal. 
Prostaglandins can be shown to affect the motility 
of the cervix, although the significance of these observations 
with respect to the transport of spermatozoa through the 
cervix is at present unknown. The isolated, non -pregnant 
human cervix was investigated by Hillier and Karim (1970), 
who found that PG E2 at levels much lower than those present 
in semen (0.025 - 0.5 )pg /ml) caused a decrease in the spon- 
taneous motility. The response to PG F2°tat physiological 
levels (0.5 - 2.0)lg /ml) was erratic. Intravenous injection 
of PG E1 has also been shown to inhibit the motility of 
the rabbit cervix in vivo, along with that of the uterus 
and oviduct (Horton et al, 1965). 
(54) 
Eskin et al (1972, 1973) investigated the effect of 
added PG 
F2o(.on 
the penetration by spermatozoa of human 
cervical mucus. Unfortunately these papers are extremely 
imprecise, almost to the point of being incomprehensible. 
The authors claim that addition of 250 )rtg (sic) of PG 
F206 
to human semen "improves significantly the penetration, 
motility and drive of sperm into cervical mucus." One 
may draw conclusions from these papers on the effectiveness 
of the refereeing process for scientific publications but 
not, alas, on the effect of prostaglandins on the penetrability 
of cervical mucus. An earlier (but much better documented) 
paper by Pomerenke and Viergiver (1947) reported that the 
ability of spermatozoa to penetrate cervical mucus was 
not significantly impaired by washing the cells and re- 
suspending them in Ringer's solution, implying that the 
endogenous seminal prostaglandins are not essential for this 
process. 
The effects of prostaglandins on sperm transport in 
the rabbit have been investigated by three groups. Mandl 
(1972) found that PG El added to rabbit semen at 375 , g/m1 
greatly increased the rate at which sperm moved from the 
vagina to the oviduct. Spilman et al (1973) found that 
intravaginal (100 yg /animal) or subcutaneous (1 mg /kg at 
0, 1, 2 and 2.75 hours after insemination) PG F2 increased 
both the rate of sperm transport and the fertilisation rate. 
Neither PG E1 nor PG E2 could be shown to have any effect. 
(55) 
Precisely the reverse was found by Chang et al (1973) who 
found intravaginal PG El or PG E2 (100 yg /ml semen) to 
increase the fertilisation rate but that PG Fla was ineffective. 
Levels of prostaglandins used in these studies are enormously 
higher than those occurring naturally in rabbit semen, 
where E prostaglandins amount to about 70 ng /ml (Poyser, 
1974) and the physiological significance of this work is 
therefore doubtful. 
The effects of prostaglandins on the fallopian tubes 
have been fairly extensively studied, and the results of 
different groups agree closely with one another. Preparations 
of human fallopian tube in vitro were studied by Sandberg 
et al (1963, 1964, 1965) who showed that PG El stimulates 
contraction of the proximal (to the uterus) quarter of 
the tube while relaxing the distal three quarters. PG E2 
has a similar action, while PG E3 relaxes the entire tube. 
F prostaglandins were shown to stimulate contraction of the 
entire length of the tube, and the effects of all of the 
prostaglandins studied could not be related to the stage 
of the menstrual cycle. 
Horton and Main (1963) showed that all three E prosta- 
glandins decrease the tone and activity of the rabbit oviduct 
while PG F2a.has the opposite effect. Horton et al (1963) 
showed that intravaginal PG El causes relaxation of the 
oviduct in rabbits even when the uterine horn is ligated 
or severed, showing that the prostaglandin must arrive 
at the organ via the systemic circulation. 
(56) 
Eliasson and Posse (1965) studied the effect of intra- 
vaginal application of a crude extract of human seminal 
prostaglandins (HSF -PG) on the resistance to gas flow 
of the fallopian tubes in women (Rubin's test), and found 
a. significant increase in resistance in three out of seven 
cases. A similar technique was employed more recently 
by Embrey et al (1976), who showed that PG E2 inhibits 
and PG F2OLstimulates the resting tone, frequency and ampli- 
tude of contractions at all stages of the menstrual cycle. 
Brundin (1968) recorded the pressure required to force 
a constant flow of saline through the oviduct of anaesthetised 
rabbits, and found that PG E1 antagonised the effect of 
noradrenaline and electrical stimulation of the hypogastric 
nerve in stimulating contraction of the oviduct. 
Coutinho and Maia (1971) used direct catheterisation 
to study the effects of prostaglandins on the human fallopian 
tube in vivo, and once more found PG Fla to stimulate, 
and PG E2 to relax the tube. As little as 100 ng of PG F 
2 
introduced into the lumen of the tube produced an increase 
in motility which was reversible by higher doses of PG E2. 
Similar results were obtained by Spilman and Harper (1973) 
using rabbits in oestrus. These authors observed that the 
effect was minimal in animals with a low level of spontaneous 
activity and concluded that the effect of prostaglandine 
may be related to tubal muscle control mechanisms. 
(57) 
The earliest demonstration of the spasmogenic effects 
of human semen was on the non -pregnant uterus, and this 
organ has continued to receive much attention since. Kurzrok 
and Lieb (1930) observed that semen applied by intracervical 
injection frequently caused contraction of the uterus, 
although later work by Cockrill et al (1935) showed that 
semen applied to myometrial strips in vitro generally pro- 
duces relaxation. Extracts of human semen (HSF -PG) were 
widely used by early workers in the investigation of the 
effects of prostaglandins on the uterus, until purified 
preparations of prostaglandins became available in the 
early 1960s. 
The rat uterus was shown by Asplund (1947b) to be stimu- 
lated in vivo by HSF -PG whether the route of administration 
was intravenous, intraperitoneal or intravaginal. Karlson 
(1949) recorded the motility of the human uterus using 
three separate pickups to measure simultaneously pressure 
changes in the corpus, isthmus and cervix. At the time of 
ovulation seminal fluid increased the activity of the corpus 
but reduced that of the isthmus and cervix, while at other 
times there was an increase in the activity of all three 
parts. 
Eliasson and Posse (1960) used HSF -PG to show that 
seminal prostaglandins administered intravaginally produced 
increased uterine activity around the time of ovulation. 
When the experiment was repeated in the presence of simul- 
taneous intravenous infusion of oxytocin and vasopressin 
(58) 
the effect was one of relaxation, an interesting observation 
which does not appear to have been followed up in later 
work. 
PG E1 was shown to relax human uterine strips in vitro 
by Sandberg et al (1963) and the same authors later showed 
the effect of PG E2 and PG E3 to be similar (Sandberg et al, 
1964), while the F prostaglandins had a stimulatory effect 
(Sandberg et al, 1965). The effect of HSF -PG on human 
myometrium in vitro was shown to be one of relaxation, 
with the highest sensitivity observed at ovulation time 
(Bygdeman and Eliasson, 1963). Bygdeman (1964) showed 
E prostaglandins to inhibit, and F prostaglandins to stimulate 
the non -pregnant human uterus in vitro, and that the effect 
of HSF -PG was essentially similar to that of PG E. The 
sensitivity of the tissue was highest at mid- cycle, although 
addition of progesterone to these preparations reduced their 
sensitivity towards prostaglandins. 
Adamson et al (1967) found the rat uterus to show 
tachyphylaxis to PG E1 and PG Fla but only slightly to 
PG E2. There was no cross -reactivity between the prosta- 
glandins with respect to this effect, and the authors therefore 
suggested that separate receptors were involved. 
The effect of the (then) newly discovered prostaglandine 
A, B and 19- hydroxy A and B were investigated by Bygdeman 
and Hamberg (1967). All eight compounds were shown to 
affect non -pregnant human isolated myometrial strips in 
(59) 
a similar way to PG E, but to be considerably less potent, 
showing from 1 - 30% of the activity of PG El. 
The effect of the pure prostaglandins on the non -pregnant 
human uterus in vivo has been studied by a number of authors, 
and the results obtained for the E prostaglandins confirm 
those found earlier using semen or HSF -PG. Roth -Brandel 
et al (1970) found that intravenous PG El and PG F20t. both 
invariably caused stimulation of the uterus regardless 
of the stage of the cycle. Essentially similar results 
were obtained by Coutinho and Maia (1971) and Karim et al 
(1971). Martin and Bygdeman (1975) found that very small 
quantities of intrauterine PG E2 (0.25 ug) stimulated the 
uterus early or late in the menstrual cycle. At the time 
of ovulation the sensitivity of the uterus was reduced, 
while during menses the action of the prostaglandin was 
reversed, 30 - 40 )g causing inhibition. 
The early observations of Kurzrok and Lieb (1930) 
and recent work by White and Glass (1976) showed that intra- 
uterine instillation of semen frequently results in strong 
uterine contractions, and the latter authors recommend 
use of no more than 0.3 ml semen for artificial insemination 
to avoid this effect. Since this does not happen after 
normal intercourse, the implication is that the seminal 
prostaglandins can penetrate the cervix only slowly if 
at all. Many workers have demonstrated effects of intra- 
vaginal prostaglandins on the female tract (Karlson, 1959; 
(6o) 
Eliasson and Posse, 1960,1965; Henzl et al, 1972) and 
the problem arises as to how the seminal prostaglandins 
reach the uterus and fallopian tubes from the vagina. 
Horton (1965) calculated that 5 ml of semen containing 
70 1g /ml of PG E would, if deposited in the vagina of a 
woman with a blood volume of 5 litres and absorbed via 
the systemic circulation, give rise to a concentration of 
70 ng /ml in the blood. In order to act upon the tissues 
the prostaglandin would need to pass into the interstitial 
fluid and so further dilution would occur, and in addition 
the rapid inactivation by the lung would further reduce the 
available concentration at the presumed target organs. 
He concluded therefore that systemic absorption of intra- 
vaginal prostaglandins could not account for their effects 
on the female tract. 
Sandberg et al (1968) have studied the rate of urinary 
excretion of radioactivity after vaginal administration 
of tritium- labelled PG E1 mixed with human semen. It was 
found that the rate of appearance of radioactivity in the 
urine was not affected by the presence of a cervical cap, 
and the authors therefore concluded that no significant 
uptake of radioactivity via the cervix occurs. The time 
taken for the bulk of radioactivity to appear in the urine 
in this experiment was, however, much longer than the time 
taken for intravaginal prostaglandins to show their effects, 
and it may well be that the rate of appearance of prostaglandin 
(61) 
metabolites is determined by processes which are much slower 
than the rates of uptake via the cervix or vaginal wall. 
We must therefore conclude that the question of the route 
of uptake of intravaginal prostaglandins is still to be 
resolved. 
The effects of prostaglandins upon the pregnant uterus 
have been widely studied, the bulk of the work concerning 
the utilisation of prostaglandins as abortifacients or 
in the induction of labour. 
One of the earliest demonstrations of an effect which 
may have been due to prostaglandins was that of Ott and 
Scott (1909), who reported that a dried extract of prostate 
gland of unspecified origin strongly stimulated the pregnant 
cat uterus in vitro. The effect of E and F prostaglandins 
on pregnant myometrium was briefly investigated by Bygdeman 
(1964), who found that PG F2ot. strongly stimulated the isolated 
human myometrium while E prostaglandins caused relaxation, 
although higher doses were required than those which relaxed 
non -pregnant strips. 
A more thorough investigation by Embrey and Morrison 
(1968) later showed that the effect of both E and F prosta- 
glandins is to stimulate contraction in vitro of myometrial 
strips taken from the upper segment of human uteri at term. 
Results obtained with lower segment strips were reported to 
be erratic, and the effect of the 2 series compounds was 
found to be more clear -cut than that of the 1 series prosta- 
glandins. 
(62) 
Prostaglandin F20L was shown to stimulate contraction 
of the pregnant human uterus in vivo, and Karim et al (1968b) 
successfully used this compound to induce labour. Embrey 
(1969) showed that infusion of E prostaglandins into pregnant 
women induced uterine contractions both at term and (unlike 
oxytocin) in early pregnancy, and subsequently used this 
method to induce abortion at 9 - 28 weeks gestation (Embrey, 
1970a) and labour at term (Embrey, 1970b). 
Roth -Brandel (1971) compared the response of the pregnant 
uterus in vivo to E prostaglandins in mid -pregnancy and 
at term, showing that the uterus responds at the same dose 
level in both cases, but that the absolute level of con- 
traction elicited is higher at term. 
Brummer (1971, 1972) investigated the interaction 
between oxytocin and prostaglandine in their action upon 
isolated pregnant human myometrial strips and showed two 
types of interaction, potentiation (short term) and enhancement 
(long term). E and F prostaglandins both potentiated the 
effect of oxytocin but only the PG Es produced enhancement, 
and the degree of enhancement was not dose -related. Brummer 
and Collins (1972) attempted to correlate myometrial and 
plasma levels of progesterone with the response of isolated 
pregnant human myometrial strips to prostaglandins, but 
were unable to demonstrate any correlation. Oestradiol 
was shown to block the action of PG E1 on isolated pregnant 
myometrium in a study by Pinto et al (1971). These authors 
(63) 
found a bimodal effect, with low doses of the prostaglandin 
stimulating contractions while high doses inhibited. 
Spilman et al (1977) studied the effect of 19- hydroxy 
prostaglandins E2 and F2OLon the pregnant rhesus monkey 
uterus in vivo. Intravenous injection of the methyl esters 
of these compounds showed that the 19R epimer of 19- hydroxy 
PG E2 was as active as PG E2 in stimulating uterine con- 
tractility, while the (unnatural) 19S epimer was about 
half as active. The methyl ester of 19- hydroxy PG F2151.. 
was much less active than PG F2. It was claimed that the 
methyl esters gave similar results to those obtained with 
the native compounds, presumably due to hydrolysis by non- 
specific serum esterases. 
Most work on the effects of prostaglandins on the 
pregnant uterus has been concerned with the pharmacological 
properties of the compounds, but since copulation continues 
to occur during pregnancy both in man and in many other 
primates, the exposure of the pregnant uterus to seminal 
prostaglandins is also of physiological interest. It has 
been suggested that coitus during pregnancy may result in 
premature labour as a result of the vaginal instillation 
of prostaglandins, and that this may explain the success 
of hospitalisation in the treatment of this condition as 
opposed to bed rest at home (Flynn, 1971). 
It seems improbable that intercourse during the first 
and second trimesters of pregnancy could lead to ill effects, 
(64) 
since the quantities of intravaginal prostaglandine required 
to induce abortion at this time are far larger than those 
present in normal ejaculates, typical values reported being 
50 mg PG 
F20Cor 
20 mg PG El (Brenner et al, 1972; Beguin 
et al, 1972; Pion et al, 1972). 
Prostaglandin synthetase inhibitors have been shown 
to prolong pregnancy in the rat (Aiken, 1972; Chester 
et al, 1972) and inhibit spontaneous and oxytocin -stimulated 
contraction of late pregnant isolated rat myometrial strips 
(Vane and Williams, 1972; Williams et al, 1974). The 
addition of indomethacin or aspirin to baths containing 
such strips has been shown to inhibit the release of F 
prostaglandins into the bathing medium (Aiken, 1972; 
Williams et al, 1974). It would seem probable in the light 
of these findings that the action of oxytocin is mediated 
via increased prostaglandin synthesis. Oxytocin and PG E2 
have been shown to have very similar effects on the dis- 
tribution of blood flow and uterine contractility in the 
pregnant rhesus monkey uterus (Novy et al, 1975). 
The mechanism of action of prostaglandins on myometrium 
is unknown at present. On the basis of their action in 
other tissues, one might expect stimulatory prostaglandins 
to act by modification of cyclic nucleotide levels. ¡3- 
adrenergic agents (which relax the uterus) have been, shown 
to raise cAMP levels (Butcher et al, 1965; Triner et al, 
1971) and if prostaglandins could be shown to produce the 
reverse effect, or to prevent, -agonist induced cAMP generation 
(65) 
this would provide strong evidence for a central role of 
cyclic AMP in mediating the action of these compounds on 
the uterus. 
Adrenaline and E prostaglandins were both shown to 
stimulate adenyl cyclase in the rat uterus in work by Harbon 
and Clauser (1971), while oxytocin and PG F20Lhad no effect 
on this enzyme. The action of oxytocin and PG 
F20Cin 
stimu- 
lating contraction of the uterus was antagonised by adrenaline 
and by dibutyryl cAMP but not by E prostaglandins, and the 
authors concluded that the intracellular cAMP level was 
not the sole parameter regulating uterine motility. Later, 
however, it was shown that rat endometrium contains an 
adenyl cyclase which is stimulated by PG E but not by/9- 
agonists (Bhalla et al, 1972), and the oestrogen- dominated 
uteri studied by Harbon and Clauser may well have included 
this enzyme. PG Es and PG F26have been shown to inhibit 
the rise in cAMP stimulated byp-agonists in myometrium 
from oophorectomised rats (Bhalla et al, 1972; Kroeger 
and Marshal, 1974). 
Treatment of oophorectomised rats with oestradiol 17 -p 
has been shown to increase uterine motility, raise levels 
of PG Fs and raise cGMP levels, however, simultaneous ad- 
ministration of indomethacin did not prevent the rise in 
cGMP while blocking PG F production (Ham et al, 1975). 
PG E1 has been shown to-facilitate the non -energised 
binding of Ca ++ to the inner membrane of rat liver mito- 
(66) 
chondria, and to inhibit the mitochondrial swelling produced 
by energised accumulation of Ca ++ (Kirtland and Baum, 1972). 
It was proposed that these effects were due to the prosta- 
glandin acting as an ionophore to facilitate the access 
of Ca ++ to binding sites on the membrane, and that calcium- 
dependant processes elsewhere (such as the contraction of 
smooth muscle) may likewise be controlled by prostaglandins 
regulating the passage of this ion across lipoprotein membanes. 
Carsten (1974) showed that PG E2, PG F2OCand oxytocin 
all inhibited the ATP -dependant binding of calcium ions 
to a subcellular fraction derived from the sarcoplasmic 
reticulum of bovine myometrium. The author proposed that 
inhibition of intracellular binding of Ca ++ increases the 
concentration of free Ca + +, leading to more interaction 
with the regulatory proteins of the myofibril and subsequent 
contraction. 
The biological effects of 19- hydroxy prostaglandins. 
Most work performed on the effects of 19- hydroxy 
prostaglandins on biological systems has so far remained 
unpublished, and results which have been made available 
to us by the authors are quoted here with their permission. 
The effects of synthetic (racemic) 19- hydroxy PG El, 
19- hydroxy PG E2 and 19- hydroxy PG F2o(.on the reproductive 
tract of anaesthetised female rabbits have been investigated 
by Horton (E.W. Horton, unpublished) who found that they 
(67) 
were similar to, but less potent than the non -hydroxylated 
parent compounds. The equipotent molar ratios (EPMRs) for 
the 19- hydroxylated compounds varied from 180 to 550 relative 
to the parent compounds. Work on the classical bioassay 
preparations, rat fundus and guinea pig ileum strips (P.S. 
Agutter, unpublished) and on blood pressure in the sheep 
and dog (R.L. Jones, unpublished) has shown a similar picture. 
The effects of 19- hydroxy PG El on various preparations 
from one male and one female patas monkey were studied by 
Vane and Higgs (J.R. Vane and,G.A. Higgs, unpublished) who 
found once more that the action of the hydroxylated compound 
on vascular and intestinal smooth muscle was similar to, but 
less potent than that of PG El. 19- hydroxy PG El was shown 
to relax the isolated oviduct at low levels, in contrast 
to PG El, PG E2 and PG 
F20Cwhich 
all produced contraction 
in this preparation. None of the prostaglandins tested 
showed any effect on isolated myometrial strips, although 
the authors point out that since only one animal of each 
sex was available little weight can be attached to negative 
results, which may have been due to setting up the tissue 
in less than optimal conditions. 
The work of Spilman et al (1977) showing 19- hydroxy 
PG E2 (methyl ester) to stimulate contraction of the pregnant 
rhesus monkey uterus in vivo has already been described. 
Similar results were obtained by Novy (M.J. Novy, unpublished) 
using natural 19- hydroxy PG El. 
(68) 
Objectives of the present work. 
After the discovery by Hamberg and Samuelsson of the 
A and B prostaglandins in 1965 little further progress was 
made in the identification of seminal prostaglandins until 
1974, when we reported the presence of 19- hydroxy PG El 
and 19- hydroxy PG E2 and showed them to be the major com- 
ponents of the seminal prostaglandins in man. The discovery 
of these compounds showed that the composition of the mixture 
of prostaglandins present in semen was still not completely 
described. In particular, the existence of the 19- hydroxy 
PG Es made it seem likely that human semen would also contain 
19- hydroxy F prostaglandins, and a major objective of the 
work described in this thesis was the fractionation of the 
lipid components of semen and identification of any further 
prostaglandins thus isolated. The results of this work 
are presented in chapter 1. 
Identification of the structures of the isolated compounds 
was made possible by the technique of combined gas chromato- 
graphy-mass spectrometry, and a subsidiary aim of the project 
was to establish a collection of mass spectra of the novel 
prostaglandins, together with data on their chromatographic 
properties. A selection of mass spectra are described in 
chapter 2, along with tables of chromatographic data. 
The identification of the 19- hydroxy PG Es as the 
major components of the human seminal prostaglandine suggested 
several further projects, including studies on the biological 
activity, biosynthesis, metabolism and species distribution 
(69) 
of these compounds. The results of a study on the effects 
of 19- hydroxy PG El on isolated myometrial strips are presented 
in chapter.3. The investigation of the biosynthesis of the 
19- hydroxy PG Es in vitro is described in chapter 4, and 
some observations on the biosynthesis of PG E and 19- hydroxy 
PG E in vivo are presented in chapter 5. 
It had been hoped that the work on the biosynthesis 
of the 19- hydroxy prostaglandins would provide some iso- 
topically- labelled 19- hydroxy PG Es which would be used 
for studies on the metabolic fate of these compounds. In 
practice, however, a biological synthesis of labelled 19- 
hydroxy prostaglandins was not achieved, and this part 
of the project was therefore postponed until such labelled 
compounds 
The results of the study on the species distribution 
of seminal 19- hydroxy E prostaglandins are given in chapter 6. 
(7o) 
General materials and methods. 
Standard prostaglandine. 
The following compounds were the gift of the persons 
listed: - 
PGs El, E2, E3, F10, F2 0and D2. - Dr J.E. Pike (Upjohn Co). 
PGs 19 -0H E1, 19-0H E2, 19 -0H 
F2oLand 
15R 19-0H E2 
- Dr N. Crossley (ICI). 
Dinor PG E2 - Dr D.A. Van Dorp (Unilever). 
8 -iso PG E1, 8 -iso PG E2 - Dr K. Sakai (Sankyo Co). 
Prostaglandins dinor Fla, 8 -iso Fla, 8 -iso F2a and 
9 -3H F3tLwere prepared by borohydride reduction of the 
appropriate PG E precursor. 
Method. Up to 1 mg of the E prostaglandin was treated with 
potassium borohydride (10 mg /ml in water /methanol 1 :2) for 
one hour at room temperature. The solution was acidified 
(HC1), diluted with water and extracted with three volumes 
of ethyl acetate. The extract was dried, and the residue 
chromatographed on LH 20 Sephadex (1.5M x 5 mm column, 
chloroform / ethyl acetate / acetic acid 50:50:1) in order 
to separate the Fa and Fie compounds. PG FoL compounds were 
identified by their ability to form n -butyl boronate deriva- 
tives, and in all cases eluted from the column before the 
FA isomer. 
In the case of tritium labelled PG F3 PG E3 (500)4g) 
was dissolved in 0.5 ml methanol /water (2 :1) and injected 
(71) 
through a rubber seal placed on the neck of a vial containing 
KB3H4 (100 mCi). Excess tritium gas was led away via a 
syringe needle penetrating the cap, and via a nylon tube 
to the fume cupboard duct. The tritiated prostaglandins 
were extracted and separated on Sephadex LH 20 as above, 
and an aliquot from each fraction counted to determine the 
position of the radioactive peaks. The reconstructed chromato- 
gram is given in fig. M.1, and shows the typical separation 
achieved between Fa and F compounds in this system. The 
yield of PG F3ccat this stage was 100 )ZCi. 
In most cases PG F compounds prepared by borohydride 
reduction were intended for reference standards on TLC, 
GLC and mass spectrometry, and the presence of minor im- 
purities was of no importance. Tritiated PG F3 however, 
was intended as a substrate for 19- hydroxylation, and since 
argentation TLC analysis showed the presence of a radioactive 
impurity corresponding to PG F2000 further stage of puri- 
fication was undertaken. 
An aluminium TLC plate (10 x 20 cm) was dipped in 
aqueous silver nitrate (5 ;) and dried (30 min. at 150 °C) 
in darkness. The sample (half of the previously prepared 
PG F3CC) was streaked across 60 mm of the origin, and the 
plate was developed in methanol / chloroform / acetic acid 
(40 :60 :1). Radioactive bands were located using a TLC 
scanner and that corresponding to PG F3 awas eluted with 
methanol. The methanol eluate was dried and re -run on a 
newly -packed LH 20 Sephadex column (the effluent from the 
(72) 
original column was too radioactive for further use even 
after washing for seven days). The final yield of 3H PG F3oc 
was 11 pCi, and the specific activity (calculated from that 
of the tritiated borohydride starting material) was 3.75 Ci/ mmol. 
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(73) 
Isotopically- labelled compounds. 
All radioactive compounds used in this work were 
obtained from the Radiochemical Centre, Amersham, with 
the exception of 14C eicosatrienoic acid, which was obtained 
from New England Nuclear Co. The position of the label 
and specific activities were as follows:- 
Eicosa -8,11,14 -trienoic acid 1-C 57.5 mCi/mmol. 
Eicosa- 5,8,11,14 -tetraenoic acid (arachidonic acid) 
1 -14C 60.2 mCi /mmol. 
Potassium borohydride KB3H4 15 Ci /mmol. 
5,6 (n) -3H 40 Ci /mmol. 
5,6,8,11,12,14,15 (n) -3H 155 Ci /mmol. 





PG D2 (1 -14C) was a by- product of the incubation of (1 -14C) 
arachidonic acid with stump- tailed macaque seminal vesicle 
homogenate (see methods specific to chapter 4). After 
isolation of the synthesised PG D2 by LH 20 Sephadex chromato- 
graphy, the identity of the radioactive peak with PG D2 was 
checked by re- running an aliquot on the LH 20 column along 
with authentic PG D2 (50 jg). An aliquot from each column 
fraction (1 /10) was counted to determine the position of 
the radioactive peak, and the remainder of the corresponding 
fractions (fr. 23 -28) derivatised (M0 /ME /TMS) and run on 
the GLC along with cholesterol acetate (48 jg) as internal 
standard to determine the position of the peak corresponding 
(74) 
to authentic PG D2 (fig. M.2). 
The remainder of the synthesised (1 -14C) PG D2 was 
used as a tracer, added to semen to check on the recovery 
of PG D2 and to facilitate identification of the corresponding 
column fractions, and was not further purified before use. 
It was not possible to estimate the specific activity of 
this material, since the amount of PG D2 present was too 
small to be detected by GCMS. 
Commonplace reagents. 
All laboratory reagents and solvents used in this work 
were 'Analar' or equivalent grade, and were not re- distilled 
or otherwise purified before use. 
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Thin layer chromatography. 
TLC was performed on Merck pre- coated aluminium plates 
(K 60- F 54)$ the chromatograms being developed in the solvent 
systems listed below and at 20 °C. Prostaglandins were 
applied to the plate in solution in ethyl acetate and dried 
at ambient temperature. After development and drying the 
spots were visualised by sulphuric acid charring. 
Three main solvent systems were used: - 
(I) Ethyl acetate / acetone / acetic acid (90 :10:1) 
(II) Chloroform / methanol / acetic acid (80 :20:1) 
(III) Ethyl acetate / acetic acid (9:1) 
System (I) is the Flu system of Anderson (1969). In the 
case of system (III) the plate was run, dried and re -run 
to the same mark, and Rf values quoted are for plates de- 
veloped twice in this way. 
Preparative TLC was performed using the same type of 
plate. Sample was streaked across the width of the plate 
and after development a narrow strip was cut from each 
edge of the plate with scissors. Spots on these strips 
were visualised and the positions of the corresponding 
bands on the remaining portion of the plate marked. These 
areas were scraped off into Pasteur pipettes containing 
a 10 mm layer of Sephadex LH 20 retained by a cotton wool 
plug. Methanol (4 ml) was passed through this composite 
column to elute the sample. This column method of elution 
proved the most efficient for the very polar 19- hydroxy 
compounds, the layer of LH 20 serving to retain the silicic acid. 
(76) 
Scintillation counting. 
Levels of radioactivity were measured by means of a 
Packard TriCarb liquid scintillation spectrometer. Samples 
(0.01 - 1 ml_in water or ethanol) were placed in 20 ml 
polypropylene counting vials containing 10 ml scintillant, 
and were permitted to equilibrate at 4°C for at least 30 
minutes before counting, which was performed at this temp- 
erature. The composition of the scintillant was as follows:- 
2,5 diphenyloxazole (PPO) 10 g. 
1,4 di(5- phenyloxazolyl) benzene (POPOP) 0.75 g. 
Toluene 2.5 1. 
Triton X -100 1.25 1. 
Counting was performed using the counting parameters 
pre -set by the manufacturer for 3H and 14C, and the counting 
efficiency was monitored continuously by external standard. 
Vials were counted for 5 minutes or 100,000 counts, and 
output was via an ASR 33 teletype / tape punch. Paper tape 
produced, containing data which included the external standard- 
isation ratio and measured counts /minute for each channel 
was fed to a PDP 81 computer where the counting efficiency 
for each vial was computed using a program written for the 
purpose (program listing in appendix). The external standard 
was calibrated periodically against the standards provided 
by Packard, and counting efficiencies were typically 35% 
for tritium and 70% for 14C. 
(77) 
Prostaglandin derivatisation methods. 
Prostaglandins are polar, non -volatile, thermolabile 
lipids, unsuited in their native state to gas liquid chroma- 
tography. In order to render these compounds more volatile 
and less polar it is necessary to derivatise the functional 
groups of the molecule. Three types of functional group 
are present in the prostaglandine, requiring up to three 
stages of derivatisation. 
Abbreviations for the various derivatives used throughout 
this report are given in brackets in the order in which 
the reactions were performed, thus (MO /ME /TMS) signifies 
that the compound was first oximated (methyl oxime) then 
esterified (methyl ester) and finally the hydroxyl groups 
were derivatised (trimethylsilyl ether). 
Carbonyl groups were derivatised as the oxime (0), methyl 
oxime (MO) or ethyl oxime (EO). Where the (0) derivative 
was used the free hydroxyl introduced was later derivatised 
along with the remaining hydroxyl groups. Methods of pre- 
paring oximes differed only in the reagent used. 
Procedure. 
Oximes- Sample material was dissolved in 1 ml pyridinium 
acetate buffer (1.5 M, pH 5.0) containing the oximating 
reagent (10 mg methoxyamine HC1 (MO), 10 mg ethoxyamine 
HC1 (EO) or 20 mg hydroxylamine HC1 (0)) in a 10 ml stoppered 
test tube. The tube was placed in an ultrasonic bath for 
45 minutes. After removal, the contents of the tube were 
(78) 
extracted using 9 ml ether /ethyl acetate (2:1). The organic 
layer was removed and dried, initially under nitrogen and 
finally under vacuum at 60°C to ensure removal of all acetic 
acid. 
An alternative procedure was used where the prosta- 
glandins were present in aqueous solution, as in semen or 
tissue homogenates. This avoided extraction of the labile 
19- hydroxy E prostaglandine until after oximation, helping 
to preserve them from dehydration. - 
Semen (0.5 ml) was added to the oximating solution 
(4.5 ml, composition as above). After treatment in the 
ultrasonic bath the solution was extracted with ether /ethyl 
acetate (45 ml), the extract being dried by means of a 
rotary evaporator. 
Carboxyl groups were esterified as methyl- (ME) or ethyl- 
(Et) esters. If left underivatised at this stage they would 
be esterified to trimethylsilyl (TMS) or t -butyl dimethyl- 
silyl (tBDMS) esters when the hydroxyl groups were deri- 
vatised at a later stage. 
Procedure. 
Sample was placed in a flat bottomed 4 ml tube and 
the solvent evaporated. Diazomethane (ME) or diazoethane (FE) 
(79) 
freshly prepared in solution in ether / methanol (9:1) 
was added (100111). The tube was stoppered, mixed and 
allowed to stand for five minutes at room temperature before 
removal of the reagent by cautious evaporation under reduced 
pressure. 
Hydroxyl groups were derivatised as various silyl ethers - 
trimethylsilyl (TMS), dimethylsilyl (DMS) or t -butyl dimethyl- 
silyl ( tBDMS) ethers. Alkyl boronates (BB, tBB and MB) 
are cyclic derivatives which can be formed only by compounds 
possessing cis 1,2 or 1,3 diols. Of the prostaglandins 
only the Fa compounds form them, and they were used to 
differentiate between F01. and F compounds. The n -butyl 
boronate (BB) was most commonly used, but I have also used 
the t -butyl (tBB) and methyl (MB) boronates. 
Procedure. 
Sample was placed in a haematocrit tube (2 x 60 mm) 
and the solvent evaporated in each case. 
(TMS) - Bis- trimethylsilyltrifluoroacetamide (up to 25 11) 
was added, the tube was sealed and heated at 60 °C for 20 
minutes. The derivative was injected in the reagent. 
(DMS) - Method as for (TMS) except that the reagent was 
a mixture of equal parts of tetramethyldisilazane and chloro- 
dimethylsilane. 
(tBDMS) - t -butyl dimethylsilyl chloride (2 M) and imidazole 
(2 M) in dimethyl formamide (100 )pl) were added, the tube 
(80) 
was sealed and heated at 120oC for one hour. The contents 
were loaded onto an LH 20 Sephadex column (30 x 5 mm) and 
eluted with 3 ml leptane / ethyl acetate (3 :1). Solvent 
was evaporated under nitrogen and the residue redissolved 
in an appropriate volume of toluene for injection. 
Alkyl boronates (BB, tBB and MB) - were prepared before 
the remaining hydroxyls were derivatised. Acetone / benzene 
(1:1, 40 )1) containing n -butyl boronic acid (BB), t -butyl 
boronic acid (tBB) or methyl boronic acid (MB) (5 mg /ml) 
was added and the tube was placed under reduced pressure 
(_00 mm Hg) at 60°C for 20 minutes. Any remaining solvent 
was removed under vacuum. 
(81) 
Gas liquid chromatography -mass spectrometry of prostaglandins. 
Mass spectra of prostaglandin derivatives were produced 
on an AEI MS 12 mass spectrometer coupled via a Watson - 
Bieman all glass molecular separator to a Hewlett- Packard 
4000 gas liquid chromatograph. A glass U tube column was 
employed (1.5 M x 3 mm), the stationary phase being Dexsil 
300 (1% on Chromosorb G). The flow rate of the helium 
carrier gas was 40 ml /min and the column oven was operated 
at 200 - 300 °C. On- column injection was employed, with 
the injection area of the column operated at the same tem- 
perature as the remainder. The GLC was coupled to the 
separator via glass -lined steel tubing, the inlet lines 
and separator being maintained at 250 - 350 °C. 
Mass spectra were produced using electron impact ion- 
isation, the electron beam energy being 20 eV and the source 
block temperature 280 °C. The ion accelerating potential 
was 8 KV and the mass spectrometer was operated at a resolving 
power of 600 -800 (10% valley definition). Detection of 
the ion beam was by electron multiplier operated at potent- 
ials up to 2.5 KV. 
Spectra were scanned at 16 seconds per decade and 
recorded by the PDP 81 computer. Data reduction was accom- 
plished by means of the AEI DS 30 data system and results 
plotted either in histogram form on an XY plotter or as a 
numerical listing on the teletype. The instrument was 
calibrated against perfluorokerosene. 
(82) 
Single ion monitoring GCMS assay of prostaglandin 
derivatives was performed on a DuPont 490 mass spectrometer 
coupled via an all -glass single jet molecular separator 
to a Varian 1400 gas liquid chromatograph. The GLC column 
was a support- coated open tubular capillary (12.5 M x 0.5 mm, 
Scientific Glass Engineering Pty.), SE 30 stationary phase. 
The column was operated isothermally at 270 °C and the flow 
rate of the helium carrier gas was 6 ml /min. The injection 
temperature was 280 °C and the inlet lines and separator 
were maintained at 250 -300 °C. 
The operating conditions for the mass spectrometer 
were as follows:- Ionisation energy 20 eV, accelerating 
potential approx 1.4 KV, electron multiplier potential 
2 KV, source block temperature 230 °C, resolution 600. 
Multiple ion detection apparatus was available, enabling 
up to six channels to be recorded simultaneously, however, 
in the present work only two channels were used for recording, 
a third channel remaining tuned to a known mass in the spectrum 
of perfluorokerosene. Perfluorokerosene was introduced into 
the source via the batch inlet system and the mass spectrometer 
was tuned to m/e 792.9506 using the 'tuning' channel of the 
MID. The high tension reference voltage was then measured 
by means of a digital voltmeter, and the voltage required 
to tune in the sample ions calculated. The 'sample' channels 
of the MID were then set to the calculated voltages and the 
perfluorokerosene pumped from the source before injection 
of the sample. Tuning of the mass spectrometer was checked 
(83) 
at intervals by readmitting perfluorokerosene, switching 
to the 'tuning' channel and optimising the magnet current 
for maximum detector response. 
(84) 
Assay of Prostaglandins. 
Assay of E and 19- hydroxy E prostaglandine by GLC. 
The measurement of E and 19- hydroxy E prostaglandins 
in semen using modern methods poses no serious problems 
since the compounds are present in relatively large amounts, 
and the method of aqueous oximation described previously 
has enabled the tendency of the 9- ketoprostaglandins to 
dehydration to be overcome. The method described here is 
a variation on that of Cooper and Kelly (1975). 
Method 
Sample (0.5 ml) was derivatised (MO /ME /TMS) using the 
techniques described under "derivatisation methods ". After 
methylation, but before formation of the TMS derivative, 
an accurately measured quantity of cholesterol acetate 
(ca. 25 jg) was added as an internal standard. (If the 
internal standard is added at the beginning of the procedure 
a certain amount of hydrolysis to free cholesterol takes 
place during oximation.) The final volume of the silanising 
agent was 10 -25 yl. 
An aliquot (up to 10 )1) was injected into the Hewlett - 
Packard / AEI MS 12 GCMS combination using the operating 
conditions specified previously. The column temperature 
was programmed from 200° to 300 °C at 2 
o 
/min. Peaks were 
detected by the total ion current monitor of the mass spectro- 
meter and quantified by computer integration using a program 
developed for the purpose (program listed in appendix). 
(85) 
A standard curve for 19- hydroxy PG E2 is reproduced in 
fig. M.3. The detection limit of the system depends critically 
on the age and past history of the column, but lies in the 
range 1-5 )mg per injection of standard compounds. (The 
detection limit is here defined as the minimum quantity 
of standard required to give a peak which exceeds system 
noise by 3o6. The ability of the system to differentiate 
between the 1 and 2 series compounds depends on the relative 
proportions of the two species present. In human semen, 
where the two series of prostaglandins are present in similar 
amounts they can be measured independently with reasonable 
accuracy. In the semen of non -human primates the peak cor- 
responding to 19- hydroxy PG E2 is reduced to a shoulder on 
the side of the 19- hydroxy PG El peak, causing the integrator 
to lump the results together, and estimates of the relative 
proportions of the two compounds must be made manually from 
the chart record. 
Precision of the assay has been tested by running 
six replicate samples from pooled semen. Results indicated 
mean levels of 182 ±10% (o') jig for 19- hydroxy PG Es and 
49-12% (o') 1g for 
PG Es (per ml of semen in both cases). 
Assay of 19- hydroxy E prostaglandine in tissue homogenates. 
The method described above was modified to increase 
the sensitivity towards 19- hydroxy PG Es at the expense of 
the E prostaglandine. Sample (1 ml) was precipitated by 
the addition of ethanol (10 ml) and the precipitate was 
(86) 
centrifuged down. The precipitate was washed with ethanol 
(10 ml) and the ethanol extracts combined and evaporated. 
The residue from this evaporation was redissolved in potassium 
phosphate buffer (10 ml, 1.0 M, pH 5.0) and extracted with 
ether (10 ml) and ethyl acetate (3 x 30 ml). The ether 
layer was discarded and the combined ethyl acetate extracts 
were dried and derivatised (MO /ME /TMS) as in the previous 
method. Gas liquid chromatography was performed isothermally 
at 270 °C. 
The differential extraction procedure removes many 
compounds less polar than the 19- hydroxy PG Es, while losing 
only 5% of the 19- hydroxy prostaglandins present. The 
cleaner sample provided by this method allowed isothermal 
operation of the GLC column at the optimum temperature for 
detection of the 19- hydroxy E prostaglandins. The detection 
limit for standards using this method was about 0.1 jig, 
however, in practice the limit was set by the presence of 
interfering compounds in the sample, and an arbitrary figure 
of 1.pg has been adopted for the purposes of this report. 
Precision of the assay was tested by running six 
replicate standards (19- hydroxy PG El, 5.2 ,.zg each). Results 
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Fig. M.3. 
Standard curve for 19-hydroxy PG E2 (GLC assay). 
Results are calculated as follows: - 
If a is the measured area of the unknown peak, 
b is the measured area of the internal standard 
peak, 
c is the weight of internal standard added, 
x 
weight of unknown 
b a x 368 
ca 627 
(368 is the molecular weight of 19 -0H PG E2, 627 is 
the molecular weight of 19 -0H PG E2 (M0 /14 /TMS)). 
(88) 
GCMS measurement of low levels of 19- hydroxy E prostaglandins. 
Measurement of low levels of 19- hydroxy E prostaglandins 
in tissue homogenates and incubations was accomplished 
by single ion monitoring using the Varian / DuPont 490 
GCMS combination. Homogenates were oximated directly without 
prior extraction and derivatised (0 /ME /tBDMS) using the 
methods described previously. This derivative, having 
four t -butyl dimethylsilyl groups gives a very strong ion 
at M -57 (798.5353 for 19-0H PG El, 796.5197 for 19-0H PG 
E2), and the high proportion of the total ion current con- 
centrated in this ion makes the derivative particularly 
suitable for single ion monitoring (Kelly and Taylor, 1976a). 
Since no deuterated 19- hydroxy PG E or other suitable internal 
standard was available the detector response was compared with 
that for a series of standards which were interspersed 
with the sample injections. The accuracy of this method 
therefore depends critically on the accuracy of the volume 
of each injection and the stability of the detector response. 
In order to minimise these sources of inaccuracy, six repli- 
cate injections were made of each sample and standard, 
and the results quoted are therefore the mean of six estimates. 
Samples and standards were run isothermally (oven 
temperature 270°C) and the detector response was quantitated 
by measuring the peaks on the chart trace by hand. Measurement 
of peak height rather than area gives a more reproducible 
measurement provided that the oven temperature (and therefore 
the peak width) does not change. Either of the two oxime 
(89) 
isomers may be used for measurement, but the first isomer 
to appear gives a more linear calibration curve at low 
levels, and was therefore used exclusively in these measure- 
ments. 
A standard curve for 19- hydroxy PG El is reproduced 
in fig. M.4. The method is extremely sensitive, since the 
absence of an internal standard eliminates the crossover 
between channels which is normally a problem when monitoring 
more than one ion. As little as 50 pg 19- hydroxy El or 
19- hydroxy E2 injected gives a visible peak, however, all 
measurements quoted here were made using injections in the 
range 1 -10 ng. 
Precision of the assay was checked by running six 
replicate samples of human semen (2.0)11 each). The derivat- 
ised samples were dissolved in toluene (100;p1) and six 
replicate injections of 1.0µl were made from each. Results 
indicated a level of 2.6 ng/injection (130 7g /ml semen) of 
19- hydroxy PG El, and the standard deviation between replicate 
samples was 19 %. It should be noted that this figure was 
not different from that for replicate injections from the 
same derivatised sample (ranging from 9% - 52% in the present 
case) and the variance contributed to the results by sampling 
errors and losses during derivatisation is therefore small 
compared with that introduced by the mass spectrometer. 
Advantage has been taken of this in the presentation of 
results on the time course of synthesis of 19- hydroxy PG 
E1 
in seminal vesicle homogenate (fig. 4.3), where the standard 
(9o) 
deviations quoted refer to replicate injections rather than 
replicate samples. Such standard deviations may not be 
used to infer statistical significance, but do convey some 
useful information since they indicate the magnitude of 
the major source of error. 
The precision between assays performed on different 
occasions has not been checked for any of the three assay 
systems described, and absolute levels of compounds quoted 
should therefore be treated with caution. In all cases 
samples derived from the same experiment were run together 
in the same assay, and relative concentrations quoted are 
therefore subject only to the errors imposed by the inter- 


























ng 19-0H PG El injected. 
Fig. M.4. 
Standard curve for 19- hydroxy PG El assayed by 
single ion monitoring. Bars represent standard devi- 
ation of replicate injections from the same derivatised 
standard. (n a 6) 
(92) 
Methods specific to chapter 1. 
(Isolation and identification of new prostaglandins 
from semen.) 
Group separation of prostaglandins. Human semen 
(68 ml) was stored in ethanol at -20 °C until required and 
was then centrifuged (3000 RPM, 5 min) and the supernatant 
evaporated to dryness under reduced pressure. The residue 
remaining after evaporation was redissolved in potassium 
phosphate buffer (1.0 M, pH 5.0, 50 ml) and extracted three 
times with ethyl acetate (3 x 150 ml). The combined ethyl 
acetate extracts were dried and their solute chromatographed 
on an LH 20 Sephadex column (1.5 M x 5mm) using chloroform/ 
ethyl acetate / acetic acid (50:50 :1) as eluting solvent. 
Fractions of 1.8 ml volume were collected, dried under nitrogen 
and taken up in ethanol (100p1 each). 
Thin layer chromatography was performed on selected 
fractions from the LH 20 column using the methods described 
previously. The two -dimensional separation of 
the seminal prostaglandins was achieved by taking an aliquot 
(5 111) from each fraction (fractions 1 -30), from alternate 
fractions (31 -100) or from every fourth fraction (101 -160) 
and loading onto a 20 x 20 cm TLC plate, which was then developed 
using solvent system III. The plate was inspected under 
ultraviolet light, and absorbing or fluorescing spots were 
ringed. The remaining spots were made visible with sulphuric 
(93) 
acid. Spots were identified by their retention volumes and 
Rf values, and also by colour (E prostaglandins produce a 
brown spot, F prostaglandine a pink spot). 
Borohydride reduction of 9- ketoprostaglandins was performed 
by treatment with potassium borohydride (10 mg /ml in methanol 
water 2:1) for one hour at room temperature. The solution 
was acidified (HC1), diluted with water and extracted three 
times with three volumes of ethyl acetate. The ethyl acetate 
extracts were combined, dried and the residue chromatographed 
on the LH 20 Sephadex column described above, in order to 
separate the resulting F« and rie compounds. The Fa compounds 
were identified by their ability to form n -butyl boronate 
derivatives, and in all cases eluted from the column before 
isomers. 
Dehydration of 9- ketoprostaglandins. 9- ketoprostaglandins 
were dehydrated to the equivalent PG Bs by treatment with 
strong base (1 N NaOH) for one hour at room temperature, 
followed by acidification and extraction. 19- hydroxy E 
prostaglandins may be dehydrated and simultaneously derivatised 
by making the (ME /TMS) derivative without prior oximation, this 
process yielding the equivalent A prostaglandin derivatives. 
Isomerisation of 9- ketoprostaglandins was performed 
using the method of Daniels et al (1968). The compounds 
were treated with potassium acetate (2p in ethanol) for seven 
days at room temperature followed by dilution with water, 
acidification and extraction into ethyl acetate. This process 
yields an equilibrium mixture of E and 8 -iso E prostaglandins 
(94) 
containing about 1Clo of the 8- isoprostaglandin. 
Incubation of semen with labelled prostaglandins. 
To a single fresh ejaculate (2.8 ml volume) was added (5,6 
(n) 3H) PG El (1.0,RCi) and (5,6,8,11,12,14,15 (n) 3H PG F204 
(1.0 µCi), each dissolved in ethanol (5,pl). The semen was 
allowed to stand for four hours at room temperature, and 
was then precipitated with four volumes of ethanol and 
stored at - 20 °C for seven days. The prostaglandins were 
then extracted and subjected to chromatography on LH 20 
Sephadex using the method described above. 1/10th of each 
fraction was removed and counted to determine the position 
of the PG E and PG F peaks and the relative quantities of 
labelled PG 
F2o[and 
8 -iso PG F2 The fractions corresponding 
to the E prostaglandins were pooled and rechromatographed 
on TLC (system I). The plate was examined using a radioactive 
TLC plate scanner, and the areas corresponding to PG El and 
8 -iso PG E1 were scraped off into scintillation vials and 
counted to determine the relative proportions of labelled 
PG El and 8 -iso PG El. 
Prostaglandin D2. The presence of this prostaglandin 
in semen was separately investigated using the following method. 
Human semen (67.5 ml) was stored in acetone at - 20 °C 
until required. 4C PG D2 (58,000 DPM) was added and the 
precipitate centrifuged down. The supernatant was evaporated 
to dryness under reduced pressure and the residue from this 
evaporation taken up directly in 0.5 ml chloroform / ethyl 
acetate / acetic acid (50:50:1) before running on the 1.5 M x 
(95) 
5 mm LH 20 Sephadex column. Fractions of 1.8 ml were collected, 
dried and taken up in ethanol (1.0 ml). An aliquot of 50/11 
was taken from each fraction for scintillation counting, and 
after location of the radioactive peak, half of each of the 
corresponding fractions were derivatised (MO /ME /TMS) for 
GCMS (scanning) and the remaining halves as (0 /ME /tBDMS) 
for single ion monitoring GCMS analysis. 
Preparation of crystalline 19- hydroxy PG El from the 
semen of Macaca arctoides. 
Seminal coagulum was collected from the cage floors 
of two stump- tailed macaques that masturbated frequently. 
Thirty two specimens were stored in ethanol at - 20 °C until 
required. The original weight of coagulum was not recorded 
since the samples were inevitably contaminated with faeces 
and other cage floor detritus. 
The coagulum was crushed in a mortar and homogenised 
in the ethanol used for storage. Solid materials were removed 
by centrifugation and the supernatant evaporated to dryness 
under reduced pressure at 40 °C. The solid residue from this 
evaporation was redissolved in potassium phosphate buffer 
(100 ml, 0.5 M, pH 5.0). This was then extracted first with 
ether (100 ml) and then three times with ethyl acetate (3 a 300 
ml). The ether extract was discarded, and the ethyl acetate 
extracts combined and dried. The residue was redissolved 
in 0.5 ml ethyl acetate / chloroform / acetic acid (50/50/1) 
and loaded onto a 400 a 5 mm LH 20 Sephadex column which 
was then eluted with the same solvent. 3.2 ml fractions 
(96) 
were collected, the fractions being immediately evaporated 
under nitrogen and redissolved in ethanol (100)0). An aliquot 
(5 )1) was taken from each fraction for GCMS analysis. 
Fractions 13 and 14, containing 19- hydroxy PG El, were 
retained, along with fractions 15 - 22 which contained di- 
hydroxy E prostaglandins. Fractions 10 - 12, which contained 
19- hydroxy El along with some 19- hydroxy E2 were pooled and 
rechromatographed (run 2). Fractions 13 and 14 from run 2 
were pooled with fractions 13 and 14 from run 1 and subjected 
to a third stage of chromatography (run 3). Fractions 13 and 
14 from run 3 contained material which partially crystallised 
on evaporation, and this material was further purified by 
recrystallisation. 
The partially crystalline 19- hydroxy PG El was dissolved 
in acetone (2 ml) and n- heptane added until a faint precipitate 
appeared. The solution was then left to evaporate from an 
open tube at room temperature until the volume was reduced 
by about half. 
18,19 -dihydroxy PG El. The presence of dihydroxy E 
prostaglandins in human semen was investigated separately. 
Semen (30 ml) was precipitated with acetone and separated 
using the method applied to stump -tailed macaque semen above. 
The fractions corresponding to the putative dihydroxy E 
compounds were pooled and derivatised (MO /ME /TMS) for GCMS 
analysis. 
(97) 
Methods specific to chapter 2. 
(Physical properties of the seminal prostaglandins) 
Measurement of GLC retention times. 
Retention time data for the prostaglandins was produced 
using the Hewlett- Packard / AEI GCMS combination described 
previously, and results are quoted as equivalent carbon 
values relative to the series of n- paraffins. Compounds 
were derivatised and injected into the GLC along with a 
mixture of paraffins of known chain length. Peaks were 
detected by the total ion current monitor of the mass spectro- 
meter, the chromatogram was digitised and the retention 
times of all peaks recorded by computer using a program 
written for the purpose. Given the equivalent carbon value 
of any four peaks, the computer then calculated the slope 
and intercept of the graph of log (retention time) against 
carbon value, and using this data calculated the carbon 
value of all the peaks detected, including those of the 
reference compounds. The re- calculation of the carbon 
values of the reference compounds provided a built -in check 
on the accuracy of the system. Provided that the unknown 
compounds emerge between the reference compounds the accuracy 
of the measurement is - 0.1 CV. 
Measurement of the equivalent carbon values was per- 
formed at a column temperature of 260 °C for the 19- hydroxy 
prostaglandins and at 240 °C for the remaining compounds. 
A program listing is given in the appendix. 
(98) 
Methods specific to chapter 3. 
(The effect of 19- hydroxy prostaglandin El on isolated 
myometrial strips.) 
Natural 19- hydroxy PG El was prepared from the semen 
of the stump -tailed macaque using the method described in 
chapter 1. The effects of this compound were compared with 
those of PG E1 and synthetic 19- hydroxy PG E1 (racemic, 
and with mixed epimers at 019). 
Non -pregnant human tissue was obtained from patients 
undergoing hysterectomy, and pregnant material was obtained 
at caesarian section. In all cases the pregnancy was at 
term, and the tissue was removed from the lower uterine 
segment. Pregnant marmoset tissue was removed from the 
upper uterine segment during hysterotomy performed at various 
stages of gestation. 
Human and marmoset tissue was transported in physio- 
logical saline and the experiment was commenced within one 
hour of operation. The tissue was cut into strips approx. 
30 x 2 mm (human) or 10 x 1 min (marmoset) before suspension 
in the organ bath. Organ baths of 20 ml capacity were 
used containing Tyrode's solution (pH 7.4), the baths being 
continuously aerated with oxygen containing 5% carbon dioxide, 
and maintained at 37oC by an external water jacket. Iso- 
metric contractions of the tissue were monitored by means 
of Washington strain gauges and recorders. 
The tissue was allowed to equilibrate in the baths 
(99) 
with occasional washing with fresh solution until a steady 
series of contractions was obtained. In some cases it 
proved necessary to stimulate the tissue by the addition 
of oxytocin (up to 0.75 mU /ml) or prostaglandin El (50 ng /ml). 
The minimum concentration of oxytocin necessary to sustain 
activity was used in each case. Prostaglandins were added 
in solution in up to 5 pl of ethanol, this concentration 
of ethanol having been shown to have no effect on the activity 
of the tissue. The effect of addition of prostaglandin was 
recorded, and the tissue was then washed with two changes 
of fresh medium. The activity of the tissue was then once 
more recorded before making the next injection. 
Activities were calculated from the chart recordings 
by measuring the area under an integral number of contractions 
(the record was photocopied and the areas for measurement 
cut out and weighed) and dividing this by the corresponding 
time. This process gives an arbitrary measure of the power 
output of the muscle strip, taking into account both frequency 
and amplitude of contraction. The effect of added prosta- 
glandin was expressed as a percentage inhibition, compared 
to the mean of the activity before injection and the activity 
after washing with fresh medium. 
If the initial activity = a 
Activity after injection = b 
Activity after washing c 
Effect of added prostaglandin a 
((a +c) /2 -b) a 100 
(a +c) /2 
(loo) 
This rather cumbersome procedure was necessitated by the 
fact that the observed activity of the muscle strips varied 
with respect to time even in the absence of added prostaglandin, 
and the activity after washing the prostaglandin out was often 
quite different from the initial activity. 
Methods specific to chapter 4. 
(In vitro biosynthesis of 19- hydroxy prostaglandine.) 
Work described in this chapter has been directed toward 
elucidation of the route of biosynthesis of the 19- hydroxy 
prostaglandine in the seminal vesicle of the stump -tailed 
macaque (Macaca arctoides). Seminal vesicles were obtained 
on two occasions, giving rise to two series of experiments, 
and since the experimental techniques employed differed, the 
two series are described separately below. 
Series 1. 
Stump- tailed macaque reproductive organs were obtained 
immediately after the animal was killed by exsanguination 
under ketamine anaesthesia. The seminal vesicles, testis, 
epididimes, prostate and ampullae were removed, weighed and 
homogenised in sodium phosphate buffer (50 mM, pH 7.4). 
An aliquot (1 ml) was taken from each homogenate and extracted 
and derivatised (MO /MxE /TMS) for GCMS analysis. Four further 
1 ml aliquots from each homogenate were incubated with either 
no substrate, eicosa -11,14,17 -trienoic acid, arachidonic acid 
or eicosa -5,8,11,14,17 -pentaenoic acid (100 pg each). Incub- 
ations were carried out under an atmosphere of oxygen / 5% 
carbon dioxide at room temperature. After one hour the incub- 
ations were stopped by the addition of 5 ml of a solution 
of methoxyamine hydrochloride (10 mg /ml) in pyridinium acetate 
buffer (1.5 M, pH 5.0). The material was derivatised (M0/ 
ME /TMS) for GCMS analysis of the synthesised prostaglandine. 
(102) 
The remaining homogenate was stored at -20 °C and used for 
the following experiments in this series. 
When stored at -20 °C both the activity of the prosta- 
glandin synthetase enzymes and the amount of endogenous 19- 
hydroxy PG E present decline, and results obtained with the 
frozen homogenate must be interpreted with this in mind. 
The following experiments are therefore presented in chrono- 
logical order, and the time of storage (in days) is indicated 
in each case. 
Time course of 19- hydroxy PG E synthesis. (29 days storage) 
Seminal vesicle homogenate (10 ml) was thawed and 
placed in a 250 ml conical flask containing arachidonic acid 
(1 mg). The flask was gassed with oxygen / 5% CO2 and in- 
cubated at ° 37 C. Samples (1 ml) were withdrawn at intervals 
of zero, 15 min., 30 min., 1, 2, 4 and 8.5 hours. After each 
withdrawal the flask was gassed, shaken and returned to the 
incubator. The samples were precipitated with ethanol (10 ml) 
and stored at -20 °C until the following day. The precipitate 
was removed by centrifugation and the supernatant dried under 
vacuum. The residue after drying was redissolved in potassium 
phosphate buffer (10 ml, 1.0 M, pH 5.0) and extracted with 
ether (10 ml) and ethyl acetate (3 x 30 ml). The combined 
ethyl acetate extracts were dried and derivatised (MO /ME /TMS) 
for GLC analysis of 19- hydroxy PG Es. The use of the differen- 
tial extraction technique provides a cleaner sample for GLC, 
allowing 19- hydroxy PG Es to be measured down to 111g. 
(103) 
Incubation with PG El_ (43 days storage) 
Four incubations were set up in 100 ml conical flasks 
with thawed seminal vesicle homogenate (2 ml) in each. Two 
of the flasks contained PG El (70)4g) and the remainder had 
no additions. The flasks were gassed, incubated (1- hours) 
and the contents precipitated, dried, differentially extracted 
and assayed as before. 
Incubation with PG E2 and PG F (46 days storage) 
Six incubations were set up as in the previous ex- 
periment. To two of the flasks was added PG E2 (60 }zg), 
while two had PG F2 (57 )ig) and the remaining two had no 
addition. 
Series 2. 
Reproductive organs were dissected from the animal 
under Saffan anaesthesia, and transported to the laboratory 
on ice. The organs were homogenised in ice -cold sodium phosphate 
buffer (50 mM, pH 7.4) and an aliquot removed from each for 
prostaglandin assay, which was performed in this case using 
single ion monitoring (O /ME /tBDMS derivative). Prostaglandin 
synthesis was investigated only in the case of the seminal 
vesicle homogenate. Labelled substrates and cofactors were 
placed in 50 ml conical flasks and dried under vacuum. 
Seminal vesicle homogenate (1 ml) was added and the flasks 
were gassed with oxygen, stoppered and incubated on a shaking 
waterbath (1 hour, 37 °C, 140 strokes per minute). Incubations 
(104) 
were stopped by the addition of acetone (50 ml). 
Two methods were used for the extraction of prosta- 
glandins prior to chromatography. Initially, the acetone 
extracts were simply dried under vacuum and taken up in the 
eluting solvent for transfer to the LH 20 column. This method 
gave variable and sometimes low recovery of radioactivity, 
and was later replaced by the following method which gave 
better results : - After drying, the acetone extracts were 
taken up in potassium phosphate buffer (50 ml, 1.0 M, pH 5.0) 
and extracted three times with ethyl acetate (3 x 150 ml). 
The ethyl acetate extracts were pooled, dried and the residue 
transferred to the LH 20 column in the eluting solvent. 
Chromatography was performed on a 1.5M x 5 mm LH 20 
Sephadex column which was eluted with chloroform / ethyl acetate 
acetic acid (50:50:1). Fractions of 1.8 ml were collected, 
dried under nitrogen and taken up in ethanol (100p1), from 
which an aliquot (10 11) was removed for scintillation counting. 
Products were identified by their retention volumes on the 
LH 20 column, compared with those of standards. 
The remaining seminal vesicle homogenate was stored 
under liquid nitrogen, and although there was a slight decline 
in prostaglandin synthetase activity on freezing, no further 
loss of activity occurred over one year's storage. Incubations 
with the stored homogenate were performed in the same way 
as those with the fresh homogenate, only sufficient material 
being thawed at any one time for the immediate purpose, the 
main bulk of homogenate remaining at liquid nitrogen temperature 
(105) 
throughout. At the end of the series of experiments described 
here the capacity of the stored homogenate to synthesise 19- 
hydroxy PG El from endogenous precursors was checked by 
means of the following experiment: - 
Frozen seminal vesicle homogenate (0.5 g) was thawed 
in sodium phosphate buffer (5 ml, 50 mMolar, pH 7.4) at 
4 °C. 2.5 ml of this suspension was then placed in each of 
two flasks, both of which contained tryptophan and reduced 
glutathione (both 1 mMolar), and one of which contained 
indomethacin (20 tiMolar). An aliquot (250 
/µl) 
was removed 
immediately from each, and the flasks were then gassed 
with oxygen and placed on the shaking waterbath. Further 
samples were removed at 5, 10, 20 and 40 minutes. Samples 
were immediately oximated and derivatised (0 /ME /tBDMS) 
for single ion monitoring GCMS assay of 19- hydroxy PG El. 
(106) 
Methods specific to chapter 5. 
(Dynamic aspects of seminal prostaglandin production 
in man.) 
Semen samples were provided by masturbation by a 
fertile volunteer who had not ejaculated for at least 36 
hours before each experiment. Sample volumes were measured 
after the semen had liquefied (15 minutes at room temperature) 
and an aliquot (0.5 ml) removed and derivatised (MO /ME/TMS) 
for GLC analysis of PG Es, 19- hydroxy PG Es and cholesterol. 
Serial ejaculates. The subject provided three samples at 
half hour intervals. The experiment was performed on two 
occasions, and the results are presented separately in fig. 
5.1 A and 5.1 B. 
Effect of aspirin. The subject, who had fasted for 14 
hours previously, took a single oral dose of 2.1 g soluble 
aspirin 30 minutes before the experiment, then provided 
three ejaculates as in the previous experiment. 
Effect of prior sexual arousal. The subject masturbated 
three times at half hour intervals, as in the previous 
experiments, but on the first two occasions stopped as 
close as possible to the point of orgasm without ejaculating. 
The ejaculate produced on the third occasion was compared 
with normal ejaculates produced on the previous day and 
on the following day. 
(107) 
Methods specific to chapter 6. 
(The species distribution of the 19- hydroxy E prostaglandine.) 
Semen samples were obtained by various methods, including 
voluntary masturbation, electroejaculation, drug -induced 
ejaculation, artificial vagina and recovery of semen from 
the vagina after coitus. Semen samples were transported 
in 4 -10 volumes of acetone or ethanol, and stored in these 
solvents at - 20 °C until required. The semen of most species 
gels after ejaculation, and where necessary these gelled 
samples were homogenised in the solvent in which they arrived. 
The homogenates were centrifuged and the supernatants evapo- 
rated to dryness before derivatisation (MO /ME/TMS) and 
GCMS analysis. In all cases where identification of 19- 
hydroxy prostaglandine is claimed mass spectra were obtained. 
(108) 
Chapter 1. 
The isolation and identification of new prostaglandins 
from semen. 
Two dimensional chromatography. 
The results of the two dimensional separation of the 
human seminal prostaglandins are given in fig. 1.1. The 
diagram was produced by making a Xerox copy of the plate, 
and a key to the spots identified is given on the overlay. 
GCMS analysis of the fractions obtained from the 
group separation showed the E prostaglandins to be located 
in fractions 29 - 34, PG Fs in fractions 45 - 55, 8-iso PG Fs 
in fractions 57 - 64, 19- hydroxy PG Es in fractions 61 - 72, 
19- hydroxy PG Fs in fractions 88 - 101 and 8 -iso 19- hydroxy 
PG Fs in fractions 121 - 137. The column did not separate 
the 8 -iso E prostaglandins from the PG Es, nor the 8 -iso 
19- hydroxy PG Es from the 19- hydroxy PG Es, and these separations 
were subsequently made by preparative TLC. 
8 -iso PG Es. Fractions 29 - 34 were pooled, and 
an aliquot run on TLC system I along with standard PG El 
and 8 -iso PG E1 showed two spots corresponding to the standard 
compounds. The remaining material was therefore separated 
by preparative TLC (system I) into two fractions containing 
PG Es and 8 -iso PG Es respectively. The identity of the 
8 -iso PG Es was confirmed by comparison of their chromatographic 
properties with those of the standard compounds. The compounds 
were shown to have identical retention volumes on the LH 20 
column, and mixtures of the biological material with the standards 
were shown to co- chromatograph on all three TLC systems, and 
(109) 
Fig. 1.1 A two dimensional separation of the seminal 
prostaglandins. 
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(110) 
after derivatisation (MO /M1 /TMS) on GLC. 
The pattern of elution of the oxime isomers of the 
8 -iso PG Es is characteristic, the oxime isomers eluting 
from the column in the reverse order as compared with those 
of the E prostaglandins (fig. 1.2A and B), a phenomenon 
previously reported by Middleditch and Desiderio (1973a). 
1 l B 
r-- 
Fig. 1.2 GLC patterns of elution of 9 -keto prosta- 
glandins extracted from human semen. All compounds 
were derivatised as the MO /ME /TMS derivative, and the 
column temperature was programmed from 200 °C at 2°/min. 
A. E prostaglandins; B. 8 -iso E prostaglandins; 
C. 19- hydroxy E prostaglandins; D. 8 -iso 19- hydroxy 
E prostaglandins. (Each pair of compounds produces 
four peaks owing to the syn /anti isomerism of the 
oxime derivative, the order of elution being E? El 
E E in each case. The order of elution of the 
major and minor oxime isomers reverses between the 
parent and 8- isoprostaglandin in both cases.) 
The mass spectra of the derivatised compounds were identical 
with those of the standards; however, the spectra did not 
differ significantly from those of the E prostaglandine, in 
agreement with the findings of Daniels et al (1968). 
8 -iso PG Fs. The 8 -iso PG Fs were completely separated 
from the F prostaglandins by LH 20, although the fractions 
containing them also contained large amounts of 19- hydroxy 
E prostaglandins. They were also separated from the PG Fs 
on GLC as the (ME /TMS) derivative. Once again the mass spectra 
were identical with those of the standard compounds but not 
significantly different from those of the F prostaglandins. 
Mixtures of the biological material with standard 8 -iso PG Fs 
were shown to co- chromatograph on GLC (ME/TMS derivative) and 
on TLC system III. TLC systems I and II proved unable to 
separate the 8 -iso PG Fs from the much larger quantities 
of 19- hydroxy PG Es present and the spot was therefore obscured 
in these systems. The biological and standard materials 
were shown to have identical retention volumes on the LH 20 
column. 
8 -iso 19- hydroxy PG Es. Fractions 65 - 72 were 
pooled and treated in a similar manner to those containing 
the E prostaglandins. Preparative TLC was carried out on 
the more polar system III, again yielding two fractions containing 
19- hydroxy PG Es and 8 -iso 19- hydroxy PG Es respectively. 
After derivatisation (MO /ME /TMS) the 8 -iso compounds were 
shown to elute from the GLC column with the major oxime isomers 
first, in a pattern closely resembling that observed for the 
(112) 
8 -iso PG Es (fig. 1.2C and D). The mass spectra of the four 
peaks were again identical with those of the 19- hydroxy E 
prostaglandins. 
Treatment of the 8 -iso 19- hydroxy E fraction with strong 
base yielded a pair of compounds identical with 19- hydroxy 
PG B1 and 19- hydroxy PG B2, as judged by comparison of their 
mass spectra, GLC retention times and Rf values on TLC with 
those of authentic compounds prepared in the same way from 
19- hydroxy PG E1 and 19- hydroxy PG E2. Treatment of an aliquot 
from either the 19- hydroxy PG E fraction or the 8 -iso 19- 
hydroxy PG E fraction with mild base yielded an equilibrium 
mixture of the two epimers containing about 10% 8 -iso 19- 
hydroxy PG Es. 
Treatment of an aliquot from the 8 -iso 19- hydroxy PG E 
fraction with potassium borohydride gave a mixture of four 
compounds, separable into two groups by LH 20 chromatography 
or TLC. One of these groups was shown to contain Fa compounds, 
judged by their ability to form n -butyl boronate derivatives, 
and to be identical with the 8 -iso 19- hydroxy PG F compounds 
described below on the basis of their mass spectra and chro- 
matographic properties. 
19- hydroxy F prostagla.ndins. Fractions 88 - 101 
were shown to contain compounds whose mass spectra were 
consistent with a 19- hydroxy F prostaglandin structure (mass 
spectra described in section 2b). The identity of the 19- 
hydroxy PG F20L compound was confirmed by comparison of its 
mass spectrum, GLC retention time and Rf values on TLC with 
(113) 
those of authentic 19- hydroxy PG F2. 19- hydroxy PG F 
201. 
was accompanied by an approximately equal amount of the 
analagous 1 series compound, 19- hydroxy PG Fla. 
8 -iso 19- bydroxy PG Fs. As with the 8 -iso PG Fs 
the 8 -iso 19- hydroxy PG Fs were completely separated from 
their parent compounds on LH 20. Fractions 121 - 137 were 
pooled and examined by TLC and GCMS. Once again the mass 
spectra of the 8 -iso 19- hydroxy PG Fs were very similar to 
those of the parent compounds. The compounds could be separated 
from the 19- hydroxy PG Fs by GLC as the (ME /TMS) or (BB /ME /TMS) 
derivatives, or by TLC systems II and III. 
The 
Rf 
values on TLC and retention times on GLC of 
all the 8- isoprostaglandins and their respective parent compounds 
are given in chapter 2 (page 166). 
Other isoprostaglandins. During the preparation of 
the 8 -iso E prostaglandins described above a third spot was 
observed on the TLC plate used to separate 8 -iso PG E from 
PG E. Elution of this area of the plate followed by deri- 
vatisation (MO /ME /TMS) and GCMS analysis showed the presence 
of a pair of compounds whose mass spectra closely resembled 
those of PG E1 and PG E2. The separation between these compounds 
and the E prostaglandins was sufficient to ensure that the 
unknown isoprostaglandins were not the result of contamination 
by the parent compounds (Rf of the PG Es was 0.22, that of 
the unknown compounds 0.46 in TLC system I). 
Each compound appeared to give only a single peak on 
the GLC trace corresponding in retention time to that of 
(114) 
the second oxime isomer of the parent E prostaglandins. 
The quantity of the unknown isoprostaglandins present was 
extremely small, and it was necessary to derivatise and inject 
the entire preparation (corresponding to 68 ml semen) in 
order to obtain satisfactory mass spectra. Inspection of 
the TLC plate used to separate the 8 -iso 19- hydroxy E prosta- 
glandins from their parent compounds showed the presence of 
analagous 19- hydroxy isoprostaglandins. In view of the very 
small quantities of these compounds present no further 
investigation of their structure was undertaken. 
Dinor E prostaglandins. Examination of fractions 36 -43 by 
GCMS showed the presence of compounds corresponding to the 
eighteen carbon prostaglandins dinor PG El and dinor PG E2. 
These compounds were separated on the LH 20 column, the 
1 series compound eluting first in fractions 36 - 40, 
followed by dinor PG E2 in fractions 40 - 43. Examination 
of the mass spectra of these compounds showed them to resemble 
those of the E prostaglandins, with the exception that all 
fragments derived from the C1 side chain were shifted downward 
in mass by 28 a.m.u. 
The spectrum of authentic dinor PG E2 showed the same 
peaks as those of the biological material, however, there 
were differences in the proportions of the various ions, and 
repeated scanning of the natural and standard materials under 
identical conditions showed that these differences were real, 
and not attributable to statistical variations in the ion 
current during scanning. It must be concluded therefore that 
(115) 
the dinor E prostaglandins of semen are isomeric with the 
authentic compounds. The nature of this isomerism remains 
to be established. (Mass spectra of the dinor prostaglandine 
E are discussed in detail in chapter 2). 
Dinor F prostaglandine. Further GCMS analysis of the 
fractions containing the 8 -iso PG Fs (57 - 64) showed the 
presence of a peak with a much shorter retention time on 
GLC than that of the 8 -iso PG Fs (ME /TMS). Unlike other 
prostaglandins studied so far the 1 and 2 series dinor F 
prostaglandine did not separate from each other on GLC. 
Examination of the mass spectrum produced by the single GLC 
peak showed that all fragments which include the C1 side 
chain produce double peaks separated by two atomic mass units. 
The spectrum may therefore be interpreted as a mixed spectrum 
of two compounds differing from one another by the presence 
of one double bond in the C1 side chain. The mass spectrum 
of the (ME /TMS) derivative closely resembles those of PG Fla 
and PG F2m except that all fragments which include the Cl 
side chain are shifted downward in mass by 28 a.m.u. 
The GLC retention time of these compounds was identical 
with that of authentic dinor PG F2& and as far as can be 
judged from a mixed spectrum the mass spectrum closely resembles 
that of the authentic compound. However, in view of the 
inability to separate the two compounds, and of demonstrated 
differences between the natural and authentic dinor E compounds 
described above, it would be premature at this stage to conclude 
(116) 
that the structure of these compounds has been definitely 
established. 
Prostaglandin D2. The radioactive peak corresponding 
to PG D2 was located in fractions 24 - 26 and the recovery 
of radioactivity was 16 %. There was no detectable amount 
of PG D2 present in these fractions by single ion monitoring 
GCMS. After correcting for losses using the figure for recovery 
of radioactivity the measured level in the original semen 
was less than 100 ng /ml. Examination of fraction 27 (where 
PG Dl would be expected) showed a significant quantity of 
PG E2, in the presence of which low levels of PG Dl would 
not be measurable. 
Dihydroxy E prostaglandins. No appreciable quantity 
of dihydroxy E prostaglandins could be detected in human 
semen using the methods described. In the absence of standard 
compounds it is not possible to quote a "less than" figure for 
the dihydroxy PG Es, but if present at all they can be no more 
than a minor component of the human seminal prostaglandins. 
Incubation of semen with labelled prostaglandins. 
There was very little conversion of the labelled prostaglandins 
in this experiment (fig 1.3). In particular, the results 
of the LH 20 separation show no peaks corresponding to dinor 
PG Es, dinor PG Fs, 8 -iso PG Fs or any 19- hydroxy prostaglandins. 
The radioactivity corresponding to the E prostaglandins 
migrated as a single band on TLC, and elution of the area 
of the plate corresponding to the 8 -iso E prostaglandins 
showed less than 2% of the recovered radioactivity to be 
(117) 
present, a quantity comparable to that obtained when the 
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Fig. 1.3 Incubation of labelled PG E1 and PG F204 
with human semen, showing no conversion of these compounds 
to compounds more polar than PG El. 
Preparation of 19- hydroxy PG E1 from the semen of Macaca arctoides. 
One milligram of 19- hydroxy PG El was obtained after 
recrystallisation, the mother liquor yielding 15 mg of less 
pure material on drying. 19- hydroxy PG E1 crystallises from 
acetone / heptane in small colourless monoclinic crystals 
(118) 
which melt with decomposition at 129 - 131 °C. GLC analysis 
of the purified 19- hydroxy PG E1 showed no measurable amounts 
of 19- hydroxy PG E2 (L 5 %), 19- hydroxy PG Fs (L 5%), E or F 
prostaglandins (L 1%). 
Dihydroxy prostaglandin El. Fractions 15 - 22 from 
the chromatographic separation of stump -tailed macaque semen 
gave a series of four peaks on GLC as the (MO /ME /TMS) derivative. 
The mass spectra given by these compounds were all consistent 
with a dihydroxy PG El structure. When derivatised as the 
ethyl oxime (EO /ME /TMS) derivative they gave analagous spectra, 
with appropriate peaks shifted upwards by fourteen a.m.u. 
indicating the presence of a single carbonyl group. Derivatisation 
of the compounds as (ME /TMS) without prior oximation caused 
them to dehydrate, giving a pair of compounds corresponding 
to dihydroxy PG Al, and treatment with strong base followed 
by derivatisation (ME /TMS) gave a single compound corresponding 
to dihydroxy PG B1. 
Examination of the mass spectra suggests that the extra 
hydroxyls are located at the 18 and 19 positions, but so far 
attempts to confirm this by making the 18,19 butyl boronate 
or cleaving the C 
18 -19 
bond with periodate have yielded no 
identifiable compounds. Identification of these compounds 
therefore rests solely on the interpretation of the mass 
spectra, which are discussed in detail in chapter 2. 
(119) 
Discussion. 
Evidence has been presented for the presence of a large 
number of previously undiscovered prostaglandins in semen. 
In the case of the compounds for which authentic reference 
standards were available, 19- hydroxy PG Fla, 8 -iso PG E1, 
8 -iso PG E2, 8 -iso PG F1ccand 8 -iso PG F2 the evidence may 
be regarded as conclusive, since the compounds were shown 
to be identical with the reference standards both by mass 
spectrometry and by co- chromatography in several systems. 
The established identity of 19- hydroxy PG Fla makes the 
structure of the accompanying 19- hydroxy PG Fla certain. 
Evidence for the structure of the 8 -iso 19- hydroxy 
prostaglandins is circumstantial, although extremely strong. 
The close similarity between the mass spectra of these compounds 
and their parent 19- hydroxy prostaglandins indicates that 
they are isomeric with the parent compounds, and that they 
are epimers rather than positional isomers. The conversion 
of the iso 19- hydroxy E prostaglandins to iso 19- hydroxy 
PG Fs by borohydride 
i 
reduction indicates that the same type 
of isomerism is present in both groups of compounds. Dehydration 
of the iso 19- hydroxy PG Es to 19- hydroxy PG Bs by base treatment 
indicates that the site of isomerism is at C8, C12 or C11' 
and the ability of the compounds to isomerise back to the 
parent prostaglandins in the presence of mild base indicates 
that the site of epimerisation is adjacent to an enolysable 
carbonyl, strongly suggesting C8. This assignment is supported 
(120) 
by the observation that the pattern of elution of the oxime 
isomers on GLC resembles that of the 8 -iso E prostaglandine. 
Rigorous proof of the structure of these prostaglandine awaits 
either the synthesis of authentic 8 -iso 19- hydroxy prostaglandine, 
or the isolation from semen of sufficient quantities of the 
pure compounds to enable physical methods such as optical 
rotatory dispersion spectrometry to be used. 
Evidence for the structure of the dihydroxy E prostaglandine, 
detected in the semen of the stump - tailed macaque but not in 
human semen, is based entirely on interpretation of the mass 
spectra of the compounds and of their dehydrated derivatives. 
In the absence of chemical degradation studies such evidence 
cannot be regarded as conclusive, and the postulated location 
of the two extra hydroxyls at C18 and C19 must, for the time 
being, be regarded as merely the most probable out of several 
possible structures. Two isomeric compounds corresponding 
to dihydroxy PG El were detected, and although the nature 
of this isomerism has not been specifically investigated 
some conclusions can be drawn from the evidence presented. 
Once again the close similarity between the mass spectra 
of the two compounds indicates that they are epimers, and 
the loss of this epimerisation on dehydration to the equivalent 
dihydroxy PG B1 implies that the chiral centre is at C8, 
C12 or 
C11. Since dehydration to dihydroxy PG Al gives a 
pair of compounds C11 may be eliminated. Of the remaining 
two possibilities, C12 seems the more probable, since the 
pattern of elution of the oxime isomers does not resemble 
(121) 
that observed in the case of 8 -iso PG E nor 8 -iso 19- hydroxy 
PG E (fig 1.2). 
Mass spectral evidence indicates that the compound 
provisionally identified as dinor PG E2 is not identical 
with authentic dinor PG E2. There is no evidence of positional 
isomerism, and it must be concluded once more that the compound 
present in semen is an epimer of dinor PG E2. The pattern 
of elution of the oxime isomers of the seminal dinor E 
prostaglandins resembles that of the E prostaglandins rather 
than that of the 8 -iso PG Es, and it seems improbable therefore 
that the site of epimerisation is located at C6 in this case. 
Further work is required to establish the configuration of 
the seminal dinor E prostaglandins. 
The seminal dinor F prostaglandins similarly require 
further study, since the lack of separation between the 1 
and 2 series compounds on GLC implies structural differences 
between these compounds and the known prostaglandins. The 
structures assigned to these eighteen- carbon F prostaglandins 
must meanwhile be regarded as tentative. 
The results of the incubation of semen with PG E1 and 
PG F2 indicate that none of the compounds described above 
are artifacts produced from the classical prostaglandins by 
the techniques employed in storage and handling of the semen 
extracts. Furthermore, if the new prostaglandins are metabolites 
of the classical prostaglandins, they are already present 
at the time of ejaculation, and are not produced by the action 
of enzymes present in the seminal plasma. 
(122) 
Of the compounds described, 8 -iso PG E1 has been reported 
previously as a product of the incubation of eicosa- 8,11,14- 
trienoic acid with seminal vesicle homogenates (Daniels et al, 
1968), and dinor PG F1othas been reported to be a urinary 
metabolite of PG in the rat (Granstrom et al, 1965), 
although neither compound has been previously described in 
semen. Parts of the work described above have been published 
or submitted for publication (Taylor and Kelly, 1975; Taylor 
and Kelly, 1979; Taylor, 1979). 
Estimates have been made of the levels of all of the 
compounds mentioned in semen, although the quality of these 
measurements is variable. In some cases measurements have 
been made on fertile semen, using well -characterised assays 
calibrated against authentic reference compounds (Templeton 
et al, 1978). In other cases no suitable reference compounds 
were available, and only preliminary estimates on pooled 
semen originating from the infertility clinic could be made. 
In the case of the 8- isoprostaglandins, the ratio of the GLC 
detector response 
8 -iso PG 
was measured, and the level of 
parent PG 
the 8- isoprostaglandin calculated from published measurements 
of the parent prostaglandins. Some measurements of this 
type are included in the synoptic table which follows, the 
figure quoted being preceded by "ca ", indicating that it 
should be regarded merely as a first order approximation. 
Table 1.1 summarises current knowlege of structures 
and levels of prostaglandins in human semen. The structural 
formulae, systematic and trivial names are given in the first 
(123) 
two columns, and since the table includes all compounds mentioned 
in the text of this thesis some compounds are included which 
have not been shown to be present in semen. The third column, 
titled "status ", gives an indication of the strength of evidence 
for the quoted formula, and the fourth column cites the apr 
propriate reference to support this. The column titled 
"concentration" gives the measured level(in fertile human 
semen unless otherwise indicated). The column titled "n" 
gives the number of samples on which the measurements were 
made, or in the case of pooled semen originating from the 
R.I.E. infertility clinic the abbreviation "IC" indicates 
this. The final column cites references to support the levels 
quoted. 
A key to the status codes and reference numbers is 
given at the end of the table. 
(124) 
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Table 1.1 Synopsis of se^=inal prostaglandins (cont.) 
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P = Structure proven. 
C = Structure depends on circumstantial evidence. 
ND. Not detected. 
NI. Not investigated. 
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Chaster The .h sical sro erties of the seminal .rosta_landins. 
Introduction. 
Since much of the work described in this thesis has 
involved mass spectrometry, the bulk of this chapter will 
be taken up with descriptions of the mass spectra of the 
newly discovered prostaglandins. My main concern, in interpreting 
these mass spectra, has been to identify the parts 
of the prostaglandin molecule responsible for the peaks 
observed, thus providing evidence to support the postulated 
structure. The actual mechanism of fragmentation and re- 
arrangement together with the final structures of the ions 
have in general not been considered, being outside the scope 
of this thesis. In the tables which follow some ions are 
represented by structural formulae: these are used simply 
as a shorthand method of depicting the original location 
of the atoms in the prostaglandin molecule and do not necessarily 
represent the structure of the ion as it arrives at the 
collector. 
All of the mass spectra depicted in figures 2.1 - 
2.6 were recorded by scanning GLC peaks, and in most cases 
the background spectrum has been subtracted. This method 
of operation introduces certain unavoidable distortions into 
the recorded spectra, while also providing more than com- 
mensurate advantages. The use of the GLC inlet system was 
mandatory, since only very rarely were pure compounds 
available for analysis. With the mass spectrometer and data 
(132) 
system used, the maximum practicable scanning speed was sixteen 
seconds per decade, and the time required for a full scan from 
about m/e 800 to m/e 28 was therefore approximately thirty 
seconds. In most cases, this represented a substantial fraction 
of the time taken for the GLC peak to pass through the system, 
and the amount of sample present in the source therefore 
varied considerably throughout the duration of the scan. 
By choosing to start each scan at or near the maximum of the 
GLC peak it was possible to emphasise the high -mass end of 
the spectrum, increasing the probability of detecting the 
molecular ion and other useful high mass fragments, and all 
the spectra reproduced here are biassed in this fashion. 
Background subtraction produces cleaner spectra, but inevitably 
sample ions whose masses coincide with those of the background 
are reduced or lost in the process, this applying particularly 
to m/e 207 in the spectra of PG El and 19- hydroxy PG El (MO /ME /TMS) 
and m/e 73, 75 and 77 in (TMS) spectra generally. 
Identification of the peaks in mass spectra was 
performed by comparison of the spectra of different derivatives 
of the same compound (a shift of 14 a.m.u. in a peak derived 
from an ethyl ester derivative compared with that of a methyl 
ester indicates that the ion includes the carboxyl group for 
example), by comparison of closely related compounds (a shift 
of 2 a.m.u. in the spectrum of a 1 series prostaglandin compared 
with that of the 2 series compound indicates an ion which 
includes C5 -6) or simply assumed to arise by mechanisms 
(133) 
analagous to those known to occur in related compounds (m /e 
117 in the spectra of (TMS) derivatives of 19- hydroxy prosta- 
glandins arises by cleavage of the 18 -19 bond; a prostaglandin 
with hydroxyls at 18 and 19 might be expected to show both 
this peak and a peak at m/e 219 arising by an analagous 
cleavage of 017 
-18). In 
no case has the identification of 
an ion been proved rigorously, as this would require the 
synthesis of isotopically labelled prostaglandins. The 
structures quoted therefore represent a series of working 
hypotheses, and in the description of the mass spectra I 
have tried to indicate as far as possible the strength of 
the circumstantial evidence in favour of each assignment. 
(134) 
a) The mass spectra of the 19- hydroxy Prostaglandins E. 
The mass spectra of the 19- hydroxy PG Es as the (MO /ME /TMS) 
derivative have already been briefly described (Taylor and 
Kelly, 1974). In this section a fuller description is given 
and the spectra are compared with those of the E prostaglandine. 
In addition, the spectra of the 19- hydroxy PG Es derivatised 
in several other ways are described. 
Formation of the oxime of a ketoprostaglandin leads 
to two isomeric compounds as a result of the asymmetry of 
the nitrogen atom. The two oxime isomers are distinguished 
here by the Roman subscripts (I) and (II), referring to the 
order in which the isomers elute from the GLC column. 
The mass spectra of the 19- hydroxy PG Es as the 
(MO /ME /TMS) derivative are given in fig. 2.1, and a list of 
peaks identified in the spectra and in those of the E PGs 
is given in table 2.1, along with postulated structures for 
the ions. The mass spectra of the E prostaglandins as this 
derivative have been examined by Green (1969), and structures 
assigned by him to the ions are for the most part retained 
here. One exception is the ion at We 133 which Green did 
not interpret. Middleditch and Desiderio (1973a) have suggested 
that this may arise by a migration of the methoxy group from 
the oxime to C11 followed by fragmentation to give an ion 
of the following structure:- 
(135) 











































































































































































































































































































Peaks identified in the mass spectra of the E and 19- hydroxy 
m/e 
E prostaglandins (MO/ME/TMS). 








205 + + 
207 + + 
223 + + 
225 + + 
295 + + 
297 + + 
313 + + 
364 + 














(from C19- C20) 
See text. 
Goo oaJ 



































m/e 19-0H El 
Table 2.1 continued. 
E2- Possible structure. 19 -0H E2 Ea 
506 + M-(90+31) 
508 + M-(90+31) 
508 + M-31 
510 + M-31 
537 + M-90 
539 + M-90 
596 + M-31 
598 + M-31 
* Ions arising from the loss of the C16 -C20 
fragment are only strong 
in the (I) isomers; otherwise, the isomer pairs have very similar spectra. 
(1 39 ) 
The ion occurs in the spectra of both the 19- hydroxy 
PG Es and is frequently the base peak, but does not occur (at 
an analagous m/e value) in the spectra of any oxime derivative 
other than the methyl oxime. The ion does not appear in the 
spectrum of the saturated prostaglandin E0 (prepared by hydro- 
genation of the natural compounds), which may indicate that 
the C unsaturated bond is involved in the fragmentation 
mechanism. 
The characteristic patterns produced by trimethyl 
silyl derivatives are present in the spectra of both E and 
19- hydroxy E prostaglandins. m/e 73 (H(CH3)2Si=CH2), m/e 
75 ((CH3)2Si =0 ±H) and m/e 77 (H(CH3)2Si0 +H2) are well repre- 
sented in all the compounds. At the other end of the spectrum 
the loss of trimethyl silanol gives rise to peaks at M - 90. 
The methyl oxime characteristically loses a methoxy radical 
giving rise to peaks at M - 31 in all the compounds. A small 
peak at m/e 205, arising from the loss of C16 -20 plus 
C 
9 -11 
is found in the spectra of almost all the 2 series prostaglandins 
as (ME /TMS) derivatives, and is present in the spectra of 
19- hydroxy PG E2 and PG E2. The analagous peak in the 1 
series compounds (m /e 207) tends to be obscured in GCMS spectra 
by the strong column bleed peak at this mass. 
Many of the strong peaks in the body of the spectrum 
involve breakage of the ring and loss of C9_ 11 (e.g. 
m/e 
223, 225, 295 and 297) and ions arising from the loss of 
016 -20 
are stronger in the (I) isomers of both groups of 
(140) 
compounds. The molecular ions, 541 and 539 for the PG Es 
and 629 and 627 for the 19- hydroxy PG Es are small, and absent 
from all but the strongest spectra. A strong peak at m/e 117 
is present in all 19- hydroxy prostaglandin (TMS) spectra. 
This fragment is characteristic of compounds with the 
-CH(OSi(CH3)3)CH3 group and probably has the structure 
CH3- CH=O ±Si(CH3)3. 
The mass spectra of the 19- hydroxy PG Es as the dimethyl 
silyl derivative (MO /ME /DMS) are less informative. The spectra 
are more complex than those of the (MO /ME /TMS) derivative, 
with fewer high mass peaks and the majority of the ion current 
concentrated in the mass range below m/e 300. However, some 
peaks analagous to those in the spectrum of the (MO /ME /TMS) 
derivative can be identified. m/e 103, analagous to 117 in 
the earlier spectra is present, although not as striking. 
The molecular ions, m/e 587 and 585 are once again small or 
absent. The loss of the methoxy radical from the methyl 
oxime gives rise once more to a peak at M - 31 (m /e 556, 
554) and the loss of dimethyl silanol to a small peak at 
M - 76 (m /e 511, 554) and a larger one at M - (31 +76) (m /e 
480, 478). Loss of the C16 -20 
fragment gives a peak at m/e 
442 and 440. 
The tertiary butyl dimethyl silyl derivatives (tBDMS) 
of these compounds display characteristically simple spectra. 
Loss of the t -butyl group gives rise to a very strong ion 
at M - 57 in the spectra of (tBDMS) derivatives of most 
(141) 
compounds which form them (Kelly and Taylor, 1976a). The 
t -butyl dimethyl silyl oxime derivative (O /ME/tBDMS) of 
the 19- hydroxy PG Es gives a particularly striking spectrum, 
consisting almost entirely of a single peak at m/e 799 
(19 -0H PG E1) or m/e 797 (19 -0H PG E2). Loss of the t -butyl 
group plus t -butyl dimethylsilanol from the methyl oxime 
derivative (MO /ME/tBDMS) gives a strong peak at M - (57 +132) 
(m /e 566, 564) in addition to the usual M - 57 at m/e 698 
and m/e 696. 
The concentration of a large proportion of the total 
ion current into one or two very intense high mass peaks 
makes these derivatives particularly suitable for the assay 
of the 19- hydroxy E prostaglandins by single ion monitoring 
GCMS analysis. 
(142) 
b) The mass spectra of the 19- hydroxy prostaglandins F. 
The structure of the 19- hydroxy F prostaglandine was 
originally established by comparison of the mass spectrum 
of the (ME/TMS) derivative of natural 19- hydroxy PG 
F204 
with 
that of the synthetic compound (Taylor and Kelly, 1975). 
The mass spectra of these derivatives (fig. 2.2) show a 
clear relationship to those of the F prostaglandine, and 
a list of the major ions given by both groups of compounds 
as this derivative, together with their postulated structures 
is given in table 2.2. 
The (ME /TMS) derivative has been widely used for the 
identification and assay of the F prostaglandine, and many 
groups have published full or partial mass spectra (see 
Crain et al, 19 75; Horvath, 1976 for references). I have, 
however, been unable to locate any detailed analysis of the 
mass spectra of this derivative combination in the literature, 
and structural assignments given here are therefore either 
original or drawn by analogy from the published spectra 
of related derivatives. In this connection, the spectra 
of the F prostaglandine as the (TMS ether, TMS ester) deriva- 
tive, analysed by Middleditch and Desiderio (1973b), have 
proved extremely useful, containing many peaks identical 
with or analagous to those present in the (ME /TMS) deriva- 
tive. 
As usual, the typical pattern produced by (TMS) deriva- 

























































































































































































































































































































































































































































































































Peaks identified in the mass spectra of the F and 19- hydroxy 
F prostaglandins (ME /TMS). 

































+ + + 
+ + + 















TMS Ö+ o TMS 
TMs 
see text 
335 - 90 
351 - 90 
397 - 90 
399 - 90 
423 - 90 
425 - 90 







492 - 90 
494 - 90 
496 - 90 
513 - 90 
515 - 90 
Conti 
(146) 
m e 19-0H 
Table 2.2 continued. 
F Fla 19-0H 
F2oc 
Fla 












M - 180 (19-0H Fla) 
M - 90 (F201) 




DIMS +TMS M-90 
M-90 
coocH3 
At the high mass end of the spectrum the loss of trimethyl- 
silanol provides peaks at M -90 and M -180 in both groups 
of compounds. The base peak of the 19- hydroxy PG F spectra 
is m/e 117, typical of the (TMS) derivatives of- hydroxy 
prostaglandins. 
Fragmentation of the ring gives rise to an intense 
ion at m/e 235 (19 -0H Fs) or m/e 237 (Fs). This probably 
arises from the loss,of the entire C1 side chain plus 
with the TMS groups from C11, C and C19. The 
C10 -11 
other example of ring fragmentation is afforded by a series 
of peaks at m/e 397/399 and 307/309 which may arise from 
the loss of C16 
-20 plus 




group of peaks is somewhat stronger 
in PG 
F2o(,and 
19- hydroxy PG F2oC. than in the corresponding 
F1 series compounds, presumably because the longer series 
of conjugated double bonds confers extra stability on the 
fragment. 
A peak at m/e 243 in both groups of compounds appears 
to arise by at least three mechanisms. Two of these routes 
lead to ions of empirical formula C11H 302Si2, and Middleditch 
and Desiderio (1973b) have suggested that these arise from 






In PG F2OLand 19- hydroxy PG F20can ion of the same nominal 
mass may arise from the loss of C16 -20 plus 
three molecules 
(148) 
of trimethylsilanol. Evidence for this mechanism is provided 
by the presence of the analagous ion at m/e 245 in the 
spectra of the F1 series compounds. 
The ions of m/e 191 (TMS- O =CH -O -TMS) and 217 
(TMS- 01-CH(CH2)2 -0 -TMS) have also been discussed by Middleditch 
and Desiderio (1973b). The former has been observed in the 
mass spectra of polyhydroxylated steroids (TMS), and probably 
arises by several routes, while the latter is derived from 
These authors also attributed the ion of m/e 173 C9 -11 
present in the spectra of (TMS) derivatives of many prosta- 
glandins to a fragment consisting of C15 
-20. 
An analagous 
ion at m/e 261 is present in the spectra of the 19- bydroxy 
prostaglandins, although in the case of the 19- hydroxy PG 
Fs an ion of the same nominal mass may arise by the loss 
of C1 plus two molecules of trimethylsilanol. 
Many of the strong peaks present in both groups of 
spectra may be ascribed to the loss of fragments from the 
two side chains. Loss of C16 -20 (plus 
molecules of trimethyl- 
silanol) leads to identical series of peaks in the spectra 
of both PG Fs and 19- hydroxy PG Fs (m /e 513/515, 423/425, 
and 333/335). Loss of C1 gives a small peak at m/e 441 
which is present only in the spectra of the 19- hydroxy 
PG Fs, and peaks at m/e 351 (19 -0H PG Fs) and 353 (PG Fs). 
The mass spectra of the 19- hydroxy F prostaglandins 
as alkyl boronates (ME /BB /TMS or ME /tBB /TMS) closely re- 
semble each other and those of the F prostaglandine. The 
(149) 
mass spectra of these derivatives are dominated by the loss 
of the X16 -20 group, 
giving rise to a single intense peak 
at m/e 437 (F1ot 
and 19 -0H Fla) or 435 
(F2c 
and 19 -0H F2a) . 
(The mass spectrum of PG F20LME /BB /TMS has been described 
by Kelly, 1973). The molecular ions are absent, the highest 
mass peaks being usually m/e 506/504, arising from the loss 
of trimethylsilanol. The spectra of the methyl boronate 
derivatives (ME/MB /TMS) are very similar, with the strong 
ion in this case located at m/e 395/393. 
The t -butyl dimethylsilyl derivatives (ME/tBDMS) as 
usual display a very intense peak at M -57 owing to the 
loss of a t -butyl group (Kelly and Taylor, 1976a), together 
with a somewhat smaller peak at M -(57 +132) from the additional 
loss of t -butyl dimethylsilanol. 
(150) 
The mass s.ectra of the 8- iso.rostaglandins. 
The spectra of the 8- isoprostaglandins as all deri- 
vatives so far studied (ME /TMS, ME /BB /TMS, ME /tBDMS, MO /ME /TMS 
or MO /ME /tBDMS as appropriate) are extremely similar to those 
of the parent compounds. In some cases there is a suggestion 
that the 8- isoprostaglandin spectrum contains a greater propor- 
tion of its total ion current in the low mass range (see for 
example the spectra of 19- hydroxy PG F2 a and 8 -iso 19- hydroxy 
PG F2 a (ME /TMS) in fig 2.2 a and 2.2 d). In no case, however, 
is the difference great enough to allow the 8- isoprostaglandin 
to be differentiated from its parent compound on the basis 
of the mass spectrum alone. 
(151) 
d The mass spectra of the dinor prostaglandins E. 
The mass spectra of the dinor E prostaglandins are 
closely analagous to those of the PG Es, all the peaks 
attributable to fragments including the C1 side chain being 
shifted downward in mass by 28 a.m.u. The spectra of both 
dinor E prostaglandins extracted from semen and that of authentic 
dinor PG E2 are given in fig. 2.3. It will be seen that the 
spectrum of the authentic material differs from that of the 
biological extract as was pointed out in chapter 1. In 
general the same ions occur in both spectra, but the proportion 
of the total ion current concentrated in the base peak of 
the compound found in semen is much greater. Repeated scanning 
of the spectra of the two compounds under identical conditions 
showed that this difference was reproducible, and not due 
to variations in the source conditions or to the statistical 
nature of the ionisation process. The similarities between 
the mass spectra indicate that the compounds are isomeric 
with one another, but the nature of this isomerism remains 
to be investigated. 
Table 2.3 lists the ions identified in the spectra 
of the (MO /ME /TMS) derivatives of the dinor E prostaglandins. 
The molecular ions are weak, only the dinor PG E2 from semen 
giving a detectable peak. In the other two cases the highest 
mass peak was m/e 498/496 corresponding to the loss of a 
methyl group. Loss of a methoxy radical gives a peak at 





















































































































































































































































































































































































































































































Peaks identified in the mass spectra of the dinor E prosta- 
glandins (MO/ME/TMS). 
dinor E1 dinor E2 
133 small 
Possible structure. 
small See section 2a. 
177 + 
179 + C: 
COOCHy 







+ 338 -90 















































*Peaks arising from the loss of the 014_18 
fragment are stronger 
in the (I) isomers. (155) 
at M - 90 (423/421). Once again, we find that the ions involving 
the loss of the C16 
-20 
fragment are much stronger in the (I) 
oxime isomers (m /e 442/440 and 352/350). As with the E and 
19- hydroxy E prostaglandins, strong ions in the body of the 
spectrum generally involve fragmentation of the ring, and 
all the peaks analagous to those in the spectrum of the E 
prostaglandins are present. The elusive m/e 133 is present 
but small in comparison with the PG Es and 19- hydroxy PG Es. 
The mass spectrum of the dinor E prostaglandine as 
the (0 /ME /tBDMS) derivative consists virtually of a single 
peak at M - 57 (m /e 640/638) making this derivative highly 
suitable for single ion monitoring. This derivative has 
also been used to obtain a spectrum of dinor PG E1 by direct 
derivatisation of fresh semen, eliminating the possibility 
of the compound arising as an artifact of storage. 
(156) 
The mass spectra of the dinor ro sta_landins F. 
The dinor F prostaglandins of semen are not separable 
from each other, either by LH 20 Sephadex chromatography or 
by GLC as either of the derivatives so far studied. The 
mass spectra obtained therefore contain peaks from both 
dinor PG Fla and dinor PG F2a. 
Fig. 2.4 gives the mass spectrum of the (ME /TMS) 
derivative and table 2.4 lists the ions identified. For 
convenience, peaks due to dinor PG F1tz 
and dinor PG F2a have 
been listed in separate columns as in the previous tables 
in this chapter. The spectrum shows an obvious relationship 
with those of the PG Fs, as many of the ions arise by loss 
of the C1 side chain, giving rise to peaks at identical 
m/e values in both groups of compounds (m /e 191, 237, 353). 
The molecular ions are once more absent, but a series of 
peaks arising from the loss of successive trimethylsilanol 
groups (M - 90, M - 180) is present, together with a similar 
series involving the loss of the pentyl side chain (M - 71, 
M - (71 +90) etc.). 
As the (ME /tBDMS) derivative, the compounds give the 
usual strong ion at M - 57 (m /e 627/625) and a smaller peak 






















































































































































































































































































Peaks identified in the mass spectra of the dinor F prosta- 
glandins (ME /TMS). 
nje dinor Fla dinor F2cc Possible structure. 
i73 + + 263-90 
191 + small TMS-QáCH-O-TMS 
217 + + TMSO.+ CH-CH=CH-0-TMS 
OTMS 
237 + + 
263 + + 353-90 
305 + M-(71+180) 
307 + M-(71+180) 
OTM! 
353 + + 
'0...o.ep.,...,,...- 
OTMS 
376 + M-180 
378 + M-180 
395 + M-(71+90) 
397 + M-(71+90) 
466 + M-90 
468 + M-90 
487 + M-71 
558/556 absent absent M. 
(159) 
f) The mass spectrum of dihydroxy prostaglandin El. 
Two compounds provisionally identified as 18,19 di- 
hydroxy prostaglandin E1 and an isomeric prostaglandin have 
been partially isolated from the semen of Macaca arctoides. 
Since the mass spectra of the two compounds are identical 
they will be discussed together. 
Table 2.5 lists the ions identified in the spectra 
of the (MO /ME /TMS) derivative of these compounds, and the 
spectra are reproduced in fig. 2.5. 
Peaks by the loss of the C16 -20 
fragment are 
identical with those produced by PG El and 19- hydroxy PG El 
(m /e 297, 470), and as in the case of these compounds m/e 470 
is stronger in the spectrum of the (I) isomer. Although 
the molecular ion (m /e 717) is absent, a series of peaks 
arising by the loss of trimethylsilanol or a methoxy radical 
(M - 31, M -(90, M - (31 +90), M - 180 etc.) act as pointers 
to its mass The presence of m/e 117 indicates that the compound 
possesses a 
T 
-hydroxyl group. A strong ion at m/e 219 is 
interpreted as being derived from C18 -20 
by a mechanism 
analagous to that which produces m/e 117 from C19 -20' A 
small peak at m/e 247 may arise from C16 -20 (An 
analagous 
peak at m/e 159 is present in the spectra of the 19- hydroxy 
prostaglandins). Loss of C19 -20 
by a mechanism analagous 
to that which produces m/e 470 gives rise to a small peak 
at m/e 600 and the additional loss of trimethylsilanol gives 




















































































































































































































































































Peaks in the mass spectrum of a compound provisionally identified 
as 18, 19 dihydroxy PG E1 (MO /ME/TMS). 

























g3 OTMS CO OC 
OTMS COO CH3 
-TMfi 
CO c C x3 
p TYiS 
470 - 90 
600 - 180 - ÇsoCH3 
OTMS 
pi -0 3 pTnS 
M - (31+180) 
600 - 90 
M - 180 




M - 31 
M 







in the (I) isomers, lending weight to the interpretation that 
they arise by a mechanism analagous to that which produces 
m/e 470. 
In the spectrum of the ethyl oxime derivative (EO /ME /TMS), 
peaks corresponding to fragments which retain the ethoxy 
group (m /e 641, 614, 551, 524, 484, 434) are shifted upward 
by 14 a.m.u. compared with the (MO /ME /TMS) spectrum, indicating 
the presence of a single carbonyl and confirming the structural 
interpretation of these ions. The remaining peaks in the 
spectrum of this derivative are unchanged. 
Derivatisation of the dihydroxy E prostaglandins as 
(ME /TMS) without prior oximation gives a pair of compounds 
whose mass spectra correspond to 18,19 dihydroxy PG Al (fig. 2.6a ).. 
The A prostaglandins as the (ME /TMS) derivative have as their 
major mode of fragmentation a mechanism giving rise to a 
strong ion from the loss of C16 -20 (m 
/e 351 in the spectra: 
of PG Al and 19- hydroxy PG A1) arid a smaller fragment from 
the further loss of carbon monoxide from the ring (m /e 323)(Throck- 
-Matson and Sweetman 1974). In the spectra of the isomeric 
B prostaglandins the relative sizes of the two peaks are 
reversed, with m/e 323 being the base peak in the spectra 
of PG B1 and 19- hydroxy PG B1. In the spectrum of dihydroxy 
PG Al these ions are present, m/e 351 being the larger of 
the pair. The major mode of ionisation in this case however 
is the analagous mechanism which involves the loss of C19 -20' 
This gives rise to a peak at m/e 481, and a further loss 
















































































































































































































































































































m/e 391. The molecular ion at m/e 598 is present, as are 
peaks at M - 90 and M - 180 arising from the loss of tri- 
methylsilanol. As in the spectra of the dihydroxy PG Es 
there are strong ions at m/e 117 and m/e 219 indicating 
the presence of hydroxyl groups at 18 and 19. 
Treatment of the dihydroxy PG Es with base gives a 
single compound whose mass spectrum (fig. 2.6b) as the 
(ME /TMS) derivative corresponds to that of dihydroxy PG B1. 
Here the major mode of fragmentation is identical with that 
observed in the spectra of PG B1 and 19- hydroxy PG B1, 
involving the loss of C16 
-20 giving 
m/e 351 and the subsequent 
loss of carbon monoxide giving m/e 323, the latter ion 
providing the base peak of the spectrum. The molecular 
ion, m/e 598 is present, together with small peaks from 
loss of trimethylsilanol (m /e 508) and loss of C19 -20 
(m /e 481). Loss of an additional methyl group from the 
latter ion may explain the intense peak at m/e 466. 
m/e 117 and m/e 219 are once more present, although small 
compared with the previous spectra. 
(165) 
Chromatographic data. 
Table 2.6 gives GLC retention time data for the prosta- 
glandins measured, the results being quoted as equivalent 
carbon values relative to the series of n- paraffins. 
Table 2.7 gives TLC Rf values for the underivatised 
compounds in three TLC systems. 
(166) 
Table 2.6 
Gas liquid chromatographic retention indices. 









dinor PG F lo( 
dinor PG F2 
19-OH PG 
F1 dl 
19-OH PG F2 
8-iso 19-0H PG F1al 







8-iso PG E1 
8-isc:'GE 
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dinor PC E1 
dinor PG E2 
19-0H PG El 
19-0H PG E2 
8-iso 19-0H PG E1 



























































System II System III 
PG E1 0.22 0.63 0.63 
8-iso PG E1 0.30 0.62 0.71 
8-iso PG E2 0.31 0.62 0.68 
PG F20( 0.10 0.50 0.49 
8-iso PG F 0.10 0.46 0.47 
8-iso PG F2 a 0.09 0.47 0.47 
19-0H PG E2 0.04 0.45 0.27 
8-iso 19-0H PG E1+2 0.09 0.42 0.40 
19-0H PG F2x 0.03 0.29 0.23 
8-iso 19-0H PG 
F1a+20t 0.03 0.25 0.20 
15R 19-0H PG F2 
á 
0.05 0.37 0.33 
15R 19-0H PG E2 0.08 0.46 0.38 
* Rf values in this system are not reproducible owing 
to the difficulty of ensuring removal of all the solvent between 
runs. Values quoted are typical and show the separations obtained. 
(168) 
Chapter 3. 
The effect of 19- hydroxy prostaglandin El on isolated myometrium. 
It proved difficult to obtain reproducible results in 
this series of experiments since the response of the tissue 
to prostaglandins was extremely variable. Sensitivity 
toward prostaglandine varied with time, being low initially 
but rising to a peak about one hour after the start of the 
experiment and then declining along with the activity of 
the muscle. It was difficult therefore to compare results 
obtained from different preparations, or even from the 
same preparation at different times. The human preparations 
were 'short lived ( about six hours) and sluggish (2 - 15 
contractions per hour) and so relatively few measurements 
could be made within the life of each preparation. 
A total of 15 strips from 5 nonrpregnant human "uteri, 
9 strips from 3 pregnant human uteri and 2 strips from 2 
pregnant marmoset uteri yielded results. On many additional 
occasions tissue supplied proved inactive and yielded no results. 
Non -pregnant human tissue. 
Table 3.1 gives a summary of the results achieved with 
non -pregnant human myometrial strips using prostaglandin El, 
synthetic 19- hydroxy PG El and natural 19- hydroxy PG El. 
The results are extremely scattered, for the reasons given 
above, but it is clear that all three compounds inhibit the 
activity of the strips, and that PG El is about four times 
as effective as natural 19- hydroxy PG El and eight times 
(169) 
Table 3.1 
The effects of prostaglandins on the contractile activity of non- 
pregnant human myometrial strips. 
a. Prostaglandin El 
Dose (ng /ml) 1.0 2.5 5.0 10 20 
Effect -13 75 100 31 82 
(% inhibition) 24 40 100 78 40 
20 loo 53 loo 
49 100 100 






5.5 45 93 54 75 
22 12 
b. Synthetic 19- hydroxy PG E1. 




2.5 5.0 10 20 40 50 
35 46 2 61 37 54 29 
24 61 20 25 83 43 









35 24 32 28 35 




Table 3.1 cont. 
Natural 19- hydroxy El 
Dose (ng /ml) 5.0 10 20 30 40 50 
Effect 38 53 82 71 51 25 


























71 68 25 
(171) 
as effective as the synthetic compound. It should be possible 
to obtain more precise results by comparing the effects obtained 
within the set of results for each individual strip with each 
other, thus eliminating variation between strips. Taking the 
ratio of 1 :4 :8 as the hypothetical equipotent molar ratio, 
and looking within the set of results for each strip for 
cases where pairs of injections have been made with the prosta- 
glandins in the correct ratio, we should find that the ratio 
of the effect produced is near unity. 
Taking the pair: natural 19 -0H El / El we find 
nine cases where these were injected in the ratio 4:1. The 
ratios of effects obtained in the nine cases were as follows: - 
1.25, 0.7, 0.9, 0.4, 1.0, 0.8, 1.0, 1.6, 1.1 
Mean ratio = 0.97 0' = 0.3 
In the case of the pair: synthetic 19 -0H El / natural 19 -0H El 
we find again that there were nine cases where these were 
injected in the ratio 2:1. Effects ratios obtained were as 
follows: - 
0.7, 1.3, 1.6, 1.25, 0.9, 0.7, 0.2, 1.2, 1.0 
Mean ratio = 0.98 or= 0.4 
As a final check we may take the pair: El / synthetic 19-0H El. 
There were six cases where these compounds were injected in 
the ratio 1:8. The ratios of the effects obtained were as 
follows: - 
1.1, 0.97, 1.4, 0.86, 2.0, 1.6 
Mean ratio = 1.32 0' = 0.4 
It is therefore concluded that the EPMR for El : 19-0H 
El : 
synthetic 19 -0H El is 1 :4 :8. 
(172) 
b. Pregnant human tissue. 
The pregnant human myometrium gave less clear cut 
results than the non -pregnant material. Table 3.2 lists 
the entire set of results for prostaglandins El and 19- 
hydroxy E1(natural compound). As the supply of tissue was 
strictly limited the effect of the synthetic compound was 
not investigated in this case. As the experiment proceeded, 
it became clear that in order to obtain a statistically 
significant result with the available material it would be 
necessary to concentrate on one dose level, and restrict the 
objective of the experiment to proving the existence of an 
effect at that level. 50 ng /ml was selected as a dose which 
gave a clear effect with 19- hydroxy PG E1, and the majority 
of results quoted are at this level. 
Results obtained with PG E1 (table 3.2a) were equivocal, 
in line with the finding of Embrey and Morrison (1968) that the 
response of lower segment human myometrial strips to PG E 
in vitro is erratic. In six out of sixteen cases, at a dose 
level of 50 ng /ml PG E1 caused stimulation of the muscle; in 
two cases it produced an inhibition of greater than 50 %, and 
in the remaining cases a more moderate degree of inhibition. 
In general, the response to 19- hydroxy PG E1 was 
one of inhibition, although in a few cases stimulation was 
observed. At a dose level of 50 ng /ml, complete inhibition 
of motility of the muscle was observed in three out of eleven 
cases, contractions resuming when the prostaglandin was washed 
(173) 
Table 3.2 
The effects of Prostaglandins on the contractile activity of pregnant 
human myometrial strips. 
a. Prostaglandin El 

































Table 3.2 cont. 
b. 19- hydroxy El 
Dose (ng /ml) 20 25 32 50 100 
Effect 9 18 -9 30 36 
(70 inhibition) 13 38 57 















out. In two cases the muscle responded with an increase in 
activity, the remaining six being cases of intermediate in- 
hibition (table 3.2b). 
It was noted that an initially quiescent strip could 
often be caused to start contracting by injecting prostaglandin 
El, although contractions could not be sustained by further 
injections, the strip requiring a background of oxytocin 
for sustained activity. In two cases where strips were started 
by PG E1 alone, the effect of PG E1 was reversed, and the 
activity of the muscle abolished by injection of an equal 
quantity of 19- hydroxy PG El (fig. 3.1). 
Statistical analysis was performed using the paired 
t test. The activity of the muscle during exposure to prosta- 
glandin was compared to the mean of its activity before injection 
and its activity after washing the prostaglandin out, the 
null hypothesis being that the activity of the muscle in the 
presence of prostaglandin was equal to that mean. Table 3.3 
gives the statistical analysis of results achieved at the 
50 ng /ml dose level. 
The paired t test shows that the activity of the 
muscle in the presence of prostaglandin El was not significantly 
different from control values (p L 0.2), while that in the 
presence of 19- hydroxy PG El was significant (p L 0.05). 
A non -parametric test was also run on the same data, as there 
was some doubt as to whether the distribution of muscle acti- 
vities was normal, and an anormal distribution might invalidate 
the t test. The Wilcoxon rank test requires no assumptions 
(176) 
Table 3.3 
Statistical analysis of the effects of prostaglandins on human pregnant 
myometrium at 50 ng /ml. 








Difference Rank Background 
no. treatment* 
D = X1- X2 
84 71 13 1 0.25 
66 48 18 2 0.25 
80 103 -23 3 0.125 
153 179 -26 4 0.125 
114 141 -27 5 0.25 
117 90 27 6 0.25 
44 80 -36 7 none 
150 103 47 8 0.5 
83 142 -59 9 none 
144 80 64 l0 0.25 
256 162 94 0.125 
429 326 103 12 
0.25 
168 55 113 13 0.25 
423 541 -118 14 0.25 
392 216 176 15 
0.25 
294 69 225 16 
0.25 
Paired t test Wilcoxon rank test 
a = 36.93 Sum of ranks corresponding 





sa = 23.1 
t = 1.6 (d.f. = 15) 
p L 0.2 
* Figures refer to the concentration of 
oxytocin present in mil/ml. 
Continued/ 
(177) 
Table 3.3 cont. 










D = X1- X2 
Background 
treatment* 
92 90 2.0 1 0.25 
182 163 19 2 0.75 
163 185 -22 3 0.25 
154 116 38 4 0.125 
111 66 45 5 E1 
59 o 59 6 E 
1 
129 198 -69 7 0.25 
524 368 156 8 0.25 
175 o 175 9 0.125 
388 166 222 10 0.25 
355 o 355 11 0.25 
Paired t test Wilcoxon rank test 








t = 2.37 (d.f. = 10) 
p l 0.05 
Sum of ranks corresponding 
to negative differences 
= 10 
p 0.05 
* Figures refer to concentration of oxytocin present in mU /ml. When 
































































































































































































































































































































































































about the frequency distribution of the population fro hic 
the samples tested are drawn, and when applied to the data 
gave identical results to those obtained with the paired 
t test. 
It is concluded therefore that 19- hydroxy prostaglandin 
E1 causes a significant inhibition of hu an lower-se rent 
pregnant uterine muscle in vitro at 50 ngjml, while the effect 
of prostaglandin E1 at the same level is erratic. 
c) Pregnant marmoset uterus. 
Of the five marmoset uteri investigated only two 
provided results, and because of the s all size of the animals 
only one strip could be taken from each uterus. Results in 
this section are extremely sparse, and no real conclusions 
can be drawn. In the case of one strip taken from an animal 
at 130 days gestation (term = 140 days) the response to PG E1 
was one of strong stimulation at 20 ng /ml (3/3 cases), while 
the response to 19- hydroxy PG E1 at dose levels of 20 - 100 
ng /ml was slight inhibition (5/6 cases) or stimulation (1/6). 
The other strip was removed from an early pregnant animal 
(40 days) and showed relatively little response to either 
prostaglandin. 
Results from the pregnant marmoset uterus are listed 
in table 3.4. 
(180) 
Table 3.4 
The effects of .rosta:landins on the motilit 
marmoset myometrial strips. 
re:nant 
a) Effect of PG E on 130 day gestation strip. 
Dose 20 ng/mi 
Effect (* inhibition) -89, -132, -85. 
b) Effect of 19- hydroxy PG E1 on 130 day gestation strip. 
Dose (ng /ml) 20 ZO 
Effect -13 28 




c) Effect of PG E1 on 40 day gestation strip. 
Dose (ng /ml) 20 5_0 
Effect -4 2 
(fib inhibition) 
100 200 400 
-9 11 19 
d) Effect of 19- hydroxy PG E1 on 40 day gestation strip. 
Dose (ng /ml) 50 100 200 400 




The effect of the classical prostaglandins on the 
non -pregnant human uterus in vitro has been shown to vary 
with the stage of the menstrual cycle of the donor of the 
tissue (Bygdeman and Eliasson, 1963; Bygdeman 1964) and 
it was originally intended that the results quoted here should 
be examined for similar effects. Unfortunately, in two cases 
this information was not available, and the results were 
therefore pooled and presented together. In the case of 
the three uteri for which we did have information, one was 
from a patient in the proliferative stage, and two were secretory. 
There were no obvious differences in response to prostaglandins 
between any of the uteri, the variation between strips from 
the same uterus being as large as the variation between uteri. 
The effect of 19- hydroxy PG E1 on the non -pregnant 
uterus is not unexpected in view of the findings of other 
workers that the 19- hydroxy PG Es were less potent than, but 
similar in action to the E prostaglandins. The measured 
EPMR PG E1 / 19- hydroxy PG E1 = 1:4 is (coincidentally ?) 
equal to the mean ratio of these compounds found in human 
semen, and if their effect on the uterus represents a physio- 
logical effect of semen, then in an average ejaculate about 
half of the effect of the 9- ketoprostaglandins is due to 
PG Es and half to 19- hydroxy PG Es. 
One point of interest concerns the measured EPMR 
for natural / synthetic 19- hydroxy PG E1 = 1:2. The synthetic 
compound used was a racemic mixture in two senses, firstly 
(182) 
about all optically active centres, and secondly and inde- 
pendently about the 19 carbon. There were therefore four 
molecular species present, only one of which was identical 
with the natural compound (fig. 3.2). 





OH OH ÓH 
OH 
COON 
OH OH OH 
Fig. 3.2 Isomers of 19- hydroxy PG El 
a) is the natural compound. 
One would expect to find an EPMR of 1:4, and the 
findings indicate that at least one of the other isomers 
is active. It seems unlikely that the enantiomeric compounds 
c) and d) are active, since they differ from the naturally 
occurring prostaglandins at the 8, 11, 12 and 15 positions. 
The implication is that the activity of isomer b) is roughly 
equal to that of isomer a), and that the uterus is indifferent 
to the configuration at C19. Spilman et al (1977) have shown 
that the methyl ester of compound b) is about half as active 
as that of compound a) in stimulating contraction of the 
pregnant rhesus monkey uterus.in vivo, results which are 
not incompatible with those reported above. 
The finding that 19- hydroxy PG El inhibits oxytocin- 
induced contractions, and reverses the stimulation induced 
by PG E1 in the pregnant uterus in vitro is interesting, 
since the effect of the 19- hydroxy compound is here quali- 
(183) 
-tatively different to that of PG E1. This finding is at 
variance with those of Spilman et al (1977), although there 
are several possible explanations for this. The semen of 
the rhesus monkey contains large amounts of 19- hyd.roxy PG E1, 
but unlike the human, rhesus monkeys do not copulate during 
pregnancy, and there may therefore be a species- difference 
in the response of the pregnant uterus. The use of the methyl 
esters of the 19- hydroxy E prostaglandins introduces complications, 
since although one would expect esterase activity in the 
blood to release the native prostaglandin, the methyl esters 
themselves may not be without activity, and this activity 
may be qualitatively different from that of the native compounds. 
Since the compounds were introduced by intravenous injection, 
the observed effects may have been due to metabolites formed 
during circulation or to stimulation of the release of 
oxytocin from the pituitary gland. Differences of effect 
of prostaglandins between in vitro and in vivo tests are not 
without precedent, since the E prostaglandins have been shown 
to inhibit the contraction of the non -pregnant human uterus 
in vitro (Sandberg et al, 1963, 1964; Bygdeman, 1964) while 
stimulating the same organ in vivo (Roth -Brandel et al, 1970; 
Coutinho and Maia, 1971; Karim et al, 1971; Martin and 
Bygdeman, 1975) and these observations have yet to be reconciled. 
The results obtained with the marmoset uterus were 
insufficient to allow any conclusions to be drawn, but in the 
case of the late pregnant uterus do not contradict those obtained 
with human material. 
(184) 
Chapter 4. 
In vitro biosynthesis of 19- hydroxy prostaglandine. 
Results - series 1. 
The weights of organs, homogenate volumes and measured 
concentrations of prostaglandins are listed in table 4.1. 
The extracts of the reproductive organ homogenates contained 
large amounts of interfering compounds, and under these conditions 
prostaglandins could not be identified with certainty below 2 1g /ml. 
Only 19- hydroxy E prostaglandins could be identified, and these 
only in the extract prepared from the seminal vesicle homogenate. 
The proportions of the two 19- hydroxy E compounds were 20% 19- 
hydroxy PG E2 and 80% 19- hydroxy PG E1, proportions similar to 
those found in the semen of the stump- tailed macaque. 
Table 4.1 
Prostaglandin content of Macaca arctoides reproductive organs. 




Seminal 32.5 150 
vesicle (1) 
Testis (1) 23.5 
Epididymis (1) 5.0 
Prostate 6.5 







PG Es 19-OH Es 












The results of the incubations performed with the seminal 
vesicle homogenate are listed in table 4.2. No prostaglandins 
were detected in the homogenates of the other organs, and 
these are therefore omitted. 
(185) 
Table 4.2 
Prostaglandin content of fresh seminal vesicle homogenate 
after incubation. 
Additions PG Es 19 -0H PG Es 
(jg /ml) (peril].) 
None L2 12.7 
Eicosa- 11,14,17 -trienoic acid 2.7 19.9 
Arachidonic acid 2.5 15.2 
Eicosa -5,8,11,14,17 -pentaenoic L2 20.3 
acid 
The addition of all three polyunsaturated fatty acids 
appeared to stimulate the synthesis of 19- hydroxy E prosta- 
glandins. The amount of E prostaglandins was small, and 
too near the detection limit of the assay for the results 
to be of significance. There was no difference in the ratio 
of 19- hydroxy PG El to 19- hydroxy PG E2 attributable to the 
substrate added. 
Experiments with frozen seminal vesicle homogenate - series 1. 
Time course of 19- hydroxy PG E synthesis. (29 days storage) 
The results of this experiment (fig. 4.1) show that 
19- hydroxy PG E levels rose on incubation from an initial 
level of 1.5 )1g /ml to 3.5 jig/ml over a period of one hour, 
remaining near this level for a further three hours and finally 
declining to near the detection limit of the assay after 8.5 
hours. 
(186) 
Experiments with frozen seminal vesicle homogenate - Results. 






Q 1 3 
Time in hours 
8.5 
Table 4.3 
The effect of added prostaglandin El on levels of 19- hydroxy 
E Prostaglandins in incubated seminal vesicle homogenate. 
Additions 19 -0R PG Es (Jig). 
none 1.3 
none 1.7 
PG El 7.9 
PG E1 7.0 
(187) 
Incubations with PG E1 (43 days storage) and with PG E2 and 
PG F days storage). 
The results of these experiments are given in tables 
4.3 and 4.4 respectively. The addition of PG E1 to the in- 
cubations produced a fivefold rise in the level of 19- hydroxy 
E prostaglandins after incubation compared with controls, 
while PG E2 produced a twofold rise, and PG Fla had no sig- 
nificant effect. Once more, there was no change in the ob- 
served ratio of 19- hydroxy PG E1 s 19- hydroxy PG E2 in either case. 
Table 4.4 
The effect of added prostaglandins E 2---2 and Fa on in vitro 
biosynthesis of 19- hydroxy E prostaglandins 
Substrate 19-OH E PGs (µg) 
None L 1 
None 1.1 
PG Fla 1.4 
PG Fla L 1 
PG E2 2.3 
PG E2 2.6 
(188) 
Results - series 2 
The measured levels of prostaglandine in the reproductive 
organs are given in table 4.5, and broadly agree with those 
measured in series 1. The higher sensitivity of the single 
ion monitoring method allowed E and 19- hydroxy E prostaglandins 
to be detected in all the tissues examined, with the exception 
of the prostate, where PG E levels were below the detection 
limit of the assay. Very high levels of 19- hydroxy E prosta- 
glandins were present only in the seminal vesicle, although 
traces were found in the other organs. It should be pointed 
out, however, that the organs were handled together and homo- 
genised using the same homogeniser, and under these conditions 
the possibility of cross -contamination cannot be ruled out. 
In particular, the minute quantities of 19- hydroxy E prosta- 
glandins detected in the testis seem likely to have arisen 
from this source. 
Incubation of the seminal vesicle homogenate with 14C 
eicosatrienoic acid or arachidonic acid yielded a pattern 
of products not significantly different to that observed 
with bovine or ovine seminal vesicle homogenates. Neither 
of these substrates, nor PG El gave rise to a significant 
incorporation of radioactivity into the 19- hydroxy prosta- 
glandin fractions (table 4.6). The highest level of in- 
corporation (3.3 %) was obtained using eicosatrienoic acid 
in the presence of testosterone, however, it cannot be concluded 
that the steroid exerted a significant effect, since 
there 
was no evidence of increased incorporation in the presence 
(189) 
of testosterone when arachidonic acid was the substrate. 
Incubations performed with the seminal vesicle homogenate 
after storage under liquid nitrogen likewise showed no evidence 
of incorporation of label into the 19- hydroxy prostaglandin 
fractions. The effects of the various cofactors added were 
similar to those reported for prostaglandin synthetase prepar- 
ations from other sources. Tryptophan stimulated production 
of PG E and PG D, while reduced glutathione strongly increased 
the yield of PG E at the expense of PG D and PG F. Cyclic 
AMP, ascorbic acid and the nicotinamide nucleotides (reduced 
or oxidised) had little effect at the levels tested, or were 
inhibitory. Cyanide, interestingly, stimulated the production 
of PG D, and to a lesser extent PG F. None of the compounds 
tested could be shown to stimulate incorporation of the label 
into the 19- hydroxy prostaglandin fractions and PG F3oc could 
not serve as a substrate for hydroxylation in this system 
(table 4.7). 
The production of 19- hydroxy PG El from endogenous 
precursors was much more rapid in this preparation than in 
that studied in series 1, and it proved necessary to dilute 
the homogenate tenfold in order to produce the time course 
shown in fig. 4.3. In the absence of indomethacin, the level 
of 19- hydroxy PG El in the diluted homogenate rose more than 
twofold over the first ten minutes of incubation and declined 
thereafter. In the presence of indomethacin (20 µMolar) 
levels did not change significantly during the first ten 
minutes, but then declined rapidly. 
(190) 
Table 4.5 
Prostaglandin content of reproductive organs- series 2. 
Organ Weight Vol. 
(g) (ml) 
Testis (1) 23.5 150 
Prostate 6.3 25 
Ampulla (1) 1.0 25 
Seminal 
vesicle 
(1) 27.2 150 
Table 4.6 
Prostaglandin content (jig /organ) 
PG El PG E El 19 -0H E2 
0.79 1.1 0.28 0.02 
L0.04 L0.08 2.0 0.13 
1.2 1.4 6.9 0.82 
90 64 1220 164 
Incubation of labelled precursors with seminal vesicle homogenate. 
Substrate Additions % radioactivity recovered as Recovery 
OH acid PGD PGE PGF 190HE 190HF 
ETA none 30.8 12.2 11.3 5.7 1.0 0.1 68% 
ETA T 36.9 16.1 12.6 6.4 3.3 0.4 50% 
ETA PG E2 31.4 7.8 8.0 4.1 0.3 0.2 49% 
Arach. none 19.5 6.2 6.7 3.9 1.2 0.6 62% 
Arach. T 31.2 7.1 6.3 3.3 0.5 0 39% 
PG E1 none 69 2.2 1.4 17% 
PG E1 T 88 1.2 0.1 43% 
The above incubations were carried out using fresh homogenate 
immediately after prepay ption. Abbreviations used in the table 
are as follows:- ETA, 4C eicosa -8,11,14- trienoic acid; T, 
testosterone. PGE was tritium labelled. Unlabelled PG E 
was 50 pg /ml and testosterone 1 mMolar. All radioactive sub- 
strates were i jzCi 
(191) 
Fig. 4.2 
Incubation of labelled precursors with seminal vesicle homogenate, 
separation of products on LH 20 Sephadex column. 
15- 
i .6 w W ,-4 
w ü = 




10 20 30 40 50 60 70 80 90 100 
Fraction number. 
Seminal vesicle homogenate (1 ml) incubated with eicosa -8, 
11,14 -trienoic acid (1 pCi) and testosterone (1 mMolar). 
The peak labelled 19-011 PG El may also contain the (hypothetical) 
19- hydroxy prostaglandin D1. 
(192) 
Table 4.7 
Incubation of labelled precursors with seminal vesicle homogenate 
after storage under liquid nitrogen. 
Substrate Additions radioactivity recovered as Recovery 
OH acid PGD. PGE PGF 190HE 190HF 
ETA none 19.0 14.2 8.3 9.4 0 0 38% 
ETA Try 16.0 20.0 13.0 7.6 0.6 0 600 
ETA GSH 24.3 3.4 26.4 4.2 0.3 0 60%. 
ETA cAMP 23.6 7.6 4.1 3.0 0 0 45% 
ETA NAD+ 19.6 5.3 5.9 6.3 0.7 o 50% 
ETA asc 17.3 11.2 6.4 6.6 0.2 0 60% 
PG 
F3 a none 
91 0.6 90% 
Arach. none 10.4 6.8 4.6 5.5 0.5 0 76% 
Arach. NADH 10.3 4.8 3.5 4.5 0.6 0 72% 
Arach. NADPH 12.8 5.7 6.9 4.0 0.9 0 95% 
Arach. KCN 13.1 11.3 6.6 5.3 0.1 0 106% 
Arach.1 Try +GSH 11.5 1.8 6.1 1.2 0.5 0.15 80% 
+NADPH 
ETA1 Try +GSH 12.8 2.7 17.1 2.2 0.9 0.2 94% 
+NADPH 
Abbreviations used are as for table 4.6, with the following 
additions- Try, tryptophan; asc, ascorbic acid. Remaining 
breviations are conventional. All substrates were 1 jiCi 
C except for PG F3 which was tritium labelled. All additions 
were 1 mMolar. 
1 The final two incubations were performed using only 
0.3 ml homogenate, remainder 1.0 ml. 
(193) 
Fig. 4.3 
Time course of 19- hydroxy PG E1 production in vitro (series 2). 
300 
s 200 . 
o 
0 10 20 30 
Minutes 
40 
(Incubation of seminal vesicle homogenate (diluted 
x 10) with reduced glutathione (1 mMolar) and trypto- 
phan (1 mMolar), total volume 2.5 ml. 
IIncubation as above plus indomethacin (20 ?Molar) 
Bars indicate standard deviation of replicate injections 
from a single sample (n = 6). (Since this standard 
deviation does not include all sources of variance 




The seminal vesicle has been shown to be the source 
of the classical prostaglandins of semen both in man (Eliasson, 
1959; Ramberg, 1976) and in the sheep (Eliasson, 1959), 
and the results reported above indicate that the seminal 
vesicle is also the source of the 19- hydroxy prostaglandine. 
Incubation of the seminal vesicle homogenates in vitro 
produced an increase in levels of 19- hydroxy PG E1, and 
this increase was inhibited by indomethacin, showing that 
the process involves biosynthesis rather than the release 
of pre- formed prostaglandin. The level of 19- hydroxy PG 
E1 present after incubation was increased by the presence 
of a number of compounds in the incubation medium, including 
eicosa- 11,14,17 -trienoic acid (which, lacking the unsaturated 
group at C8, cannot be a substrate for prostaglandin bio- 
synthesis) and PG E2. It seems probable that this effect 
was due to inhibition of the breakdown of 19- hydroxy PG E1 
formed from endogenous precursors, since neither arachidonic 
acid nor PG E1, which were both shown to raise 19- hydroxy 
PG E1 levels in the first series of incubations, could serve 
as precursors when isotopically labelled. 
Three routes are suggested for the biosynthesis of 
19- hydroxy PG E1 from esterified eicosa- 8,11,14 -trienoic 
acid which is presumed to be the original precursor (fig. 
4.4). Route A involves hydroxylation of PG E1, and a prosta- 
glandin hydroxylase capable of forming 19- hydroxy and 20- 
(195) 
hydroxy prostaglandins by this route has been shown to be 
present in guinea pig liver (Israelsson et al, 1969; Kupfer 
et al, 1978). In the seminal vesicle homogenates, however, 
no incorporation of label into 19- hydroxy PG El could be 
detected when 3H PG E1 was used as a substrate, effectively 
eliminating this pathway as a possibility. 
A microsomal oxidase capable of hydroxylating fatty 
acids at the position, as required by route B, has been 
shown to exist in rat liver (Hamberg and Bjorkem, 1971) 
but the failure of the seminal vesicle homogenate to pro- 
duce labelled 19- hydroxy PG E1 in significant quantities 
in the presence of 14C ETA indicates that this is not an 
important pathway in the seminal vesicle. 
GCMS analysis of macaque seminal vesicle homogenates 
has shown no evidence for the presence of 19- hydroxy fatty 
acids, however, there is also very little free eicosatrienoic 
or arachidonic acid, so the esterase step may be rate -limiting, 
leading to low levels of the precursors for both E and 
19- hydroxy E prostaglandins. Sih et al (1969) incubated 
19- hydroxy arachidonic acid with bovine seminal vesicle 
microsomes, and showed that 19- hydroxy PG E2 was produced 
only in very low yield; it may be however, that there are 
species differences in the specificity of the cyclo- oxygenase 
enzyme towards these hydroxylated substrates. 
In the absence of any positive evidence, it cannot 
be concluded that the remaining pathway, route C, is identi- 
fied as the biosynthetic pathway involved. The definitive 
(196) 
experiment, incubation of seminal vesicle homogenate with 
phospholipase, lipase or other esterases in the presence 
of indomethacin, followed by isolation of the released 
19- hydroxy eicosatrienoic acid, must await the supply of 
further primate seminal vesicles. 
It should be noted that a small amount of a compound 
having a retention volume on LH 20 Sephadex similar to that 
of 19- hydroxy PG E was formed from eicosatrienoic acid, 
however, the low yield compared with that of PG E suggests 
that a roundabout route was involved, possibly involving 
esterification of the acid as in route C. 
Fig. 4.4 
Possible routes for the biosynthesis of 19- hydroxy PG E1_ 
A B C 
ETA ester ETA ester ETA ester 
esterase esterase hydroxylase 
ETA ETA 19-0H ETA ester 
PG synthetase hydroxylase esterase 
PG E1 19-0H ETA 19-0H ETA 
ihydroxylase PG synthetase PG synthetase 
19 -0H PG E1 19 -0H PG E1 19 -0H PG E1 
(197) 
Cha ter D namic as ects of seminal rosta'landin 
biosynthesis in man. 
Early work by Eliasson (1959) showed that the prosta- 
glandin content of human semen (as measured by bioassay) 
was not affected when ejaculates were produced at 24 hour 
intervals, but beyond this the time course of biosynthesis 
of the seminal prostaglandins has so far received little 
attention. In most tissues, prostaglandins are not stored, 
but synthesised rapidly in response to a stimulus. In 
the case of the seminal prostaglandins, however, it is 
possible that the very large amounts produced in an ejacu- 
late may require storage. There are essentially three 
possibilities for the time course of seminal prostaglandin 
biosynthesis: the prostaglandins may be synthesised almost 
instantaneously at the point of orgasm; they may be synthe- 
sised during the period of sexual arousal preceding orgasm; 
or they may be produced continuously in the period between 
ejaculations. The experiments described in this section 
were designed to contribute to an evaluation of these three 
possibilities. 
Results of the serial ejaculate experiments are 
summarised in fig. 5.1. There was no change in the ratio 
PG El : PG L2 or 19 -0H PG El : 19 -0H PG E2 and for the sake 
of clarity results are quoted in terms of total PG E and 
total 19 -0H PG E. 
In terms of the absolute quantities produced, the 
amount of all three compounds measured fell with each suc- 
cessive ejaculation. There was, however, a parallel fall 
(198) 
Fig. 5.1 Serial ejaculate results. 













































Each cell of the diagram gives the concentration of the 
compounds identified at the top of the page (yg /ml) or 
seminal volume (ml) for three successive ejaculates taken 
at half hour intervals. A and B are duplicate control 
experiments, C gives results obtained after aspirin ingestion. 
(199) 
in seminal volume, and when this is taken into account the 
concentrations of the measured compounds can be seen to 
behave differently. The concentration of the 19- hydroxy 
E prostaglandins fell to half to two thirds of its initial 
value over the three ejaculates, while that of the E prosta- 
glandins showed no consistent trend. Cholesterol levels, 
on the other hand rose with each successive ejaculation. 
Aspirin showed no marked effect on the levels of 
prostaglandins in this experiment. Levels of E prosta- 
glandins fell in the second and third ejaculates after 
aspirin treatment, but the initial level of PG E was higher 
than in the control experiments, and the final value reached 
after aspirin treatment was very similar to that in the 
controls. The seminal volume was unusually high in the 
first ejaculate after aspirin treatment, and the absolute 
quantities of prostaglandins produced were therefore higher 
than control values. 
Results of the experiment on the effect of prior 
sexual arousal are given in fig. 5.2. It proved possible 
to stop masturbation extremely close to the point of ejacu- 
lation, and in fact, in the first two episodes a single 
drop of fluid was produced before masturbation 
ceased. Subjectively, this process produces extremely 
unpleasant symptoms, including a diffuse ache in the lower 
pelvis, enlarged and tender testes and a sensation as of 
incipient diarrhoea. All of these symptoms were immediately 
relieved by complete ejaculation. Neither the prostaglandin 
(200) 
Fig. 5.2 Effect of prior sexual arousal on seminal 
prostaglandin levels. 













Each cell of the diagram gives the prostaglandin 
concentration (jig /ml) or seminal volume (ml) for 
three ejaculates spaced at 24 hour intervals. 
Open bars (days 1 and 3) represent control ejacu- 
lates. Solid bars (day 2) represent an ejaculate 
produced after two prior episodes of masturbation 
stopping short of ejaculation. 
(201) 
levels nor the seminal volume were affected by previous 
sexual arousal, and the ejaculate produced was similar 
in all respects to the control ejaculates produced on the 
previous and following days. 
Discussion. 
It should be pointed out that the results reported 
above consist of single measurements made on a relatively 
small number of ejaculates. None of the prostaglandin 
levels reported in figs. 5.1 and 5.2 fall outside the normal 
range of levels for fertile semen as reported by Templeton 
et al (1978), and the results cannot be considered statistically 
significant. In view of the obvious experimental difficulties 
attendant upon this work, it was not possible to obtain 
sufficient samples for statistical analysis, and any con- 
clusions drawn from these results must be considered spe- 
culative. 
Chronic aspirin ingestion, sufficient to depress 
seminal prostaglandin levels, showed no effect on seminal 
volume (Collier and Flower, 1971; Horton et al, 1973), 
and therefore presumably the reduced availability of 
prostaglandins in closely spaced ejaculates is not the 
factor determining reduced seminal volume. The relatively 
constant levels of E prostaglandins observed in serial 
ejaculates indicates the presence of a regulatory mechanism 
responding to the available volume of fluid. The falling 
levels of 19- hydroxy E prostaglandins suggest that in this 
(202) 
case the demand was sufficient to outstrip the biosynthetic 
capacity of the system, and that 19- hydroxy PG Es are replaced 
more slowly than the E prostaglandins relative to their 
normal levels. 
It had been hoped that the administration of a single 
large dose of aspirin shortly before a series of ejaculates 
would allow differentiation between the various possibilities 
for the time course of seminal prostaglandin biosynthesis. 
If the prostaglandins present in each ejaculate were syn- 
thesised during the processes of sexual arousal and ejacu- 
lation, aspirin present at the time should depress prosta- 
glandin levels in all three ejaculates, whereas if prosta- 
glandin synthesis was a steady -state process taking place 
in the resting period between ejaculates, the prostaglandin 
levels in the first ejaculate should be unaffected, while 
those in the second and third ejaculates should be depressed. 
In practice, the initial levels of E prostaglandins 
present were higher than in the controls, and although 
levels fell in the subsequent ejaculates the final concen- 
tration was similar to that in the controls. Levels of 
19- hydroxy E prostaglandins in all three ejaculates after 
aspirin treatment were not notably different from control 
values. The lack of action of aspirin in this experiment 
may be due to a slow uptake into the seminal vesicles, 
since the dose employed (2.1 g) was similar to that which 
produced a significant depression of seminal prostaglandin 
levels when administered in distributed doses (2.4 g /day 
(203) 
Collier and Flower, 1971; 3.6 and 7.2 g /day, Horton et al, 
1973). 
The failure of previous sexual arousal to depress 
19- hydroxy PG E levels in a subsequent ejaculate may indicate 
that the seminal prostaglandins are not synthesised during 
sexual arousal, however, this result must be treated with 
caution, since control levels on days one and three were 
rather low compared with those measured in the serial ejacu- 
late experiments. The subjective symptoms reported by the 
subject during the course of this experiment could possibly 
be due to leakage of the synthesised prostaglandins from 
the seminal vesicles, and the results of this experiment 
must be considered inconclusive. 
(204) 
Chapter 6. 
The species distribution of the 19- hydroxy E prostaglandins. 
Table 6.1 gives the concentration of 19- hydroxy PG El 
and 19- hydroxy PG E2 found in the semen of species examined 
so far. In addition to those species listed we have examined 
a small sample (ca. 50 pl) of semen obtained from the Barbary 
ape (Macaca sylvestris) by electroejaculation. Although 
containing motile sperm, this sample contained no detectable 
prostaglandins, and it is probable that ejaculation was 
not complete in this case. Similarly, in the case of the 
electroejaculated gorilla semen listed in table 6.1 the 
seminal volume was extremely small (ca. 100 ,1), and it is 
suspected that the measured concentration of prostaglandins 
is not representative of that produced during coitus. 
We have also attempted to obtain semen samples from 
the marmoset (Callithrix jacchus) by injection of a synthetic 
prostaglandin analogue (ICI 81008, fig. 6.1) which is said 
to induce ejaculation in some species. We were unable to 
induce ejaculation in this case. :However, examination 
of the urine produced by the animal after injection of the 
drug showed the presence of 19- hydroxy F prostaglandins 
and 19- hydroxy PG Al. It is possible that in this case 
the ICI compound induced retroejaculation, and 
that the 
19- hydroxy PG El present dehydrated to 19- hydroxy 
PG Al 
during exposure to the urine. Recovery of semen 
from the 




Table 6.1 Concentrations of 19- hydroxy E prostaglandine 
in non -human semen. 
Species Source No. of 1-OH E,..1-OH E 
























M 2 390 84 
E 1 5 NI 
E 2 54 NI 
M 8 420 84 
M 1 78o 150 
AV 1 ND ND 
AV 3 ND ND 
AV 8 ND ND 
AV 2 ND ND 
AV 3 ND ND 
LM 1 ND ND 
M Masturbation 
E Electroejaculation 
AV Artificial vagina 
LM Lumbar massage 
NI Not identified (mass spectra 
unobtainable due to interfering 
compounds or low levels of PG) 
ND Not detectable (L 1 ug /ml) 








The results of the analyses of non -human semen have 
shown that the 1'9- hydroxy prostaglandins are' characteristic 
of the semen of primates, although since this work was 
performed a report has appeared describing the presence 
of 19- hydroxy F prostaglandins in the semen of a marsupial, 
Trichosurus vulpecula (Marley et al, 1977). Measurable 
levels of E and F prostaglandine were found only in human 
and in ra semen, other primates' semen containing only 
a trace of these components. No ; rrostaglandins were detected 
in the semen of non -primates other than the ram. The absence 
of prostaglandins from bull semen is in accordance with 
earlier reports (Eliasson, 1959; Voglmayr, 1973), but is 
nonetheless surprising, since bull seminal vesicles are 
a rich source of prostaglandin synthetase, and are used 
commercially as a source of this enzy e. 
(207) 
General discussion. 
The pattern of prostaglandins present in human semen, 
as revealed in chapter 1 raises several interesting qùestions. 
Assuming that the seminal prostaglandins represent part of 
a functional mechanism, what sort of mechanism requires 
such a diversity of compounds to perform its function? 
The answer which springs most readily to mind is that the 
pattern of prostaglandins which we see in human semen repre- 
sents mainly metabolites, and that the functional compounds 
are much fewer in number. Many of the compounds described 
in chapter 1 have been shown to be produced (by other tissues) 
as metabolites of the classical prostaglandine - dinor PG F2 
0(. 
as a urinary metabolite of PG F2o,in the rat (Granstrom 
et al, 1965), 8 -iso PG E2 and 8 -iso PG F20cas minor products 
of the incubation of PG E2 with guinea pig liver homogenates 
(Hamberg and Israelsson, 1970) and 19-hydroxy PG El as a 
product of the incubation of PG E1 with guinea pig liver 
microsomes in the presence of NADPH (Kupfer et al, 1978). 
The balance of evidence presented here, however, indicates 
that the compounds described are not metabolites of PG E 
or PG F, although they can all be regarded in a sense as 
metabolites of the appropriate endoperoxide precursors. 
The incubation of semen with isotopically- labelled PG El 
and PG 
F2o(.has 
shown that none of the prostaglandins described 
are formed in semen as metabolites of these compounds 
(chapter 1), and the incubation of seminal vesicle homogenates 
(208) 
with labelled PG El, PG 
F2ocand PG F3a 
indicates that these 
compounds are not metabolised to 19- hydroxy prostaglandine 
in the seminal vesicle (chapter 4). The inability of the 
seminal vesicle homogenates to synthesise significant quan- 
tities of 19- hydroxy prostaglandine from added arachidonic 
acid or eicosatrienoic acid while retaining the capacity 
to do so from endogenous precursors indicates that the 
pathway leading to the 19- hydroxy prostaglandine is completely 
separate from that leading to the classical prostaglandine. 
One possible explanation for the high levels of 19- 
hydroxy prostaglandine in primate semen concerns the solubility 
of these compounds. Although PG E and PG F are quite soluble 
in water, their immediate precursors, PG G and PG H are 
considerably less polar (Hamberg et al, 1974) and could 
be expected to show lower solubility in aqueous solvents. 
Hydroxylation of the fatty acid precursor prior to cyclisation 
would increase the polarity of the endoperoxides and render 
them more soluble. The presence of 19- hydroxy prostaglandine 
may therefore represent an adaptation permitting higher 
concentrations of the endoperoxide precursors to be present 
in the seminal vesicles. 
Another possible explanation for the presence of 19- 
hydroxy prostaglandine in primate semen is connected with 
the effects of the seminal prostaglandine on the pregnant 
uterus. In man, and in some other primate species, copulation 
serves a social as well as a reproductive function, and 
(209) 
continues to occur during pregnancy. The pregnant uterus 
is therefore exposed to frequent doses of seminal prosta- 
glandins. The results reported in chapter 3 of this thesis 
indicate that 19- hydroxy PG El antagonises the effects of 
both PG E1 and oxytocin on the human pregnant uterus in 
vitro. It is possible therefore that the 19- hydroxy E 
prostaglandins represent an evolutionary adaptation in 
primates, serving to counteract the deleterious effects 
of the seminal prostaglandins on the pregnant female. 
Neither of these explanations offer us any clues about 
the primary function of the seminal prostaglandins however. 
Why should sheep and primates require relatively huge amounts 
of these compounds in their semen when most other mammals 
manage perfectly well without? A particularly interesting 
paradox arises in the case of the bull, an animal which 
possesses large seminal vesicles which are richly endowed 
with prostaglandin synthetase. Bull seminal vesicle micro - 
somes are commercially available as a source of prostaglandin 
synthetase, and are used for the commercial production of 
prostaglandins, yet bull semen contains almost no prosta- 
glandins (Voglmayr, 1973; Kelly et al, 1976). 
One possible explanation for this is that the prosta- 
glandin synthetase of bull seminal vesicles represents 
a vestigial character whose function has been lost in the 
animal's evolutionary development. Kunze and Vogt (1971) 
have shown that incubation of bull seminal vesicles yields 
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very little prostaglandin (unlike those of the sheep) unless 
phospholipase A is added to the medium. However, acetone 
powders prepared from bull seminal vesicle were shown to 
contain more phospholipase A activity than those prepared 
from the sheep seminal vesicle, BO the lack of activity 
in the intact cell presumably represents an effect of com- 
partmentalisation. It seems possible then, that the bovine 
seminal vesicle prostaglandin synthetase system is disabled 
in vivo and that the species has lost the capacity to syn- 
thesise seminal prostaglandins even though retaining the 
appropriate enzymes. 
Homogenisation of the seminal vesicle prior to incubation 
with substrates for PG synthesis undoubtedly introduces 
artifacts. The major prostaglandin product of such incu- 
bations with the stump- tailed macaque seminal vesicle in 
the absence of added cofactors was PG D (chapter 4), a 
prostaglandin shown to be absent from human semen (chapter 1) 
and certainly not present at high levels in the semen of 
the stump -tailed macaque. Similarly, the hydroxy acids 
produced by the prostaglandin synthetase in vitro have 
not been reported to be present in semen. These effects 
may be due to changes in availability of cofactors resulting 
from the destruction of compartments during homogenisation, 
or alternatively may be due to selective passage of the 
various products of the prostaglandin synthetase system 
across the cell membrane in vivo. 
Another possible solution to the paradox of the bull 
(211) 
lies in the observations that mammalian spermatozoa can 
bind prostaglandins (Bartoszewicz et al, 1975; Mercado 
et al, 1978) and that bull semen contains an extremely 
high concentration of spermatozoa (Mann, 1964). It is 
possible, therefore, that the function of the seminal prosta- 
glandins is connected with their ability to bind to spermato- 
zoa, and that the free prostaglandins which we can detect 
in semen simply represent excess production. Early obser- 
vations by Sturde (1968) showed significantly higher prosta- 
glandin activity in the semen of azoospermic men. Recent 
measurements of E and 19- hydroxy E prostaglandins (Kelly et al, 
1979) have shown that the converse is also true, that men with 
very high sperm- counts (more than 3x108 /m1) have significantly 
lower seminal prostaglandin levels. Seminal prostaglandins 
have also been shown to rise after vasectomy (Brummer, 
1973). 
The complex pattern of prostaglandins observed in 
semen is somewhat simplified when we consider the endoperoxide 
precursors. Prostaglandins D, E and F have all been shown 
to arise from the same pool of endoperoxide (Wlodawer and 
Samuelsson, 1973). Work reported here (chapter 4) indicates 
that the 19- hydroxy prostaglandins are probably synthesised 
via a different pathway. It is not known at present whether 
the 8- isoprostaglandins arise from the same endoperoxide 
precursors as their parent compounds or from 8 -iso 
PG G 
and 8 -iso PG H. Nonetheless, if binding of the prostaglandins 
to sperm takes place before the endoperoxide precursors 
(212) 
decay to PG E and PG F the picture of prostaglandin production 
in the seminal vesicle is considerably simplified. In 
addition, relatively minor non -functional byproducts of 
the prostaglandin synthetase may not be bound, and their 
levels in semen would therefore be selectively increased. 
Such a subtractive process would also go a long way towards 
explaining the enormous variation in prostaglandin levels 
found in the semen of fertile men (Templeton et al, 1978; 
Perry and Desiderio, 1977). 
It is unfortunate that relatively little progress has 
been made in the elucidation of the biosynthetic pathway 
leading to the 19- hydroxy E prostaglandins, since a knowlege 
of this mechanism offers the possibility of a practical 
application of this work. The biosynthesis of 19- hydroxy 
prostaglandins appears to be confined to the seminal vesicle, 
and if these compounds are shown to be functional the bio- 
chemistry of the seminal vesicle therefore offers a point 
of pharmacological attack on the reproductive system. The 
prostaglandin synthetase system of bull seminal vesicles 
has been shown to utilise 19- hydroxy arachidonic acid only 
poorly (Sih et al, 1969), and this may be true for the 
prostaglandin synthetase of other organs which do not normally 
synthesise 19- hydroxy prostaglandins. It may therefore 
be 
possible to design a specific inhibitor for the 19- hydroxy 
prostaglandin synthetase of the primate seminal vesicle. 
Such an inhibitor would be a useful tool for the investigation 
of the function of the 19- hydroxy prostaglandins, 
and, should 
(213) 
the 19- hydroxy prostaglandine prove to be functional, it 
is just conceivable that it could function as a contraceptive. 
A further possible practical application arises from 
the work presented in chapter 3. The inhibition of activity 
of pregnant human myometrium by 19- hydroxy PG E1 suggests 
that this compound could be used in the treatment of premature 
labour. Results reported on the rhesus monkey in vivo 
(Spillman et al, 1977; M.J. Novy, unpublished) indicate 
that here the action is stimulatory, although this may be 
due to a species difference. Nevertheless, the lack of 
activity of 19- hydroxy PG E1 on smooth muscle other than 
the human uterus, and the fact that the human female is 
frequently exposed as a result of intercourse to moderately 
large doses of this compound without ill effect implies 
that a low incidence of adverse side effects may be expected. 
(214) 
List of abbreviations and symbols. 
a.m.u. Atomic mass units (Daltons). 
asc. Ascorbic acid. 
ATP Adenosine 5' triphosphate. 
(BB) n -butyl boronate derivative. 
ca Circa. 
cAMP Cyclic adenosine 3'5' monophosphate. 
cGMP Cyclic guanosine 3'5' monophosphate. 
CPM Counts per minute. 
DPM Disintegrations per minute. 
(DMS) Dimethyl silyl derivative. 
(EE) Ethyl ester derivative. 
(EO) Ethyl oxime derivative. 
EPA Eicosa- 5,8,11,14,17 -pentaenoic acid 
EPMR Equipotent molar ratio. 
ETA Eicosa -8,11,14 -trienoic acid. 
GCMS Combined gas- liquid chromatography -mass spectrometry. 
GLC Gas -liquid chromatography. 
GSH Glutathione, 6-glutamyl cysteinyl glycine. 
HHT 12- hydroxy heptadeca- 5,8(cis),10(trans)- trienoic acid. 
HSF -PG A crude extract of semen containing PGs. 
IR Infra red spectrometry. 
(MB) Methyl boronate derivative. 
(ME) Methyl ester derivative. 
m/e Mass /charge ratio of ions. Since only singly charged 
ions are discussed m/e - mass in a.m.u. 
MID Multiple ion detector. 
(MO) Methyl oxime derivative. 
NAD+ ft- Nicotinamide- adenine dinucleotide (oxidised form). 
NADH ,e- Nicotinamide adenine dinucleotide (reduced form). 
NADP+ 0- Nicotinamide adenine dinucleotide phosphate 
(oxidised form). 




NMR Nuclear magnetic resonance spectrometry. 
(0) Oxime derivative. 
PG Prostaglandin (systematic names of all prostaglandins 
are given in Table 1.1, P. 125). 
T Testosterone (Androst -4 -ene 17 -o1,3 -one). 
(tBB) t -butyl boronate derivative. 
(tBDMS) t -butyl dimethyl silyl derivative. 
TLC Thin layer chromatography. 
(TMS) Trimethyl silyl derivative. 
Try Tryptophan (Indole- 3- (2- amino)acetic acid). 
When used in connection with PG F compounds refers 
to the steric configuration of the hydroxyl at C9. 
o- Standard deviation. 
Refers to the penultimate numbered carbon atom of 
a compound, ie C in the 20- carbon PGs, C in 
the dinor PGs. 
(216) 
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Appendix - computer programs. 
Computer programs used in this work were written in 
the high level interpretive language 'Focal' (Digital equipment 
Co.) for use on the PDP 81 computer. Since only 4K of core 
was available the programs contain no comments in order 
to conserve space. A pragmatic attitude has been adopted 
in the writing of these programs; no claim is made that 
they represent the most economical or the most elegant 
solutions to the problems posed, it was sufficient that 
they work and give accurate results. 
Programs as listed on the teletype cannot be bound into 
a thesis since the margins are too narrow. The programs 
listed here were therefore re -typed on a typewriter. 
Experience has shown that it is extremely difficult to 
transcribe programs in this way without error, and errors 
can only be detected by running and debugging the tran- 
scribed program. The program listings have been carefully 
checked against the originals, but may still contain some 
transcription errors, and in this respect I must crave the 
reader's indulgence. 
GLC integrator program. 
"Focal" is loaded together with the FADC patch (bin) 
and started (SA =0200). Program tape is inserted in the 
high speed reader and read in by typing *(CR). Type 'GO' 
to start the initial dialogue;- 
(Al) 
GLC integrator program. 
C-FOCAL,1969 
01.0 A "SLOPE SENSITIVITY" S;S S=1/S 
01.12 A "NO. OF SAMPLES" NS 
01.13 A "MAX +VE BASELINE SLOPE" G 
01.15 S T=O;F K=1,6;D 2. 
01.20 I (S-D)1.30,1.40,1.40 
01.30 S C=1;S-BL=B;S TS(C)=T;T "I";S I=0 
01.31 S I=I+R(6);D 2. 
01.32 I (D+s)1.50,1.50,1.31 
01.40 S Z=Z+R(6);D 2.;G 1.270 
01.50 S T( C)=T; T %5.0 T*NS00 
01.55 D 1.31 
01.60 I (D+s/2)1.55,1.65,1.65 
01.65 I (((B-BL)*100/(T-TS(1)))-G)1.70,1.75,175 
01.70 S TE(C)=T;S V=CS I(C)=I;G 4.10 
01.75 S TE(C)=T;S I(C=I;S C=C+1;S TS(C)=T;T :,"S"P 2.;S I=O;G 1.32 
02.05 S A=0;F N=1 NS;S A=A+FADC 
02.06 I (A-8.8*NS2.10,2.07,2.07 
02,07 T "+" 
02.10 F N=1 6;S R(N)=R(N+1) 
02.15 S R(6=A 
02.17 S D=0 
02.20 F N=2,6;S D=D+R(N)-R(N-1) 
02.25 S T=T+1 
02.30 S B=R(5) 
04.10 T ;;S BD=(B-BL)/(TE(V)-TS(1)) 
04.15 F C=1,V;D 5. 
04.20 G 1.20 
05.05 S P=P+1;I (P-39)510,506,506 
05.06 D 9.;G 1.15 
05.10 S BS=BL+BD*(TS(C)-TS(1)) 
05.15 S BE=BL+BD*(TE(C)-TS(1)) 
05.20 S PT(P)=T(C)*NS/100 
05.30 S PV(P)=I(C)-((BS+BE)/2)*(TE(C)-TS(C)-1) 
09.10 F N=1,P;T %5.0 PT(N);T %.6.2 PV(N),! 
(A2) 
Slope sensitivity. This is an arbitrary number determining 
the threshold slope at which the computer detects a peak. 
Values between 10 and 100 were used in this work. 
No. of samples. The program samples the output of the A/D 
converted a predetermined number of times and the sum of 
these samples constitutes one data point. Ten samples 
per point were invariably used in this work. 
Max. +ve baseline slope. At the end of the integration 
process for each peak the program checks to see if the base- 
line has fallen to near its original value. If not, it 
starts to integrate a new peak unresolved from the first. 
In order to cope with the rising baselines produced by 
temperature programming, the maximum possible rise in the 
baseline since the start of integration is calculated using 
this parameter. The figure entered is an arbitrary number 
determined by practice, and depends on the amount of column 
bleed and the rate of the temperature program. Values 
used here were 0.1 - 0.2. 
After entering "max +ve baseline slope" the carriage 
return is not depressed until after the injection is made 
and the solvent peak passed. The program then begins to 
collect data points (para. 02.). If the output from the 
A/D converter approaches the maximum output of the total 
ion current monitor amplifier the program types a series 
of ' +' signs to indicate overloading (lines 02.06, 02.07). 
(A3) 
A stack consisting of the last six data points is held in 
memory, and this data is differentiated to give the slope 
(line 02.20). 
The slope is compared with the reciprocal of "slope 
sensitivity" parameter (01.20) and if it exceeds it integra- 
tion of the peak begins (01.30). The program types 'I' to 
indicate this. Integration continues until the slope goes 
negative by an amount equal to or greater than the reciprocal 
of slope sensitivity (01.32). Having thus detected the 
top of the peak, the program types the retention time (in 
arbitrary units)(01.50), and continues to integrate the 
peak until the (negative) slope falls to half the reciprocal 
slope sensitivity (01.60). The reciprocal slope sensitivity 
is here halved to allow for asymmetry of the GLC peak. 
The value of the baseline is then compared with a 
value computed from its initial value at the beginning of 
integration and the "max +ve baseline slope" parameter 
(01.65). If the baseline has returned to permissible values 
the integrated value of the peak(s) is computed in para. 
04. and 05. and the program returns to tracking baseline, 
issuing a carriage return to indicate this. If the baseline 
is high, the program types an TS' to indicate a shoulder 
or unresolved peak and continues to integrate (01.75). 
Unresolved peaks are quantitated by dropping perpendiculars 
from the valleys to the computed value of the baseline at 
that point and integrating the areas so defined. 
The run is terminated (CTRL /C) after all peaks have 
(4) 
passed and the program is restarted at line 09.10 to type 
out a table of retention times and integrated values for the 
peaks collected. 
Validation. 
Results obtained using the integrator program were 
compared with those obtained on the same samples by photo- 
copying the chart record, cutting out the peaks and weighing 
them. Samples run included semen (MO /ME /TMS)(6 replicates 
from pooled semen), standard 19- hydroxy PG El (MO /ME /TMS) 
5.2 - 52 )4g /injection and extracts of stump- tailed macaque 
seminal vesicle homogenate (MO /ME /TMS)(3 replicates). 
In all cases, for total PG E, total 19- hydroxy PG E 
and cholesterol, the ratio of internal standard /sample was 
within 7% for the two methods. In addition, the integrator 
program gave slightly smaller standard deviations for 
replicate samples, and all results quoted here were there- 
fore measured using it. 
(A5) 
GLC retention indices program. 
The program is loaded and started in tha same way as 
the GLC integrator. The initial dialogue in this case 
requires only one parameter, slope sensitivity. The pro- 
gram is started before injection of the sample, and commences 
to measure time on detecting the rise of the solvent peak 
(01.20). Data points are collected in a similar manner to 
the previous program. Detection of the top of the peaks 
(01.26) takes place when the differentiated signal is equal 
to zero rather than minus the reciprocal of the slope sens- 
itivity as in the GLC integrator. This gives a more accurate 
measure of retention time but is more prone to noise inter- 
ference on very small peaks. 
After the sample and standard peaks have passed the 
program is stopped (CTRL /C) and re- started at line 03.01. 
The program requests "identify standards" and the operator 
enters the equivalent carbon values for any four peaks, 
identifying them by the reference numbers printed out during 
data collection. The computer then constructs the regression 
line for loge CV vs. retention time (lines 04.10 -04.46) 
and using this interpolates and prints out the measured 
equivalent carbon values for all the peaks detected, in- 
cluding the reference standards. Equivalent carbon values 
may be measured against any homologous series of compounds. 
In the present work the series of n- paraffins were used. 
Validation. 
The program is essentially self -validating, since the 
(A6) 
GLC Retention indices program. 
C-FOCAL,1969 
01.05 E 
01.10 A "SLOPE SENSITIVITY" S;S S=1/S 
01.20 D 2.;I (S-D)1.25,1.30,1.30 
01.25 S T=0 
01.26 D 2.;I (D)1.28,1.28,1.27 
01.27 G 1.26 
01.28 S RT(X)=T;T 02.0 X,:;S X=X+1;G 1.35 
01.30 G 1.20 
01.35 D 2.;I (S-D)1.26,1.40,1.40 
01.40 G 1.35 
02.05 S A=O;F N=1,10;S A=A+FADC() 
02.10 F N=1,6;S M(N)=M(N+1) 
02.15 S M(6)=A;S D=0;F N=2,6;S+D=D+M(N)-M(N-1) 
02.20 S T=T+1 
03.0í S Z=x 
03.02 T "IDENTIFY STANDARDS",: 
03.05 F N=1,4;A "PK NO." PK(N);A "CARBON NO." C(N),! 
04.10 S M(1)=(FLOG(RT(PK(4)))-FLOG(RT(PK(3))) 
04.15 S M(2=(FLOG(RT(PK(4)))-FLOG(RT(PK(2))) 
04.20 S M(3 =(FLOG(RT(PK(4)))-FLOG(RT(PK(1))) 
04.25 S M(4)=(FLOGRT(PK(3)))-FLOG(RT(PK(2))) 
S M 5 -(FLOG RT PK 3)) -FLOG(RT PK 1) ) 
04.35 S M6=(FLOG(RTPK2))-FLOG(RTPK1)3) 
04.37 S Mx=O;F N=1,6;s MX=MX+M(N) 







IX=O;F N=1,4;S IX=IX+I(N) 
Ix=IX/4 
X=1,(Z-1);T 02.0 X;T 08.04 (FLOG(RT(X))-IX)/MX,: 
(A7) 
re- calculation of the equivalent carbon value of the reference 
standards provides a built -in check on the accuracy of the 
regression line. The properties of the system were investigated 
by running paraffin wax, which contains all the n- paraffins 
from C14 - C40. Identification of any four peaks allowed 
the measurement of peaks falling between these four to 
better than 0.1 CV accuracy. Accuracy falls off somewhat 
outside the four reference compounds, and so all measurements 
quoted in chapter 2 were made using paraffin reference 
compounds selected to straddle the sample peak. 
(A8) 
Disintegrations -per- minute calculator program. 
This program accepts paper tape punched by the Packard 
liquid scintillation spectrometer containing counts -per- 
minute data for 4C and tritium and the external standard- 
isation ratio. Using standards of known counting efficiency 
it constructs the curve of efficiency vs. standardisation 
ratio for each isotope and interpolates the measured standard- 
isation ratio to obtain the efficiency for each sample. It 
then corrects the measured counts for efficiency and prints 
out the result as DPM for the two isotopes. A running total 
of counts is also kept to enable total recoveries to be 
calculated. 
(A9) 
DPM calculator program. 
C-FOCAL,1969 
01.10 A "CALIBRATE? Y/N" Q; I (Q-0Y)1.20,8.10,1.20 
01.20 I (Q-0)1.10,1.30,1.10 
01.30 * T "TUBE NO. 3H 14C" 
01.31 A RX;I (RX-1)1.32,1.33,1.33 . 
01.32 I (Rx-0.1)1.33,1.33,1.35 
01.33 T " ",:;G 1.31 
01.35 D 2. 
01.37 A Z; T%3. gS Z; F N=1,4; A Z 
01.40 A CT;T %8.04 CT*100/ETX 
01.42 S TT=TT+CT*100/ETX 
01.43 A " "Z 
¢1.45 A CC; T CC*100/ECX,: 
01.46 S TC=TC+CC*100/ECX 
01.47 F N=1,2;A Z 
01.50 G 1.31 
02.10 S N=1 
02.15 I (RT(N)-RX)2.20,2.20,2.30 
02.20 S N=N+1;G 2.15 
02.30 S ETX=((ET(N)-ET(N-1))*(RX-RT(N-1))/(RT(N)-RT(N-1)))+ET(N-1) 
02.40 D 2.10 
02.45 I (RC(N)-Rx)2.5¢,2.50,2.55 
02.50 S N=N+1;G 2.45 
¢2.55 S ECXa((EC(N)-EC(N-1))*(RX-RC(N-1))/(RC(N)-RC(N-1)))+EC(N-1) 
02.60 R 
08.10 T :;S TT-0;S TC=0 
08.19 * 
08.20 F N=1,8;A RT(N);A ET(N) 
08.35 F N=1,8;A RC(N);A EC(N) 
08.36 S RT(9)=1;S RC(9)=1;S ET(9)=ET(8);S EC(9)=EC(8) 
08.39 * 
08.40 A "READY ?" Z;T :,::;G 1.30 
09.10 T "TOTAL COUNTS",: 
09.15 T "3H" TT,: 
09.20 T "14C" TC,: 
(A10) 
